gse,gsm,gpl,data_row_count,class,subclass,diagnosis,time,living_donor,transplant,donor_gender,donor_age,recipient_gender,recipient_age,race,treatment,title,source_name_ch1,characteristics_ch1,treatment_protocol_ch1,source_name_ch2,characteristics_ch2,description,molecule_ch1,organism_ch1
GSE10419,GSM263590,GPL887,22153,NR,STA,Normal,1h,0,1,,22,0,39,,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 1 donor,1 hour biopsy sample of transplanted kidney DCD 1 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263591,GPL887,22153,NR,STA,Normal,1h,0,1,,63,1,37,asian,"Basiliximab, CsA, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 2 donor,1 hour biopsy sample of transplanted kidney DCD 2 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263592,GPL887,22153,NR,STA,Normal,1h,0,1,,58,1,56,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 3 donor,1 hour biopsy sample of transplanted kidney DCD 3 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263593,GPL887,22153,NR,STA,Normal,1h,0,1,,52,1,60,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 4 donor,1 hour biopsy sample of transplanted kidney DCD 4 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263594,GPL887,22153,NR,STA,Normal,1h,0,1,,68,1,32,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 5 donor,1 hour biopsy sample of transplanted kidney DCD 5 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263595,GPL887,22153,NR,STA,Normal,1h,0,1,,15,1,36,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 6 donor,1 hour biopsy sample of transplanted kidney DCD 6 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263596,GPL887,22153,NR,STA,Normal,1h,0,1,,52,1,50,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 7 donor,1 hour biopsy sample of transplanted kidney DCD 7 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263597,GPL887,22153,NR,STA,Normal,1h,0,1,,61,1,59,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 8 donor,1 hour biopsy sample of transplanted kidney DCD 8 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263598,GPL887,22153,NR,STA,Normal,1h,0,1,,75,1,47,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 9 donor,1 hour biopsy sample of transplanted kidney DCD 9 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263599,GPL887,22153,NR,STA,Normal,1h,0,1,,64,0,45,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 10 donor,1 hour biopsy sample of transplanted kidney DCD 10 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263600,GPL887,22153,NR,STA,Normal,1h,0,1,,50,1,63,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 11 donor,1 hour biopsy sample of transplanted kidney DCD 11 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263601,GPL887,22153,NR,STA,Normal,1h,0,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 12 donor,1 hour biopsy sample of transplanted kidney DCD 12 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263602,GPL887,22153,NR,STA,Normal,1h,0,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 13 donor,1 hour biopsy sample of transplanted kidney DCD 13 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263603,GPL887,22153,NR,STA,Normal,1h,0,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from DCD 14 donor,1 hour biopsy sample of transplanted kidney DCD 14 with Cy5,kidney sample from DCD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263618,GPL887,22153,Control,Normal,Control,,,0,,,,,asian,"Basiliximab, FK, MMF, steroid",human control for DCD study,"commerical normal kidney, control with Cy5",normal kidney sample commercially,,"commerical normal kidney, control with Cy3",normal kidney sample commercially,human control for DCD study,total RNA,Homo sapiens
GSE10419,GSM263619,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 1 donor,1 hour biopsy sample of transplanted kidney LD 1 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263620,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 2 donor,1 hour biopsy sample of transplanted kidney LD 2 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263621,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 3 donor,1 hour biopsy sample of transplanted kidney LD 3 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263622,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 4 donor,1 hour biopsy sample of transplanted kidney LD 4 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263623,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 5 donor,1 hour biopsy sample of transplanted kidney LD 5 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263624,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 6 donor,1 hour biopsy sample of transplanted kidney LD 6 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263625,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 7 donor,1 hour biopsy sample of transplanted kidney LD 7 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263626,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 8 donor,1 hour biopsy sample of transplanted kidney LD 8 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263627,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 9 donor,1 hour biopsy sample of transplanted kidney LD 9 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263628,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 10 donor,1 hour biopsy sample of transplanted kidney LD 10 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263629,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 11 donor,1 hour biopsy sample of transplanted kidney LD 11 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263630,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 12 donor,1 hour biopsy sample of transplanted kidney LD 12 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263631,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 13 donor,1 hour biopsy sample of transplanted kidney LD 13 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263632,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 14 donor,1 hour biopsy sample of transplanted kidney LD 14 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE10419,GSM263633,GPL887,22153,NR,STA,Normal,1h,1,1,,,,,asian,"Basiliximab, FK, MMF, steroid",1 hour biopsy sample of transplanted kidney from LD 15 donor,1 hour biopsy sample of transplanted kidney LD 15 with Cy5,kidney sample from LD donor (1 hr after reperfusion),,normal control with Cy3,normal kidney sample commercially,Kidney one hour biopsy from DCD donor or from living donor,total RNA,Homo sapiens
GSE11166,GSM281084,GPL570,54675,Normal,Normal,Normal,0,1,1,0,39.9,1,14.7,,,KT0412_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, training set",,,,KT0412_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281085,GPL570,54675,STA,STA,NR,3,1,1,,,,,,,KT1041_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT1041_3_L_test3,total RNA,Homo sapiens
GSE11166,GSM281259,GPL570,54675,STA,Normal,Normal,0,1,1,0,57.7,1,21.5,,,KT0624_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, trainingset",,,,KT0624_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281276,GPL570,54675,STA,Normal,Normal,0,1,1,1,21.9,1,1.8,,,KT0613_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, training set",,,,KT0613_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281277,GPL570,54675,STA,Normal,Normal,0,1,1,0,30.5,1,9.2,,,KT0636_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, training set",,,,KT0636_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281345,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,,KT0422_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0422_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281346,GPL570,54675,STA,Normal,Normal,0,1,1,0,52.5,1,8.5,,,KT0650_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, training set",,,,KT0650_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281347,GPL570,54675,STA,Normal,Normal,0,1,1,,,,,,,KT0690_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, training set",,,,KT0690_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281351,GPL570,54675,STA,Normal,Normal,0,0,1,0,26,1,17.6,,,KT0736_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, training set",,,,KT0736_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281352,GPL570,54675,STA,Normal,Normal,0,1,1,0,33.3,1,1.1,,,KT0730_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, trainingset",,,,KT0730_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281354,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,Steroid-free,KT0760_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set 3","24 months, living donor, test set 3",,,,KT0760_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281356,GPL570,54675,STA,Normal,Normal,0,0,1,0,26,1,17.6,Black/African American,Steroid-free,KT0776_0_D_training,"kidney allograft biopsy, baseline, deceased donor, training set","baseline, deceased donor, training set",,,,KT0776_0_D_training,total RNA,Homo sapiens
GSE11166,GSM281357,GPL570,54675,STA,Normal,Normal,0,1,1,0,21.5,0,18.6,,,KT0755_0_L_training,"kidney allograft biopsy, baseline, living donor, training set","baseline, living donor, training set",,,,KT0755_0_L_training,total RNA,Homo sapiens
GSE11166,GSM281359,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,,KT0703_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0703_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281398,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,,KT1007_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT1007_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281399,GPL570,54675,STA,Normal,Normal,0,0,1,0,20,1,17.3,,,KT0781_0_D_training,"kidney allograft biopsy, baseline, deceased donor, training set","baseline, deceased donor, training set",,,,KT0781_0_D_training,total RNA,Homo sapiens
GSE11166,GSM281400,GPL570,54675,STA,Normal,Normal,0,0,1,0,20,1,17.3,Other,Steroid-based,KT0796_0_D_training,"kidney allograft biopsy, baseline, deceased donor, training set","baseline, deceased donor, training set",,,,KT0796_0_D_training,total RNA,Homo sapiens
GSE11166,GSM281401,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,Steroid-free,KT0727_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0727_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281403,GPL570,54675,STA,Normal,Normal,0,0,1,1,25,1,18,,,KT0812_0_D_training,"kidney allograft biopsy, baseline, deceased donor, training","baseline, deceased donor, training",,,,KT0812_0_D_training,total RNA,Homo sapiens
GSE11166,GSM281404,GPL570,54675,AR,BL,"STA, IFTA",24,0,1,,,,,,steroid-free immunosuppressive protocol,KT0607_24_D_test3,"kidney allograft biopsy, 24 months, deceased donor, test set3","24 months, deceased donor, test set3",,,,KT0607_24_D_test3,total RNA,Homo sapiens
GSE11166,GSM281406,GPL570,54675,STA,Normal,Normal,0,0,1,,,,,,,KT0817_0_D_training,"kidney allograft biopsy, baseline, deceased donor, training set","baseline, deceased donor, training set",,,,KT0817_0_D_training,total RNA,Homo sapiens
GSE11166,GSM281407,GPL570,54675,STA,Normal,Normal,0,0,1,,,,,,,KT0986_0_D_training,"kidney allograft biopsy, baseline, deceased donor, training set","baseline, deceased donor, training set",,,,KT0986_0_D_training,total RNA,Homo sapiens
GSE11166,GSM281408,GPL570,54675,STA,Normal,Normal,0,0,1,1,36,1,14.3,,,KT0922_0_D_training,"kidney allograft biopsy, baseline, deceased donor, training set","baseline, deceased donor, training set",,,,KT0922_0_D_training,total RNA,Homo sapiens
GSE11166,GSM281409,GPL570,54675,STA,STA,NR,24,1,1,,,,,,,KT0600_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0600_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281412,GPL570,54675,STA,STA,NR,24,1,1,,,,,,,KT0597_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0597_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281414,GPL570,54675,STA,Normal,Normal,0,1,1,1,36,1,14.3,,,KT0801_0_L_test1,"kidney allograft biopsy, baseline, living donor, test set1","baseline, living donor, testset1",,,,KT0801_0_L_test1,total RNA,Homo sapiens
GSE11166,GSM281415,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,Steroid-free,KT0516_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0516_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281416,GPL570,54675,STA,Normal,Normal,0,1,1,0,25,0,17.3,,,KT0816_0_L_test1,"kidney allograft biopsy, baseline, living donor, test set1","baseline, living donor, testset1",,,,KT0816_0_L_test1,total RNA,Homo sapiens
GSE11166,GSM281417,GPL570,54675,STA,Normal,Normal,0,0,1,0,14.2,0,18.2,,,KT0575_0_D_test1,"kidney allograft biopsy, baseline, deceased donor, test set1","baseline, deceased donor, testset1",,,,KT0575_0_D_test1,total RNA,Homo sapiens
GSE11166,GSM281418,GPL570,54675,STA,STA,STA,24,1,1,,,,,,,KT0387_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0387_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281419,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,Steroid-free,KT0352_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT0352_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281420,GPL570,54675,STA,Normal,Normal,0,0,1,,,,,,,KT0799_0_D_test1,"kidney allograft biopsy, baseline, deceased donor, test set1","baseline, deceased donor, testset1",,,,KT0799_0_D_test1,total RNA,Homo sapiens
GSE11166,GSM281423,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,,KT1125_24_L_test3,"kidney allograft biopsy, 24 months, living donor, test set3","24 months, living donor, test set3",,,,KT1125_24_L_test3,total RNA,Homo sapiens
GSE11166,GSM281424,GPL570,54675,STA,Normal,Normal,0,0,1,0,31,0,5,,,KT0833_0_D_test1,"kidney allograft biopsy, baseline, deceased donor, test set1","baseline, deceased donor, testset1",,,,KT0833_0_D_test1,total RNA,Homo sapiens
GSE11166,GSM281425,GPL570,54675,CAN,CAN,IFTA,12m,1,1,1,40.8,1,15,,steroid-free immunosuppressive protocol,KT1046_12_L_test2_test3,"kidney allograft biopsy, 12 months, living donor, test set2 and test set3","12 months, living donor, test set2 and test set3",,,,KT1046_12_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281426,GPL570,54675,STA,STA,NR,3,1,1,1,21.9,1,1.8,,steroid-free immunosuppressive protocol,KT0652_3_L_test2_test3,"kidney allograft biopsy, 3 months, living donor, test set2 and test set3","3 months, living donor, test set2 and test set3",,,,KT0652_3_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281427,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,,KT0331_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0331_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281428,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,,KT0596_12_L_test2_test3,"kidney allograft biopsy, 12 months, living donor, test set2 and test set3","12 months, living donor, test set2 and test set3",,,,KT0596_12_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281429,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,,KT0664_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0664_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281430,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,,KT0581_24_L_test2_test3,"kidney allograft biopsy, 24 months, living donor, test set2 and test set3","24 months, living donor, test set2 and test set3",,,,KT0581_24_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281431,GPL570,54675,CAN,CAN,"STA, IFTA",3m,1,1,1,33.8,1,2,,steroid-free immunosuppressive protocol,KT0567_3_L_test2_test3,"kidney allograft biopsy, 3 months, living donor, test set2 and test set3","3 months, living donor,test set2 and test set3",,,,KT0567_3_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281432,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,,KT0296_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0296_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281433,GPL570,54675,CAN,CAN,IFTA,24,1,1,,,,,,,KT0563_24_L_test2_test3,"kidney allograft biopsy, 24 months, living donor, test set2 and test set3","24 months, living donor, test set2 and test set3",,,,KT0563_24_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281434,GPL570,54675,CAN,CAN,IFTA,6,1,1,1,33.1,1,9.8,,steroid-free immunosuppressive protocol,KT0525_6_L_test2_test3,"kidney allograft biopsy, 6 months, living donor, test set2 and test set3","6 months, living donor, test set2 and test set3",,,,KT0525_6_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281435,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,Steroid-free,KT0452_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0452_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281436,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,,KT0474_12_L_test2,"kidney allograft biopsy, 12 months, living donor, test set2","12 months, living donor, test set2",,,,KT0474_12_L_test2,total RNA,Homo sapiens
GSE11166,GSM281437,GPL570,54675,STA,STA,NR,3,1,1,0,21.3,0,11.4,,steroid-free immunosuppressive protocol,KT0367_3_L_test2_test3,"kidney allograft biopsy, 3 months, living donor, test set2 and test set 3","3 months, living donor, test set2 and test set 3",,,,KT0367_3_L_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281438,GPL570,54675,CAN,CAN,IFTA,12,0,1,0,31,0,5,,steroid-free immunosuppressive protocol,KT1131_12_D_test2_test3,"kidney allograft biopsy, 12 months, deceased donor, test set2 and test set3","12 months, deceased donor, test set2 and test set3",,,,KT1131_12_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281439,GPL570,54675,STA,STA,STA,12,1,1,,,,,,,KT0614_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0614_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281440,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,,KT0646_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0646_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281441,GPL570,54675,STA,STA,STA,12,1,1,,,,,,,KT0955_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0955_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281442,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,,KT1111_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT1111_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281632,GPL570,54675,STA,STA,STA,12,0,1,1,21,1,9.3,,steroid-free immunosuppressive protocol,KT1122_12_D_test2_test3,"kidney allograft biopsy, 12 months, deceased donor, test set2 and test set3","12 months, deceased donor, test set2 and test set3",,,,KT1122_12_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281633,GPL570,54675,CAN,CAN,CAN,6,0,1,1,14,1,18.3,,steroid-free immunosuppressive protocol,KT0947_6_D_test2_test3,"kidney allograft biopsy, 6 months, deceased donor, test set2 and test set3","6 months, deceased donor, test set2 and test set3",,,,KT0947_6_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281634,GPL570,54675,STA,STA,STA,12,0,1,0,16.8,0,11.7,,steroid-free immunosuppressive protocol,KT0626_12_D_test2_test3,"kidney allograft biopsy, 12 months, deceased donor, test set2 and test set3","12 months, deceased donor, test set2 and test set3",,,,KT0626_12_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281635,GPL570,54675,STA,STA,STA,3,0,1,,,,,,steroid-free immunosuppressive protocol,KT0602_3_D_test2_test3,"kidney allograft biopsy, 3 months, deceased donor, test set2 and test set3","3 months, deceased donor, test set2 and test set3",,,,KT0602_3_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281636,GPL570,54675,STA,STA,STA,3,0,1,1,29.1,1,18.6,,steroid-free immunosuppressive protocol,KT0588_3_D_test2_test3,"kidney allograft biopsy, 3 months, deceased donor, test set2 and test set3","3 months, deceased donor, test set2 and test set3",,,,KT0588_3_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281637,GPL570,54675,CAN,CAN,IFTA,12,1,1,,,,,,steroid-free immunosuppressive protocol,KT0998_12_L_test3,"kidney allograft biopsy, 12 months, living donor, test set3","12 months, living donor, test set3",,,,KT0998_12_L_test3,total RNA,Homo sapiens
GSE11166,GSM281638,GPL570,54675,CAN,CAN,"STA, IFTA",12,0,1,1,21.2,1,18.1,,steroid-free immunosuppressive protocol,KT0481_12_D_test2,"kidney allograft biopsy, 12 months, deceased donor, test set2","12 months, deceased donor, test set2",,,,KT0481_12_D_test2,total RNA,Homo sapiens
GSE11166,GSM281639,GPL570,54675,CAN,CAN,NR,24,0,1,,,,,,,KT0555_24_D_test2_test3,"kidney allograft biopsy, 24 months, deceased donor, test set2 and test set3","24 months, deceased donor, test set2 and test set3",,,,KT0555_24_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281640,GPL570,54675,CAN,CAN,IFTA,6,1,1,,,,,,Steroid-free,KT0545_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0545_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281641,GPL570,54675,STA,STA,NR,6,1,1,,,,,,,KT0519_6_L_test3,"kidney allograft biopsy, 6 months. living donor, test set3","6 months. living donor, test set3",,,,KT0519_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281642,GPL570,54675,CAN,CAN,"STA, IFTA",12,1,1,0,39.9,1,14.7,,steroid-free immunosuppressive protocol,KT0548_12_L_paired,"kidney allograft biopsy, 12 months, living donor, paired set","12 months, living donor, paired set",,,,KT0548_12_L_paired,total RNA,Homo sapiens
GSE11166,GSM281643,GPL570,54675,CAN,CAN,IFTA,6,1,1,,,,,,steroid-free immunosuppressive protocol,KT0325_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0325_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281644,GPL570,54675,CAN,CAN,IFTA,6,1,1,,,,,,steroid-free immunosuppressive protocol,KT0322_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0322_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281645,GPL570,54675,CAN,CAN,IFTA,6,1,1,,,,,,steroid-free immunosuppressive protocol,KT0440_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0440_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281646,GPL570,54675,CAN,CAN,IFTA,3,0,1,1,22.8,1,2.3,,steroid-free immunosuppressive protocol,KT0430_3_D_test2_test3,"kidney allograft biopsy, 3 months, deceased donor, test set2 and test set3","3 months, deceased donor, test set2 and test set3",,,,KT0430_3_D_test2_test3,total RNA,Homo sapiens
GSE11166,GSM281647,GPL570,54675,CAN,CAN,IFTA,6,1,1,,,,,,,KT0878_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0878_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281648,GPL570,54675,STA,STA,STA,6,1,1,,,,,,Steroid-free,KT0877_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0877_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281649,GPL570,54675,STA,STA,STA,6,1,1,,,,,,Steroid-free,KT0704_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0704_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281650,GPL570,54675,AR,AR+CAN,IFTA,3,1,1,,,,,,,KT0691_3_L_paired_test3,"kidney allograft biopsy, 3 months, living donor, paired set and test set3","3 months, living donor, paired set and test set3",,,,KT0691_3_L_paired_test3,total RNA,Homo sapiens
GSE11166,GSM281652,GPL570,54675,STA,STA,STA,12,1,1,0,47,1,16.6,,steroid-free immunosuppressive protocol,KT0921_12_L_paired_test3,"kidney allograft biopsy, 12 months, living donor, paired set and test set3","12 months, living donor, paired set and test set3",,,,KT0921_12_L_paired_test3,total RNA,Homo sapiens
GSE11166,GSM281653,GPL570,54675,CAN,CAN,CAN,6m,1,1,0,33,1,10,Asian,Steroid-free,KT1084_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT1084_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281654,GPL570,54675,CAN,CAN,NR,3,1,1,0,33.3,1,1.1,,steroid-free immunosuppressive protocol,KT0780_3_L_paired,"kidney allograft biopsy, 3 months, living donor, paired set","3 months, living donor, paired set",,,,KT0780_3_L_paired,total RNA,Homo sapiens
GSE11166,GSM281655,GPL570,54675,CAN,CAN,IFTA,6,0,1,,,,,,steroid-free immunosuppressive protocol,KT0975_6_D_test3,"kidney allograft biopsy, 6 months, deceased donor, test set3","6 months, deceased donor, test set3",,,,KT0975_6_D_test3,total RNA,Homo sapiens
GSE11166,GSM281656,GPL570,54675,STA,STA,STA,3,1,1,1,27.1,0,1.2,,steroid-free immunosuppressive protocol,KT0785_3_L_paired,"kidney allograft biopsy, 3 months, living donor, paired set","3 months, living donor, paired set",,,,KT0785_3_L_paired,total RNA,Homo sapiens
GSE11166,GSM281664,GPL570,54675,STA,STA,NR,12,1,1,0,30.5,1,9.2,,steroid-free immunosuppressive protocol,KT0876_12_L_paired,"kidney allograft biopsy, 12 months, living donor, paired set","12 months, living donor, paired set",,,,KT0876_12_L_paired,total RNA,Homo sapiens
GSE11166,GSM281665,GPL570,54675,CAN,CAN,NR,6,1,1,1,40.8,1,15,,steroid-free immunosuppressive protocol,KT0880_6_L_paired,"kidney allograft biopsy, 6 months, living donor, paired set","6 months, living donor, paired set",,,,KT0880_6_L_paired,total RNA,Homo sapiens
GSE11166,GSM281666,GPL570,54675,STA,STA,STA,6,1,1,,,,,,,KT0889_6_L_test3,"kidney allograft biopsy, 6 months, living donor, test set3","6 months, living donor, test set3",,,,KT0889_6_L_test3,total RNA,Homo sapiens
GSE11166,GSM281667,GPL570,54675,STA,STA,STA,3,1,1,,,,,,,KT0663_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT0663_3_L_test3,total RNA,Homo sapiens
GSE11166,GSM281668,GPL570,54675,STA,STA,NR,3,1,1,,,,,,,KT0497_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT0497_3_L_test3,total RNA,Homo sapiens
GSE11166,GSM281669,GPL570,54675,CAN,CAN,IFTA,3,1,1,,,,,,,KT0381_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT0381_3_L_test3,total RNA,Homo sapiens
GSE11166,GSM281670,GPL570,54675,CAN,CAN,IFTA,3,1,1,,,,,,,KT0477_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT0477_3_L_test3,total RNA,Homo sapiens
GSE11166,GSM281671,GPL570,54675,STA,STA,STA,3,1,1,,,,,,,KT0723_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT0723_3_L_test3,total RNA,Homo sapiens
GSE11166,GSM281672,GPL570,54675,STA,STA,STA,3,1,1,,,,,,,KT0627_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT0627_3_L_test3,total RNA,Homo sapiens
GSE11166,GSM281673,GPL570,54675,CAN,CAN,IFTA,3,1,1,,,,,,,KT0763_3_L_test3,"kidney allograft biopsy, 3 months, living donor, test set3","3 months, living donor, test set3",,,,KT0763_3_L_test3,total RNA,Homo sapiens
GSE11513_A,GSM289993,GPL6875,41568,,IMD,IgAN,26m,1,0,,,1,30,,none,S5-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I11-T aRNA 2rounds,1 ug I11-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/54639.gif;	Disease State: stable;	Individual: 5",total RNA,Homo sapiens
GSE11513_A,GSM289994,GPL6875,41568,,IMD,IgAN,39m,1,0,,,1,38,,none,S11-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I14-T aRNA 2rounds,1 ug I14-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/53838.gif;	Disease State: stable;	Individual: 11",total RNA,Homo sapiens
GSE11513_B,GSM289995,GPL6878,41472,,noIMD,FSGS,31m,1,0,,,1,21,,"steroids, cyclosporin A",P1-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD2-T aRNA 2rounds,1 ug PD2-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-01/58614.gif;	Disease State: progressive;	Individual: 15",total RNA,Homo sapiens
GSE11513_C,GSM289996,GPL6877,41472,,noIMD,FSGS,31m,1,0,,,1,21,,"steroids, cyclosporin A",P1-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD2-T aRNA 2rounds,1 ug PD2-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-01/58617.gif;	Disease State: progressive;	Individual: 15",total RNA,Homo sapiens
GSE11513_C,GSM289997,GPL6877,41472,,IMD,RPGN,23m,1,0,,,0,21,,none,P4-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 14 no DNase aRNA 2rounds,1 ug PD 14 no DNase aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-12/65942.gif;	Disease State: progressive;	Individual: 18",total RNA,Homo sapiens
GSE11513_C,GSM289998,GPL6877,41472,,IMD,IgAN,29m,1,0,,,0,24,,none,P2-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 19 no DNase aRNA 2rounds,1 ug PD 19 no DNase aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-12/65943.gif;	Disease State: progressive;	Individual: 16",total RNA,Homo sapiens
GSE11513_C,GSM289999,GPL6877,41472,,IMD,RPGN,23m,1,0,,,0,21,,none,P4-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 14 no DNase aRNA 2rounds,1 ug PD 14 no DNase aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-12/65944.gif;	Disease State: progressive;	Individual: 18",total RNA,Homo sapiens
GSE11513_C,GSM290000,GPL6877,41472,,IMD,MGN,36m,1,0,,,0,62,,none,P3-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 17 no DNase aRNA 2rounds,1 ug PD 17 no DNase aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-12/65945.gif;	Disease State: progressive;	Individual: 17",total RNA,Homo sapiens
GSE11513_B,GSM290001,GPL6878,41472,,IMD,LN,24m,1,0,,,0,30,,"steroids, cyclosporin A, RAAS blockade",P5-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 15 no DNase aRNA 2rounds,1 ug PD 15 no DNase aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-12/65947.gif;	Disease State: progressive;	Individual: 19",total RNA,Homo sapiens
GSE11513_A,GSM290002,GPL6875,41568,,IMD,IgAN,26m,1,0,,,1,59,,steroids,S1-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I15-T aRNA 2rounds,1 ug I15-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/53532.gif;	Disease State: stable;	Individual: 1",total RNA,Homo sapiens
GSE11513_A,GSM290003,GPL6875,41568,,noIMD,FSGS,30m,1,0,,,0,34,,,S2-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug F1-T aRNA 2rounds,1 ug F1-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/53605.gif;	Disease State: stable;	Individual: 2",total RNA,Homo sapiens
GSE11513_A,GSM290004,GPL6875,41568,,IMD,IgAN,26m,1,0,,,1,30,,none,S5-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I11-T aRNA 2rounds,1 ug I11-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-09/55403.gif;	Disease State: stable;	Individual: 5",total RNA,Homo sapiens
GSE11513_B,GSM290005,GPL6878,41472,,IMD,LN,24m,1,0,,,0,30,,"steroids, cyclosporin A, RAAS blockade",P5-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 15  no DNase aRNA 2rounds,1 ug PD 15  no DNase aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-09/64137.gif;	Disease State: progressive;	Individual: 19",total RNA,Homo sapiens
GSE11513_A,GSM290006,GPL6875,41568,,noIMD,FSGS,46m,1,0,,,1,22,,steroids,S12-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug F7-T aRNA 2rounds,1 ug F7-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-09/55405.gif;	Disease State: stable;	Individual: 12",total RNA,Homo sapiens
GSE11513_A,GSM290007,GPL6875,41568,,IMD,IgAN,35m,1,0,,,0,42,,none,S13-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I18-T aRNA 2rounds,1 ug I18-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-09/55332.gif;	Disease State: stable;	Individual: 13",total RNA,Homo sapiens
GSE11513_B,GSM290008,GPL6878,41472,,IMD,MGN,36m,1,0,,,0,62,,none,P3-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 17  no DNase aRNA 2rounds,1 ug PD 17  no DNase aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2005-09/64138.gif;	Disease State: progressive;	Individual: 17",total RNA,Homo sapiens
GSE11513_A,GSM290009,GPL6875,41568,,IMD,IgAN,26m,1,0,,,1,59,,steroids,S1-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I15-T aRNA 2rounds,1 ug I15-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-09/55406.gif;	Disease State: stable;	Individual: 1",total RNA,Homo sapiens
GSE11513_C,GSM290010,GPL6877,41472,,IMD,MPGN II,30m,1,0,,,1,75,,none,P6-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 24-T aRNA 2rounds,1 ug PD 24-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2006-08/69903.gif;	Disease State: progressive;	Individual: 20",total RNA,Homo sapiens
GSE11513_C,GSM290011,GPL6877,41472,,noIMD,MPA (p-ANCA pos),26m,1,0,,,1,58,,steroids,P7-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug PD 28-T aRNA 2rounds,1 ug PD 28-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2006-08/69904.gif;	Disease State: progressive;	Individual: 21",total RNA,Homo sapiens
GSE11513_B,GSM290012,GPL6878,41472,,noIMD,FSGS,34m,1,0,,,1,18,,none,S6-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug F2-T aRNA 2rounds,1 ug F2-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/55085.gif;	Disease State: stable;	Individual: 6",total RNA,Homo sapiens
GSE11513_A,GSM290013,GPL6875,41568,,noIMD,FSGS,46m,1,0,,,1,22,,steroids,S12-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug F7-T aRNA 2rounds,1 ug F7-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-09/55336.gif;	Disease State: stable;	Individual: 12",total RNA,Homo sapiens
GSE11513_D,GSM290014,GPL6876,41472,,noIMD,MCD,24m,1,0,,,0,32,,,S3-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug M2-T aRNA 2rounds,1 ug M2-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/54268.gif;	Disease State: stable;	Individual: 3",total RNA,Homo sapiens
GSE11513_A,GSM290015,GPL6875,41568,,noIMD,FSGS,30m,1,0,,,0,34,,,S2-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug F1-T aRNA 2rounds,1 ug F1-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/54640.gif;	Disease State: stable;	Individual: 2",total RNA,Homo sapiens
GSE11513_A,GSM290016,GPL6875,41568,,IMD,IgAN,34m,1,0,,,1,49,,steroids,S9-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I7-T aRNA 2rounds,1 ug I7-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/55086.gif;	Disease State: stable;	Individual: 9",total RNA,Homo sapiens
GSE11513_A,GSM290017,GPL6875,41568,,noIMD,MCD,24m,1,0,,,0,32,,,S3-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug M2-T aRNA 2rounds,1 ug M2-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-09/55337.gif;	Disease State: stable;	Individual: 3",total RNA,Homo sapiens
GSE11513_B,GSM290018,GPL6878,41472,,IMD,IgAN,24m,1,0,,,1,32,,none,S14-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I19-T aRNA 2rounds,1 ug I19-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2006-08/69907.gif;	Disease State: stable;	Individual: 14",total RNA,Homo sapiens
GSE11513_A,GSM290019,GPL6875,41568,,noIMD,MCD,39m,1,0,,,0,33,,RAAS blockade,S7-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug M6-T aRNA 2rounds,1 ug M6-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/55087.gif;	Disease State: stable;	Individual: 7",total RNA,Homo sapiens
GSE11513_A,GSM290020,GPL6875,41568,,IMD,IgAN,39m,1,0,,,1,38,,none,S11-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I14-T aRNA 2rounds,1 ug I14-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/55088.gif;	Disease State: stable;	Individual: 11",total RNA,Homo sapiens
GSE11513_A,GSM290021,GPL6875,41568,,noIMD,MCD,25m,1,0,,,1,63,,none,S4-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug M8-T aRNA 2rounds,1 ug M8-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/53575.gif;	Disease State: stable;	Individual: 4",total RNA,Homo sapiens
GSE11513_A,GSM290022,GPL6875,41568,,IMD,IgAN,24m,1,0,,,1,25,,none,S8-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I1-T aRNA 2rounds,1 ug I1-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/54468.gif;	Disease State: stable;	Individual: 8",total RNA,Homo sapiens
GSE11513_A,GSM290023,GPL6875,41568,,noIMD,MCD,25m,1,0,,,1,63,,none,S4-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug M8-T aRNA 2rounds,1 ug M8-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/54469.gif;	Disease State: stable;	Individual: 4",total RNA,Homo sapiens
GSE11513_A,GSM290024,GPL6875,41568,,noIMD,FSGS,22m,1,0,,,0,41,,steroids,S10-2,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug F8-T aRNA 2rounds,1 ug F8-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-09/55645.gif;	Disease State: stable;	Individual: 10",total RNA,Homo sapiens
GSE11513_A,GSM290025,GPL6875,41568,,IMD,IgAN,24m,1,0,,,1,25,,none,S8-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I1-T aRNA 2rounds,1 ug I1-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/53848.gif;	Disease State: stable;	Individual: 8",total RNA,Homo sapiens
GSE11513_A,GSM290026,GPL6875,41568,,noIMD,MCD,39m,1,0,,,0,33,,RAAS blockade,S7-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug M6-T aRNA 2rounds,1 ug M6-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/54121.gif;	Disease State: stable;	Individual: 7",total RNA,Homo sapiens
GSE11513_A,GSM290027,GPL6875,41568,,noIMD,FSGS,34m,1,0,,,1,18,,none,S6-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug F2-T aRNA 2rounds,1 ug F2-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-08/54863.gif;	Disease State: stable;	Individual: 6",total RNA,Homo sapiens
GSE11513_A,GSM290028,GPL6875,41568,,IMD,IgAN,34m,1,0,,,1,49,,steroids,S9-1,Stratagene Universal Human Reference RNA,1 ug STR  aRNA 2rounds vom 27.04.04,,1 ug I7-T aRNA 2rounds,1 ug I7-T aRNA 2rounds,"Simple annotation: Kidney, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2004-07/54271.gif;	Disease State: stable;	Individual: 9",total RNA,Homo sapiens
GSE12682,GSM318464,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.37 glomeruli fraction,Human kidney sample No.37,"Healthy glomeruli;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male glomeruli,total RNA,Homo sapiens
GSE12682,GSM318465,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.50 glomeruli fraction,Human kidney sample No.50,"Healthy glomeruli;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male glomeruli,total RNA,Homo sapiens
GSE12682,GSM318466,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.77 glomeruli fraction,Human kidney sample No.77,"Healthy glomeruli;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male glomeruli,total RNA,Homo sapiens
GSE12682,GSM318467,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.79 glomeruli fraction,Human kidney sample No.79,"Healthy glomeruli;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male glomeruli,total RNA,Homo sapiens
GSE12682,GSM318468,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.81 glomeruli fraction,Human kidney sample No.81,"Healthy glomeruli;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male glomeruli,total RNA,Homo sapiens
GSE12682,GSM318469,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.110 glomeruli fraction,Human kidney sample No.110,"Healthy glomeruli;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male glomeruli,total RNA,Homo sapiens
GSE12682,GSM318470,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.107 glomeruli fraction,Human kidney sample No.107,"Healthy glomeruli;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male glomeruli,total RNA,Homo sapiens
GSE12682,GSM318471,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.21 glomeruli fraction,Human kidney sample No.21,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318472,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.33 glomeruli fraction,Human kidney sample No.33,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318473,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.39 glomeruli fraction,Human kidney sample No.39,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318474,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.53 glomeruli fraction,Human kidney sample No.53,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318475,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.76 glomeruli fraction,Human kidney sample No.76,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318476,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.82 glomeruli fraction,Human kidney sample No.82,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318477,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.83 glomeruli fraction,Human kidney sample No.83,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318478,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.98 glomeruli fraction,Human kidney sample No.98,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318479,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.118 glomeruli fraction,Human kidney sample No.118,"Healthy glomeruli;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female glomeruli,total RNA,Homo sapiens
GSE12682,GSM318480,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.31 tubulointerstitial fraction,Human kidney sample No.31,"Healthy tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male tubuli,total RNA,Homo sapiens
GSE12682,GSM318481,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.37 tubulointerstitial fraction,Human kidney sample No.37,"Healthy tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male tubuli,total RNA,Homo sapiens
GSE12682,GSM318482,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.50 tubulointerstitial fraction,Human kidney sample No.50,"Healthy tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male tubuli,total RNA,Homo sapiens
GSE12682,GSM318483,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.64 tubulointerstitial fraction,Human kidney sample No.64,"Healthy tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male tubuli,total RNA,Homo sapiens
GSE12682,GSM318484,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.77 tubulointerstitial fraction,Human kidney sample No.77,"Healthy tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male tubuli,total RNA,Homo sapiens
GSE12682,GSM318485,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.79 tubulointerstitial fraction,Human kidney sample No.79,"Healthy tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male tubuli,total RNA,Homo sapiens
GSE12682,GSM318486,GPL571,22277,Control,Normal,Healthy,,,0,,,1,,,,Male human kidney sample No.81 tubulointerstitial fraction,Human kidney sample No.81,"Healthy tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy male tubuli,total RNA,Homo sapiens
GSE12682,GSM318487,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.17 tubulointerstitial fraction,Human kidney sample No.17,"Healthy tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female tubuli,total RNA,Homo sapiens
GSE12682,GSM318488,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.39 tubulointerstitial fraction,Human kidney sample No.39,"Healthy tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female tubuli,total RNA,Homo sapiens
GSE12682,GSM318489,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.53 tubulointerstitial fraction,Human kidney sample No.53,"Healthy tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female tubuli,total RNA,Homo sapiens
GSE12682,GSM318490,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.76 tubulointerstitial fraction,Human kidney sample No.76,"Healthy tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female tubuli,total RNA,Homo sapiens
GSE12682,GSM318491,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.82 tubulointerstitial fraction,Human kidney sample No.82,"Healthy tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female tubuli,total RNA,Homo sapiens
GSE12682,GSM318492,GPL571,22277,Control,Normal,Healthy,,,0,,,0,,,,Female human kidney sample No.98 tubulointerstitial fraction,Human kidney sample No.98,"Healthy tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from healthy female tubuli,total RNA,Homo sapiens
GSE12682,GSM318493,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.34 tubulointerstitial fraction,Human kidney sample No.34,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318494,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.56 tubulointerstitial fraction,Human kidney sample No.56,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318495,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.58 tubulointerstitial fraction,Human kidney sample No.58,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318496,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.65 tubulointerstitial fraction,Human kidney sample No.65,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318497,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.67 tubulointerstitial fraction,Human kidney sample No.67,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318498,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.92 tubulointerstitial fraction,Human kidney sample No.92,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318499,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.94 tubulointerstitial fraction,Human kidney sample No.94,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318500,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.95 tubulointerstitial fraction,Human kidney sample No.95,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318501,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,1,,,,Male human kidney sample No.51 tubulointerstitial fraction,Human kidney sample No.51,"Diseased tubulointerstitium;	Male",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased male tubuli,total RNA,Homo sapiens
GSE12682,GSM318502,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.36 tubulointerstitial fraction,Human kidney sample No.36,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318503,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.43 tubulointerstitial fraction,Human kidney sample No.43,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318504,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.44 tubulointerstitial fraction,Human kidney sample No.44,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318505,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.45 tubulointerstitial fraction,Human kidney sample No.45,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318506,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.48 tubulointerstitial fraction,Human kidney sample No.48,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318507,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.59 tubulointerstitial fraction,Human kidney sample No.59,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318508,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.62 tubulointerstitial fraction,Human kidney sample No.62,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318509,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.70 tubulointerstitial fraction,Human kidney sample No.70,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318510,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.72 tubulointerstitial fraction,Human kidney sample No.72,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318511,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.74 tubulointerstitial fraction,Human kidney sample No.74,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318512,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.78 tubulointerstitial fraction,Human kidney sample No.78,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318513,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.80 tubulointerstitial fraction,Human kidney sample No.80,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318514,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.88 tubulointerstitial fraction,Human kidney sample No.88,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE12682,GSM318515,GPL571,22277,CKD,CKD,Fibrosis,,,0,,,0,,,,Female human kidney sample No.93 tubulointerstitial fraction,Human kidney sample No.93,"Diseased tubulointerstitium;	Female",Kidney tissue was obtained in the operating room immediately after removal from the patient. Tissue was placed into RNALater right after removal from the body and was kept at 4C. 1mmx1mm biopsy tissues were placed under Olympus model SZX12 stereomicroscope using 90 x magnification. The biopsy tissue was manually microdissected at 4C in RNALater for glomerular and tubular compartment using 2 fine tip (1mm) forceps. Dissected tissue was homogenized using Powergen125 (Fisher) homogenizer and stored at -80C.,,,Gene expression data from diseased female tubuli,total RNA,Homo sapiens
GSE14328,GSM357851,GPL570,54675,AR,TCMR,TCMR IA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR8,"AR8 kidney allograft biopsy, acute rejection","kidney allograft biopsy, acute rejection;	banff classification: Grade 1B",,,,K_AR8,total RNA,Homo sapiens
GSE14328,GSM357859,GPL570,54675,AR,TCMR,TCMR IB,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR9,"AR9 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR9,total RNA,Homo sapiens
GSE14328,GSM357860,GPL570,54675,AR,Mixed,AR,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR6,"AR6 kidney allograft biopsy, acute rejection",acute rejection,,,,K_AR6,total RNA,Homo sapiens
GSE14328,GSM357861,GPL570,54675,AR,TCMR,TCMR IA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR16,"AR16 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1A",,,,K_AR16,total RNA,Homo sapiens
GSE14328,GSM357862,GPL570,54675,AR,TCMR,TCMR IB,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR13,"AR13 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR13,total RNA,Homo sapiens
GSE14328,GSM357863,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA3,"STA3 kidney allograft biopsy, stable",stable,,,,K_STA3,total RNA,Homo sapiens
GSE14328,GSM358003,GPL570,54675,AR,TCMR,TCMR IA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR14,"AR14 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1A",,,,K_AR14,total RNA,Homo sapiens
GSE14328,GSM358004,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA7,"STA7 kidney allograft biopsy, stable",stable,,,,K_STA7,total RNA,Homo sapiens
GSE14328,GSM358005,GPL570,54675,AR,TCMR,TCMR IA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR17,"AR17 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1A",,,,K_AR17,total RNA,Homo sapiens
GSE14328,GSM358006,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA13,"STA13 kidney allograft biopsy, stable",stable,,,,K_STA13,total RNA,Homo sapiens
GSE14328,GSM358007,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA2,"STA2 kidney allograft biopsy, stable",stable,,,,K_STA2,total RNA,Homo sapiens
GSE14328,GSM358008,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA1,"STA1 kidney allograft biopsy, stable",stable,,,,K_STA1,total RNA,Homo sapiens
GSE14328,GSM358009,GPL570,54675,AR,Mixed,AR,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR7,"AR7 kidney allograft biopsy, acute rejection",acute rejection,,,,K_AR7,total RNA,Homo sapiens
GSE14328,GSM358015,GPL570,54675,AR,TCMR,TCMR IA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR12,"AR12 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR12,total RNA,Homo sapiens
GSE14328,GSM358016,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA18,"STA18 kidney allograft biopsy, stable",stable,,,,K_STA18,total RNA,Homo sapiens
GSE14328,GSM358017,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA4,"STA4 kidney allograft biopsy, stable",stable,,,,K_STA4,total RNA,Homo sapiens
GSE14328,GSM358018,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA8,"STA8 kidney allograft biopsy, stable",stable,,,,K_STA8,total RNA,Homo sapiens
GSE14328,GSM358020,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA6,"STA6 kidney allograft biopsy, stable",stable,,,,K_STA6,total RNA,Homo sapiens
GSE14328,GSM358021,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA11,"STA11 kidney allograft biopsy, stable",stable,,,,K_STA11,total RNA,Homo sapiens
GSE14328,GSM358258,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA5,"STA5 kidney allograft biopsy, stable",stable,,,,K_STA5,total RNA,Homo sapiens
GSE14328,GSM358259,GPL570,54675,AR,Mixed,AR,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR18,"AR18 kidney allograft biopsy, acute rejection",acute rejection,,,,K_AR18,total RNA,Homo sapiens
GSE14328,GSM358265,GPL570,54675,AR,TCMR,TCMR IB,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR2,"AR2 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR2,total RNA,Homo sapiens
GSE14328,GSM358266,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA14,"STA14 kidney allograft biopsy, stable",stable,,,,K_STA14,total RNA,Homo sapiens
GSE14328,GSM358268,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA12,"STA12 kidney allograft biopsy, stable",stable,,,,K_STA12,total RNA,Homo sapiens
GSE14328,GSM358269,GPL570,54675,AR,TCMR,TCMR IA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR11,"AR11 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1A",,,,K_AR11,total RNA,Homo sapiens
GSE14328,GSM358281,GPL570,54675,AR,TCMR,TCMR IB,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR1,"AR1 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR1,total RNA,Homo sapiens
GSE14328,GSM358282,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA16,"STA16 kidney allograft biopsy, stable",stable,,,,K_STA16,total RNA,Homo sapiens
GSE14328,GSM358286,GPL570,54675,AR,TCMR,TCMR IA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR15,"AR15 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1A",,,,K_AR15,total RNA,Homo sapiens
GSE14328,GSM358287,GPL570,54675,AR,TCMR,TCMR IB,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR5,"AR5 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR5,total RNA,Homo sapiens
GSE14328,GSM358288,GPL570,54675,AR,TCMR,TCMR IIA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR10,"AR10 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 11A",,,,K_AR10,total RNA,Homo sapiens
GSE14328,GSM358289,GPL570,54675,AR,TCMR,TCMR IB,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR3,"AR3 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR3,total RNA,Homo sapiens
GSE14328,GSM358290,GPL570,54675,AR,TCMR,TCMR IB,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_AR4,"AR4 kidney allograft biopsy, acute rejection","acute rejection;	banff classification: Grade 1B",,,,K_AR4,total RNA,Homo sapiens
GSE14328,GSM358291,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA10,"STA10 kidney allograft biopsy, stable",stable,,,,K_STA10,total RNA,Homo sapiens
GSE14328,GSM358292,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA15,"STA15 kidney allograft biopsy, stable",stable,,,,K_STA15,total RNA,Homo sapiens
GSE14328,GSM358293,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA9,"STA9_ kidney allograft biopsy, stable",stable,,,,K_STA9,total RNA,Homo sapiens
GSE14328,GSM358294,GPL570,54675,NR,STA,STA,,,1,,,,,,"Tacrolimus, MMF, (and steroid). Daclizumab induction therapy",K_STA17,"STA17 kidney allograft biopsy, stable",stable,,,,K_STA17,total RNA,Homo sapiens
GSE14700,GSM366880,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 101 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366881,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 106 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366882,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 113 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366883,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 113 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366884,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 168 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366885,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 172 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366886,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 195 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366887,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 198 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366888,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 198 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366889,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 501 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366890,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 124 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366891,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 124 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366892,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 134 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366893,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 139 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366894,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 139 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366895,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 145 right kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366896,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 157 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366897,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 184 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366898,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 386 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366899,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,methylprednisolone,corticosteroid donor 389 left kidney,kidney wedge biopsy,agent: corticosteroid,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366900,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,none,placebo donor 117 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366901,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,none,placebo donor 125 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366902,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,none,placebo donor 131 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366903,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,none,placebo donor 138 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366904,GPL8150,34599,Control,Normal,Control*,0,0,1,,,,,,none,placebo donor 162 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366906,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 180 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366908,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 355 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366910,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 376 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366913,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 393 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366915,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 503 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366917,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 117 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366918,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 118 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366919,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 118 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366920,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 143 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366921,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 147 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366922,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 151 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366923,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 196 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366924,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 327 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366925,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 505 left kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE14700,GSM366926,GPL8150,34599,Control,Normal,Control,0,0,1,,,,,,none,placebo donor 505 right kidney,kidney wedge biopsy,agent: placebo,After brain death was declared the deceased donor was randomized to receive 1000mg of methylprednisolone (corticosteroid) or blinded placebo (0.9% saline) at least three hours before organ harvesting.,Stratagene Universal reference RNA,different cell lines,"Two micrograms of isolated total RNA were amplified using the RiboAmp RNA amplification kit (Arcturus, Mountain View, California). The amplified RNA was inspected on an ethidium bromide stained 1% agarose gel and on the Agilent 2100 Bioanalyzer. For the 40 zero hour kidney biopsies the RNA was of sufficient quality to proceed with microarray analysis.",total RNA,Homo sapiens
GSE1563,GSM26836,GPL8300,12625,Control,Normal,Control,0,1,1,,,0,38,,none,C1BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 38;	Sex: Female;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 0.8;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26837,GPL8300,12625,Control,Normal,Control,0,1,1,,,1,42,,none,C2BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 42;	Sex: Male;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 0.9;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26838,GPL8300,12625,Control,Normal,Control,0,1,1,,,0,35,,none,C3BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 35;	Sex: Female;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 0.6;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26839,GPL8300,12625,Control,Normal,Control,0,1,1,,,0,39,,none,C4BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 39;	Sex: Female;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 0.9;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26840,GPL8300,12625,Control,Normal,Control,0,1,1,,,1,39,,none,C5BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 39;	Sex: Male;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 1.2;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26841,GPL8300,12625,Control,Normal,Control,0,1,1,,,1,44,,none,C6BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 44;	Sex: Male;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 0.8;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26842,GPL8300,12625,Control,Normal,Control,0,1,1,,,1,36,,none,C7BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 36;	Sex: Male;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 1.2;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26843,GPL8300,12625,Control,Normal,Control,0,1,1,,,0,35,,none,C8BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 35;	Sex: Female;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 0.8;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26844,GPL8300,12625,Control,Normal,Control,0,1,1,,,0,50,,none,C9BX,kidney,,,,,"Clinical status: control healthy donor kidney;	Age: 50;	Sex: Female;	Immunosupression: none;	Histopathology: none;	Donor type: LD;	Scr (mg/dL): 0.6;	Days post transplant: 0;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26845,GPL8300,12625,AR,TCMR,TCMR,285d,0,1,,,1,42,,CsA/MMF/P,AR1BX,kidney,,,,,"Clinical status: sample from transplant patient with kidney undergoing acute rejection;	Age: 42;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Banff IIA;	Donor type: CAD;	Scr (mg/dL): 12.0;	Days post transplant: 285;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26846,GPL8300,12625,AR,TCMR,TCMR,1467d,1,1,,,1,28,,FK/MMF/P,AR2BX,kidney,,,,,"Clinical status: sample from transplant patient with kidney undergoing acute rejection;	Age: 28;	Sex: Male;	Immunosupression: FK/MMF/P;	Histopathology: Banff IIA;	Donor type: LD;	Scr (mg/dL): 5.9;	Days post transplant: 1467;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26847,GPL8300,12625,AR,TCMR,TCMR,119d,0,1,,,1,18,,CsA/MMF/P,AR3BX,kidney,,,,,"Clinical status: sample from transplant patient with kidney undergoing acute rejection;	Age: 18;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Banff IA;	Donor type: CAD;	Scr (mg/dL): 2.2;	Days post transplant: 119;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26848,GPL8300,12625,AR,TCMR,TCMR,366d,0,1,,,0,28,,FK/MMF/P,AR4BX,kidney,,,,,"Clinical status: sample from transplant patient with kidney undergoing acute rejection;	Age: 28;	Sex: Female;	Immunosupression: FK/MMF/P;	Histopathology: Banff IA;	Donor type: CAD;	Scr (mg/dL): 1.5;	Days post transplant: 366;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26849,GPL8300,12625,AR,TCMR,TCMR,278d,0,1,,,0,26,,CsA/MMF/P,AR5BX,kidney,,,,,"Clinical status: sample from transplant patient with kidney undergoing acute rejection;	Age: 26;	Sex: Female;	Immunosupression: CsA/MMF/P;	Histopathology: Banff borderline;	Donor type: CAD;	Scr (mg/dL): 2.0;	Days post transplant: 278;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26850,GPL8300,12625,AR,TCMR,TCMR,68d,0,1,,,1,55,,SRL/MMF/P,AR6BX,kidney,,,,,"Clinical status: sample from transplant patient with kidney undergoing acute rejection;	Age: 55;	Sex: Male;	Immunosupression: SRL/MMF/P;	Histopathology: Banff borderline;	Donor type: CAD;	Scr (mg/dL): 2.9;	Days post transplant: 68;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26851,GPL8300,12625,AR,TCMR,TCMR,184d,0,1,,,1,35,,SRL/MMF/P,AR7BX,kidney,,,,,"Clinical status: sample from transplant patient with kidney undergoing acute rejection;	Age: 35;	Sex: Male;	Immunosupression: SRL/MMF/P;	Histopathology: Banff IA;	Donor type: CAD;	Scr (mg/dL): 2.0;	Days post transplant: 184;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26852,GPL8300,12625,NR,STA,Normal,674d,0,1,,,1,21,,CsA/MMF/P,TX10BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 21;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: CAD;	Scr (mg/dL): 1.5;	Days post transplant: 674;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26853,GPL8300,12625,NR,STA,Normal,932d,0,1,,,1,51,,CsA/MMF/P,TX1BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 51;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: CAD;	Scr (mg/dL): 1.5;	Days post transplant: 932;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26854,GPL8300,12625,NR,STA,Normal,911d,1,1,,,1,56,,CsA/MMF/P,TX2BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 56;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: LD;	Scr (mg/dL): 1.3;	Days post transplant: 911;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26855,GPL8300,12625,NR,STA,Normal,902d,0,1,,,1,52,,CsA/MMF/P,TX3BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 52;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: CAD;	Scr (mg/dL): 1.2;	Days post transplant: 902;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26856,GPL8300,12625,NR,STA,Normal,651d,1,1,,,0,31,,CsA/MMF/P,TX4BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 31;	Sex: Female;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: LD;	Scr (mg/dL): 1.1;	Days post transplant: 651;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26857,GPL8300,12625,NR,STA,Normal,689d,1,1,,,0,53,,CsA/MMF/P,TX5BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 53;	Sex: Female;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: LD;	Scr (mg/dL): 1.1;	Days post transplant: 689;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26858,GPL8300,12625,NR,STA,Normal,776d,1,1,,,1,32,,CsA/MMF/P,TX6BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 32;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: LD;	Scr (mg/dL): 1.6;	Days post transplant: 776;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26859,GPL8300,12625,NR,STA,Normal,713d,0,1,,,0,46,,CsA/MMF/P,TX7BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 46;	Sex: Female;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: CAD;	Scr (mg/dL): 1.2;	Days post transplant: 713;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26860,GPL8300,12625,NR,STA,Normal,733d,0,1,,,1,61,,CsA/MMF/P,TX8BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 61;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: CAD;	Scr (mg/dL): 0.9;	Days post transplant: 733;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26861,GPL8300,12625,NR,STA,Normal,718d,1,1,,,1,44,,CsA/MMF/P,TX9BX,kidney,,,,,"Clinical status: sample from well-functioning transplant with no clinical evidence of rejection;	Age: 44;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: Normal;	Donor type: LD;	Scr (mg/dL): 1.8;	Days post transplant: 718;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26862,GPL8300,12625,NR,CAN,CNI toxicity,456d,1,1,,,1,55,,CsA/MMF/P,NR1BX,kidney,,,,,"Clinical status: sample from transplant with renal dysfunction without rejection;	Age: 55;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: CNI toxicity;	Donor type: LD;	Scr (mg/dL): 1.7;	Days post transplant: 456;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26863,GPL8300,12625,NR,CAN,CNI toxicity,155d,1,1,,,1,38,,FK/MMF/P,NR2BX,kidney,,,,,"Clinical status: sample from transplant with renal dysfunction without rejection;	Age: 38;	Sex: Male;	Immunosupression: FK/MMF/P;	Histopathology: CNI toxicity;	Donor type: LD;	Scr (mg/dL): 2.3;	Days post transplant: 155;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26864,GPL8300,12625,NR,DGF,ATN,11d,1,1,,,1,61,,SRL/MMF/P,NR3BX,kidney,,,,,"Clinical status: sample from transplant with renal dysfunction without rejection;	Age: 61;	Sex: Male;	Immunosupression: SRL/MMF/P;	Histopathology: ATN;	Donor type: LD;	Scr (mg/dL): 5.2;	Days post transplant: 11;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26865,GPL8300,12625,NR,DGF,ATN,16d,0,1,,,1,35,,CsA/MMF/P,NR5BX,kidney,,,,,"Clinical status: sample from transplant with renal dysfunction without rejection;	Age: 35;	Sex: Male;	Immunosupression: CsA/MMF/P;	Histopathology: ATN;	Donor type: CAD;	Scr (mg/dL): 6.3;	Days post transplant: 16;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1563,GSM26866,GPL8300,12625,NR,,FSGS,78d,1,1,,,0,22,,FK/MMF/P,NR8BX,kidney,,,,,"Clinical status: sample from transplant with renal dysfunction without rejection;	Age: 22;	Sex: Female;	Immunosupression: FK/MMF/P;	Histopathology: FSGS;	Donor type: LD;	Scr (mg/dL): 3.3;	Days post transplant: 78;	Abbreviations used in sample description: Abreviations used to describe patient samples include the following: BX - Biopsy; PBL- Peripheral Blood Lymphocytes; CsA -Cyclosporine; MMF - Mycophenolate Mofetil; P - Prednisone; FK - Tacrolimus;  SRL - Sirolimus; CAD -Cadaveric;  LD - Live Donor; Scr - Serum Creatinine; ATN - Acute Tubular Necrosis CNI - Calcineurin Inhibitor; FSGS - Focal Segmental Glomerulosclerosis;	Keywords = DNA microarrays, gene expression, kidney, rejection, transplant",total RNA,Homo sapiens
GSE1743,GSM30418,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA01,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30419,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA02,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30420,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA03,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30421,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA04,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30422,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA05,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30423,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA06,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30424,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA07,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30425,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA08,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30426,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA09,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30427,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA10,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30428,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA11,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30429,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA12,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30430,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA13,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30431,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA14,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30432,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA15,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30433,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA16,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30434,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA17,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30435,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA18,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30436,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA19,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30437,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA20,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30438,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA21,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30439,GPL96,22283,,,,2y,,1,,,,,,CSA,CSA22,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A CYCLOSPORINE IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30440,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA01,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30441,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA02,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30442,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA03,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30443,GPL96,22283,,,,2y,,1,,,,,,RARA,RARA04,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30444,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA05,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30445,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA06,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30446,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA07,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30447,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA08,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30448,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA09,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30449,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA10,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30450,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA11,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30451,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA12,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30452,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA13,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30453,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA14,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30454,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA15,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30455,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA16,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30456,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA17,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30457,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA18,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE1743,GSM30458,GPL96,22283,,,,2y,,1,,,,,,RAPA,RAPA19,HUMAN KIDNEY,,,,,"BIOPSY FROM A HUMAN KIDNEY WITH A SIROLIMUS (RAPAMYCIN) IMMUNOSUPPRESSIVE REGIMEN;	Keywords = CSA;	Keywords = SRL;	Keywords = DNA MICROARRAYS;	Keywords = TRANSPLANT",total RNA,Homo sapiens
GSE21374,GSM533921,GPL570,54675,NR,STA,NR,277d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 100A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 277;	time from biopsy to failure/censoring (days): 1084;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533922,GPL570,54675,NR,STA,NR,134d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 101A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 134;	time from biopsy to failure/censoring (days): 1170;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533923,GPL570,54675,NR,STA,NR,795d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 103A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 795;	time from biopsy to failure/censoring (days): 127;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533924,GPL570,54675,NR,STA,NR,2358d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 104A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2358;	time from biopsy to failure/censoring (days): 1430;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533925,GPL570,54675,NR,STA,NR,64d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 105A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 64;	time from biopsy to failure/censoring (days): 1244;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533926,GPL570,54675,R,Mixed,R,8d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 106A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8;	time from biopsy to failure/censoring (days): 1154;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533927,GPL570,54675,R,Mixed,R,745d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 108A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 745;	time from biopsy to failure/censoring (days): 1410;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533928,GPL570,54675,NR,STA,NR,1309d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 109A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1309;	time from biopsy to failure/censoring (days): 1254;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533929,GPL570,54675,NR,STA,NR,1461d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 110A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1461;	time from biopsy to failure/censoring (days): 1277;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533930,GPL570,54675,NR,STA,NR,2086d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 110A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2086;	time from biopsy to failure/censoring (days): 652;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533931,GPL570,54675,R,Mixed,R,3442d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 111A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3442;	time from biopsy to failure/censoring (days): 1240;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533932,GPL570,54675,NR,STA,NR,1591d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 113A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1591;	time from biopsy to failure/censoring (days): 79;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533933,GPL570,54675,NR,STA,NR,881d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 115A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 881;	time from biopsy to failure/censoring (days): 1276;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533934,GPL570,54675,NR,STA,NR,7d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 116A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 7;	time from biopsy to failure/censoring (days): 1112;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533935,GPL570,54675,R,Mixed,R,117d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 120A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 117;	time from biopsy to failure/censoring (days): 1153;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533936,GPL570,54675,R,Mixed,R,611d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 120A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 611;	time from biopsy to failure/censoring (days): 659;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533937,GPL570,54675,R,Mixed,R,615d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 120A6AGX8",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 615;	time from biopsy to failure/censoring (days): 655;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533938,GPL570,54675,NR,STA,NR,1703d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 124A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1703;	time from biopsy to failure/censoring (days): 1258;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533939,GPL570,54675,NR,STA,NR,42d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 126A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 42;	time from biopsy to failure/censoring (days): 1167;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533940,GPL570,54675,NR,STA,NR,281d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 126A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 281;	time from biopsy to failure/censoring (days): 928;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533941,GPL570,54675,NR,STA,NR,36d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 128A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 36;	time from biopsy to failure/censoring (days): 1138;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533942,GPL570,54675,NR,STA,NR,178d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 129A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 178;	time from biopsy to failure/censoring (days): 907;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533943,GPL570,54675,NR,STA,NR,85d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 130A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 85;	time from biopsy to failure/censoring (days): 1234;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533944,GPL570,54675,NR,STA,NR,7387d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 134A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 7387;	time from biopsy to failure/censoring (days): 1176;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533945,GPL570,54675,NR,STA,NR,398d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 135A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 398;	time from biopsy to failure/censoring (days): 1143;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533946,GPL570,54675,NR,STA,NR,2094d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 139A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2094;	time from biopsy to failure/censoring (days): 1185;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533947,GPL570,54675,NR,STA,NR,1242d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 140A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1242;	time from biopsy to failure/censoring (days): 1182;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533948,GPL570,54675,NR,STA,NR,2502d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 142A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2502;	time from biopsy to failure/censoring (days): 1181;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533949,GPL570,54675,NR,STA,NR,4120d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 143A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4120;	time from biopsy to failure/censoring (days): 1051;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533950,GPL570,54675,NR,STA,NR,2533d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 144A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2533;	time from biopsy to failure/censoring (days): 1206;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533951,GPL570,54675,R,Mixed,R,2404d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 145A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 2404;	time from biopsy to failure/censoring (days): 585;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533952,GPL570,54675,R,Mixed,R,2752d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 145A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 2752;	time from biopsy to failure/censoring (days): 237;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533953,GPL570,54675,NR,STA,NR,1524d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 146A2AGX8",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1524;	time from biopsy to failure/censoring (days): 1171;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533954,GPL570,54675,NR,STA,NR,3584d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 148A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3584;	time from biopsy to failure/censoring (days): 1035;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533955,GPL570,54675,R,Mixed,R,603d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 150A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 603;	time from biopsy to failure/censoring (days): 740;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533956,GPL570,54675,R,Mixed,R,685d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 150A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 685;	time from biopsy to failure/censoring (days): 658;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533957,GPL570,54675,R,Mixed,R,240d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 152A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 240;	time from biopsy to failure/censoring (days): 775;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533958,GPL570,54675,NR,STA,NR,3204d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 155A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3204;	time from biopsy to failure/censoring (days): 1148;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533959,GPL570,54675,R,Mixed,R,4445d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 156A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4445;	time from biopsy to failure/censoring (days): 1002;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533960,GPL570,54675,NR,STA,NR,110d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 157A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 110;	time from biopsy to failure/censoring (days): 1110;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533961,GPL570,54675,NR,STA,NR,79d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 162A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 79;	time from biopsy to failure/censoring (days): 1036;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533962,GPL570,54675,NR,STA,NR,73d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 163A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 73;	time from biopsy to failure/censoring (days): 1124;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533963,GPL570,54675,R,Mixed,R,3775d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 164A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 3775;	time from biopsy to failure/censoring (days): 364;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533964,GPL570,54675,R,Mixed,R,742d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 165A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 742;	time from biopsy to failure/censoring (days): 456;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533965,GPL570,54675,NR,STA,NR,100d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 166A5AGX8",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 100;	time from biopsy to failure/censoring (days): 1022;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533966,GPL570,54675,NR,STA,NR,345d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 166A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 345;	time from biopsy to failure/censoring (days): 777;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533967,GPL570,54675,NR,STA,NR,2384d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 168A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 2384;	time from biopsy to failure/censoring (days): 731;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533968,GPL570,54675,NR,STA,NR,630d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 169A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 630;	time from biopsy to failure/censoring (days): 1106;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533969,GPL570,54675,NR,STA,NR,26d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 16A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 26;	time from biopsy to failure/censoring (days): 1590;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533970,GPL570,54675,NR,STA,NR,287d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 171A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 287;	time from biopsy to failure/censoring (days): 827;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533971,GPL570,54675,NR,STA,NR,387d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 171A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 387;	time from biopsy to failure/censoring (days): 727;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533972,GPL570,54675,NR,STA,NR,402d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 171A7AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 402;	time from biopsy to failure/censoring (days): 712;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533973,GPL570,54675,NR,STA,NR,2559d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 180A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 2559;	time from biopsy to failure/censoring (days): 902;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533974,GPL570,54675,NR,STA,NR,3617d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 185A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3617;	time from biopsy to failure/censoring (days): 1078;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533975,GPL570,54675,R,Mixed,R,553d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 190A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 553;	time from biopsy to failure/censoring (days): 507;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533976,GPL570,54675,R,Mixed,R,162d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 193A10AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 162;	time from biopsy to failure/censoring (days): 1002;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533977,GPL570,54675,R,Mixed,R,8d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 193A7AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8;	time from biopsy to failure/censoring (days): 1156;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533978,GPL570,54675,R,Mixed,R,71d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 193A8AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 71;	time from biopsy to failure/censoring (days): 1093;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533979,GPL570,54675,NR,STA,NR,134d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 193A9AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 134;	time from biopsy to failure/censoring (days): 1030;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533980,GPL570,54675,R,Mixed,R,1148d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 1A10AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1148;	time from biopsy to failure/censoring (days): 1216;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533981,GPL570,54675,NR,STA,NR,1662d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 1A11AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1662;	time from biopsy to failure/censoring (days): 702;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533982,GPL570,54675,NR,STA,NR,1041d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 1A9AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1041;	time from biopsy to failure/censoring (days): 1323;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533983,GPL570,54675,NR,STA,NR,4726d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 200A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4726;	time from biopsy to failure/censoring (days): 887;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533984,GPL570,54675,NR,STA,NR,4135d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 204A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4135;	time from biopsy to failure/censoring (days): 981;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533985,GPL570,54675,NR,STA,NR,4811d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 205A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4811;	time from biopsy to failure/censoring (days): 873;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533986,GPL570,54675,NR,STA,NR,46d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 206A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 46;	time from biopsy to failure/censoring (days): 1011;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533987,GPL570,54675,NR,STA,NR,78d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 206A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 78;	time from biopsy to failure/censoring (days): 979;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533988,GPL570,54675,R,Mixed,R,511d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 206A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 511;	time from biopsy to failure/censoring (days): 546;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533989,GPL570,54675,R,Mixed,R,534d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 206A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 534;	time from biopsy to failure/censoring (days): 523;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533990,GPL570,54675,R,Mixed,R,216d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 20A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 216;	time from biopsy to failure/censoring (days): 1440;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533991,GPL570,54675,NR,STA,NR,242d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 20A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 242;	time from biopsy to failure/censoring (days): 1414;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533992,GPL570,54675,NR,STA,NR,3361d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 212A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3361;	time from biopsy to failure/censoring (days): 951;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533993,GPL570,54675,NR,STA,NR,6468d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 219A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 6468;	time from biopsy to failure/censoring (days): 254;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533994,GPL570,54675,NR,STA,NR,6547d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 219A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 6547;	time from biopsy to failure/censoring (days): 175;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533995,GPL570,54675,R,Mixed,R,678d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 21A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 678;	time from biopsy to failure/censoring (days): 246;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533996,GPL570,54675,NR,STA,NR,14d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 220A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 14;	time from biopsy to failure/censoring (days): 945;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533997,GPL570,54675,NR,STA,NR,743d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 221A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 743;	time from biopsy to failure/censoring (days): 1076;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533998,GPL570,54675,NR,STA,NR,922d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 232A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 922;	time from biopsy to failure/censoring (days): 882;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM533999,GPL570,54675,NR,STA,NR,85d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 233A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 85;	time from biopsy to failure/censoring (days): 905;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534000,GPL570,54675,NR,STA,NR,57d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 234A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 57;	time from biopsy to failure/censoring (days): 746;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534001,GPL570,54675,R,Mixed,R,161d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 234A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 161;	time from biopsy to failure/censoring (days): 590;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534002,GPL570,54675,NR,STA,NR,5744d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 235A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 5744;	time from biopsy to failure/censoring (days): 936;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534003,GPL570,54675,NR,STA,NR,3082d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 236A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3082;	time from biopsy to failure/censoring (days): 967;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534004,GPL570,54675,NR,STA,NR,46d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 238A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 46;	time from biopsy to failure/censoring (days): 884;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534005,GPL570,54675,R,Mixed,R,3878d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 239A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 3878;	time from biopsy to failure/censoring (days): 464;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534006,GPL570,54675,NR,STA,NR,6938d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 23A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 6938;	time from biopsy to failure/censoring (days): 10;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534007,GPL570,54675,R,Mixed,R,306d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 241A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 306;	time from biopsy to failure/censoring (days): 463;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534008,GPL570,54675,R,Mixed,R,465d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 246A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 465;	time from biopsy to failure/censoring (days): 322;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534009,GPL570,54675,R,Mixed,R,514d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 246A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 514;	time from biopsy to failure/censoring (days): 273;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534010,GPL570,54675,R,Mixed,R,5985d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 247A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 5985;	time from biopsy to failure/censoring (days): 901;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534011,GPL570,54675,NR,STA,NR,846d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 249A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 846;	time from biopsy to failure/censoring (days): 820;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534012,GPL570,54675,NR,STA,NR,1213d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 249A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1213;	time from biopsy to failure/censoring (days): 453;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534013,GPL570,54675,NR,STA,NR,8d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 24A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8;	time from biopsy to failure/censoring (days): 1696;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534014,GPL570,54675,R,Mixed,R,245d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 250A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 245;	time from biopsy to failure/censoring (days): 630;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534015,GPL570,54675,NR,STA,NR,969d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 251A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 969;	time from biopsy to failure/censoring (days): 881;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534016,GPL570,54675,R,Mixed,R,2650d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 252A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2650;	time from biopsy to failure/censoring (days): 837;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534017,GPL570,54675,NR,STA,NR,2676d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 252A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2676;	time from biopsy to failure/censoring (days): 811;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534018,GPL570,54675,NR,STA,NR,5414d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 254A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 5414;	time from biopsy to failure/censoring (days): 650;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534019,GPL570,54675,NR,STA,NR,23d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 255A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 23;	time from biopsy to failure/censoring (days): 698;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534020,GPL570,54675,R,Mixed,R,2022d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 257A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2022;	time from biopsy to failure/censoring (days): 719;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534021,GPL570,54675,NR,STA,NR,2043d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 257A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2043;	time from biopsy to failure/censoring (days): 698;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534022,GPL570,54675,NR,STA,NR,66d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 258A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 66;	time from biopsy to failure/censoring (days): 768;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534023,GPL570,54675,R,Mixed,R,93d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 258A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 93;	time from biopsy to failure/censoring (days): 741;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534024,GPL570,54675,R,Mixed,R,126d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 258A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 126;	time from biopsy to failure/censoring (days): 708;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534025,GPL570,54675,NR,STA,NR,182d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 258A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 182;	time from biopsy to failure/censoring (days): 652;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534026,GPL570,54675,NR,STA,NR,3760d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 25A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 3760;	time from biopsy to failure/censoring (days): 469;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534027,GPL570,54675,NR,STA,NR,1093d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 261A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1093;	time from biopsy to failure/censoring (days): 844;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534028,GPL570,54675,R,Mixed,R,544d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 266A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 544;	time from biopsy to failure/censoring (days): 581;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534029,GPL570,54675,NR,STA,NR,183d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 26A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 183;	time from biopsy to failure/censoring (days): 1650;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534030,GPL570,54675,NR,STA,NR,230d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 26A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 230;	time from biopsy to failure/censoring (days): 1603;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534031,GPL570,54675,NR,STA,NR,330d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 26A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 330;	time from biopsy to failure/censoring (days): 1503;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534032,GPL570,54675,R,Mixed,R,148d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 273A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 148;	time from biopsy to failure/censoring (days): 697;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534033,GPL570,54675,R,Mixed,R,175d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 273A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 175;	time from biopsy to failure/censoring (days): 670;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534034,GPL570,54675,NR,STA,NR,7730d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 274A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 7730;	time from biopsy to failure/censoring (days): 375;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534035,GPL570,54675,NR,STA,NR,58d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 275A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 58;	time from biopsy to failure/censoring (days): 762;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534036,GPL570,54675,NR,STA,NR,742d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 276A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 742;	time from biopsy to failure/censoring (days): 75;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534037,GPL570,54675,NR,STA,NR,8973d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 277A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8973;	time from biopsy to failure/censoring (days): 575;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534038,GPL570,54675,NR,STA,NR,302d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 279A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 302;	time from biopsy to failure/censoring (days): 700;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534039,GPL570,54675,R,Mixed,R,1118d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 27A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1118;	time from biopsy to failure/censoring (days): 1559;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534040,GPL570,54675,NR,STA,NR,2526d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 280A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2526;	time from biopsy to failure/censoring (days): 144;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534041,GPL570,54675,NR,STA,NR,13d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 281A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 13;	time from biopsy to failure/censoring (days): 693;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534042,GPL570,54675,NR,STA,NR,2847d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 282A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2847;	time from biopsy to failure/censoring (days): 694;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534043,GPL570,54675,R,Mixed,R,541d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 285A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 541;	time from biopsy to failure/censoring (days): 413;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534044,GPL570,54675,NR,STA,NR,633d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 286A1AGX8",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 633;	time from biopsy to failure/censoring (days): 142;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534045,GPL570,54675,NR,STA,NR,654d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 288A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 654;	time from biopsy to failure/censoring (days): 579;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534046,GPL570,54675,NR,STA,NR,725d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 288A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 725;	time from biopsy to failure/censoring (days): 508;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534047,GPL570,54675,NR,STA,NR,21d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 289A1AGX8",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 21;	time from biopsy to failure/censoring (days): 773;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534048,GPL570,54675,NR,STA,NR,28d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 289A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 28;	time from biopsy to failure/censoring (days): 766;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534049,GPL570,54675,NR,STA,NR,135d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 289A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 135;	time from biopsy to failure/censoring (days): 659;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534050,GPL570,54675,NR,STA,NR,1700d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 290A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1700;	time from biopsy to failure/censoring (days): 141;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534051,GPL570,54675,NR,STA,NR,6d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 292A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 6;	time from biopsy to failure/censoring (days): 817;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534052,GPL570,54675,NR,STA,NR,278d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 295A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 278;	time from biopsy to failure/censoring (days): 680;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534053,GPL570,54675,NR,STA,NR,12831d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 296A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 12831;	time from biopsy to failure/censoring (days): 639;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534054,GPL570,54675,NR,STA,NR,2914d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 300A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 2914;	time from biopsy to failure/censoring (days): 642;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534055,GPL570,54675,R,Mixed,R,571d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 301A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 571;	time from biopsy to failure/censoring (days): 599;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534056,GPL570,54675,NR,STA,NR,452d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 303A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 452;	time from biopsy to failure/censoring (days): 229;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534057,GPL570,54675,NR,STA,NR,3911d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 305A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3911;	time from biopsy to failure/censoring (days): 209;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534058,GPL570,54675,NR,STA,NR,7d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 306A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 7;	time from biopsy to failure/censoring (days): 819;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534059,GPL570,54675,NR,STA,NR,1020d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 307A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1020;	time from biopsy to failure/censoring (days): 633;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534060,GPL570,54675,NR,STA,NR,4409d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 313A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4409;	time from biopsy to failure/censoring (days): 595;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534061,GPL570,54675,NR,STA,NR,1464d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 315A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1464;	time from biopsy to failure/censoring (days): 216;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534062,GPL570,54675,R,Mixed,R,476d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 316A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 476;	time from biopsy to failure/censoring (days): 264;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534063,GPL570,54675,R,Mixed,R,4995d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 317A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 4995;	time from biopsy to failure/censoring (days): 502;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534064,GPL570,54675,R,Mixed,R,1875d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 321A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1875;	time from biopsy to failure/censoring (days): 811;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534065,GPL570,54675,NR,STA,NR,772d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 323A2AGX8",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 772;	time from biopsy to failure/censoring (days): 596;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534066,GPL570,54675,NR,STA,NR,1985d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 325A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1985;	time from biopsy to failure/censoring (days): 592;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534067,GPL570,54675,NR,STA,NR,5383d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 330A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 5383;	time from biopsy to failure/censoring (days): 146;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534068,GPL570,54675,NR,STA,NR,963d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 331A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 963;	time from biopsy to failure/censoring (days): 652;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534069,GPL570,54675,NR,STA,NR,10d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 332A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 10;	time from biopsy to failure/censoring (days): 652;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534070,GPL570,54675,R,Mixed,R,908d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 334A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 908;	time from biopsy to failure/censoring (days): 15;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534071,GPL570,54675,NR,STA,NR,23d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 337A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 23;	time from biopsy to failure/censoring (days): 650;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534072,GPL570,54675,NR,STA,NR,15d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 338A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 15;	time from biopsy to failure/censoring (days): 643;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534073,GPL570,54675,NR,STA,NR,273d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 339A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 273;	time from biopsy to failure/censoring (days): 8;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534074,GPL570,54675,NR,STA,NR,2045d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 340A2AGX8",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2045;	time from biopsy to failure/censoring (days): 636;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534075,GPL570,54675,NR,STA,NR,11453d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 342A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 11453;	time from biopsy to failure/censoring (days): 476;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534076,GPL570,54675,NR,STA,NR,169d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 343A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 169;	time from biopsy to failure/censoring (days): 802;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534077,GPL570,54675,NR,STA,NR,174d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 343A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 174;	time from biopsy to failure/censoring (days): 797;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534078,GPL570,54675,NR,STA,NR,1249d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 346A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1249;	time from biopsy to failure/censoring (days): 168;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534079,GPL570,54675,NR,STA,NR,3233d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 347A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3233;	time from biopsy to failure/censoring (days): 854;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534080,GPL570,54675,NR,STA,NR,6034d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 349A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 6034;	time from biopsy to failure/censoring (days): 766;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534081,GPL570,54675,NR,STA,NR,2806d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 360A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2806;	time from biopsy to failure/censoring (days): 307;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534082,GPL570,54675,NR,STA,NR,1562d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 361A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1562;	time from biopsy to failure/censoring (days): 577;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534083,GPL570,54675,NR,STA,NR,715d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 362A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 715;	time from biopsy to failure/censoring (days): 321;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534084,GPL570,54675,NR,STA,NR,8d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 366A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8;	time from biopsy to failure/censoring (days): 613;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534085,GPL570,54675,NR,STA,NR,464d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 367A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 464;	time from biopsy to failure/censoring (days): 527;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534086,GPL570,54675,NR,STA,NR,5547d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 370A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 5547;	time from biopsy to failure/censoring (days): 90;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534087,GPL570,54675,R,Mixed,R,1123d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 371A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1123;	time from biopsy to failure/censoring (days): 606;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534088,GPL570,54675,NR,STA,NR,9056d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 373A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 9056;	time from biopsy to failure/censoring (days): 545;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534089,GPL570,54675,NR,STA,NR,37d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 374A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 37;	time from biopsy to failure/censoring (days): 658;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534090,GPL570,54675,NR,STA,NR,21d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 380A1AX13",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 21;	time from biopsy to failure/censoring (days): 587;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534091,GPL570,54675,NR,STA,NR,10436d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 382A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 10436;	time from biopsy to failure/censoring (days): 81;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534092,GPL570,54675,R,Mixed,R,390d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 385A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 390;	time from biopsy to failure/censoring (days): 357;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534093,GPL570,54675,NR,STA,NR,2052d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 387A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2052;	time from biopsy to failure/censoring (days): 494;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534094,GPL570,54675,R,Mixed,R,49d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 388A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 49;	time from biopsy to failure/censoring (days): 605;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534095,GPL570,54675,R,Mixed,R,176d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 38A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 176;	time from biopsy to failure/censoring (days): 437;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534096,GPL570,54675,NR,STA,NR,121d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 38A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 121;	time from biopsy to failure/censoring (days): 492;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534097,GPL570,54675,NR,STA,NR,4349d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 395A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4349;	time from biopsy to failure/censoring (days): 421;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534098,GPL570,54675,NR,STA,NR,3240d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 396A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3240;	time from biopsy to failure/censoring (days): 399;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534099,GPL570,54675,NR,STA,NR,17d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 397A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 17;	time from biopsy to failure/censoring (days): 704;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534100,GPL570,54675,NR,STA,NR,52d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 397A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 52;	time from biopsy to failure/censoring (days): 669;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534101,GPL570,54675,NR,STA,NR,115d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 397A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 115;	time from biopsy to failure/censoring (days): 606;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534102,GPL570,54675,NR,STA,NR,772d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 398A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 772;	time from biopsy to failure/censoring (days): 524;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534103,GPL570,54675,NR,STA,NR,246d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 39A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 246;	time from biopsy to failure/censoring (days): 1581;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534104,GPL570,54675,NR,STA,NR,267d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 39A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 267;	time from biopsy to failure/censoring (days): 1560;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534105,GPL570,54675,NR,STA,NR,770d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 402A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 770;	time from biopsy to failure/censoring (days): 551;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534106,GPL570,54675,R,Mixed,R,8d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 403A2AGX8",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8;	time from biopsy to failure/censoring (days): 557;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534107,GPL570,54675,NR,STA,NR,18d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 406A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 18;	time from biopsy to failure/censoring (days): 547;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534108,GPL570,54675,R,Mixed,R,360d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 40A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 360;	time from biopsy to failure/censoring (days): 238;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534109,GPL570,54675,R,Mixed,R,372d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 40A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 372;	time from biopsy to failure/censoring (days): 226;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534110,GPL570,54675,R,Mixed,R,427d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 40A7AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 427;	time from biopsy to failure/censoring (days): 171;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534111,GPL570,54675,NR,STA,NR,493d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 40A8AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 493;	time from biopsy to failure/censoring (days): 105;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534112,GPL570,54675,R,Mixed,R,19d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 412A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 19;	time from biopsy to failure/censoring (days): 539;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534113,GPL570,54675,NR,STA,NR,1402d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 413A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1402;	time from biopsy to failure/censoring (days): 697;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534114,GPL570,54675,NR,STA,NR,1667d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 424A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1667;	time from biopsy to failure/censoring (days): 779;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534115,GPL570,54675,R,Mixed,R,3614d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 426A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3614;	time from biopsy to failure/censoring (days): 523;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534116,GPL570,54675,NR,STA,NR,1170d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 427A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1170;	time from biopsy to failure/censoring (days): 39;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534117,GPL570,54675,NR,STA,NR,1082d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 428A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1082;	time from biopsy to failure/censoring (days): 113;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534118,GPL570,54675,NR,STA,NR,513d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 435A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 513;	time from biopsy to failure/censoring (days): 833;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534119,GPL570,54675,NR,STA,NR,588d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 437A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 588;	time from biopsy to failure/censoring (days): 454;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534120,GPL570,54675,R,Mixed,R,687d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 438A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 687;	time from biopsy to failure/censoring (days): 701;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534121,GPL570,54675,R,Mixed,R,2224d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 43A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2224;	time from biopsy to failure/censoring (days): 1411;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534122,GPL570,54675,NR,STA,NR,2350d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 43A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2350;	time from biopsy to failure/censoring (days): 1435;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534123,GPL570,54675,NR,STA,NR,1317d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 441A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1317;	time from biopsy to failure/censoring (days): 656;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534124,GPL570,54675,NR,STA,NR,1462d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 441A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1462;	time from biopsy to failure/censoring (days): 511;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534125,GPL570,54675,NR,STA,NR,995d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 444A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 995;	time from biopsy to failure/censoring (days): 664;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534126,GPL570,54675,NR,STA,NR,4974d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 445A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4974;	time from biopsy to failure/censoring (days): 362;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534127,GPL570,54675,NR,STA,NR,474d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 446A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 474;	time from biopsy to failure/censoring (days): 392;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534128,GPL570,54675,NR,STA,NR,185d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 44A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 185;	time from biopsy to failure/censoring (days): 1355;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534129,GPL570,54675,NR,STA,NR,443d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 44A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 443;	time from biopsy to failure/censoring (days): 1097;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534130,GPL570,54675,R,Mixed,R,867d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 44A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 867;	time from biopsy to failure/censoring (days): 673;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534131,GPL570,54675,NR,STA,NR,996d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 453A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 996;	time from biopsy to failure/censoring (days): 435;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534132,GPL570,54675,NR,STA,NR,1732d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 45A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1732;	time from biopsy to failure/censoring (days): 1602;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534133,GPL570,54675,NR,STA,NR,622d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 460A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 622;	time from biopsy to failure/censoring (days): 477;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534134,GPL570,54675,NR,STA,NR,3099d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 464A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3099;	time from biopsy to failure/censoring (days): 259;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534135,GPL570,54675,NR,STA,NR,461d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 467A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 461;	time from biopsy to failure/censoring (days): 658;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534136,GPL570,54675,NR,STA,NR,4174d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 468A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4174;	time from biopsy to failure/censoring (days): 466;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534137,GPL570,54675,NR,STA,NR,46d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 473A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 46;	time from biopsy to failure/censoring (days): 543;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534138,GPL570,54675,NR,STA,NR,5181d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 479A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 5181;	time from biopsy to failure/censoring (days): 282;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534139,GPL570,54675,NR,STA,NR,11d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 47A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 11;	time from biopsy to failure/censoring (days): 1612;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534140,GPL570,54675,NR,STA,NR,1665d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 48A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1665;	time from biopsy to failure/censoring (days): 1480;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534141,GPL570,54675,NR,STA,NR,2108d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 492A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2108;	time from biopsy to failure/censoring (days): 639;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534142,GPL570,54675,NR,STA,NR,498d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 497A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 498;	time from biopsy to failure/censoring (days): 638;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534143,GPL570,54675,NR,STA,NR,8d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 49A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8;	time from biopsy to failure/censoring (days): 1497;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534144,GPL570,54675,NR,STA,NR,30d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 49A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 30;	time from biopsy to failure/censoring (days): 1475;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534145,GPL570,54675,NR,STA,NR,65d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 49A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 65;	time from biopsy to failure/censoring (days): 1440;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534146,GPL570,54675,NR,STA,NR,408d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 503A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 408;	time from biopsy to failure/censoring (days): 22;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534147,GPL570,54675,NR,STA,NR,1583d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 507A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 1583;	time from biopsy to failure/censoring (days): 427;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534148,GPL570,54675,NR,STA,NR,637d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 509A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 637;	time from biopsy to failure/censoring (days): 442;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534149,GPL570,54675,NR,STA,NR,18d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 513A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 18;	time from biopsy to failure/censoring (days): 566;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534150,GPL570,54675,NR,STA,NR,947d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 518A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 947;	time from biopsy to failure/censoring (days): 353;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534151,GPL570,54675,NR,STA,NR,601d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 525A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 601;	time from biopsy to failure/censoring (days): 310;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534152,GPL570,54675,R,Mixed,R,8419d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 526A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 8419;	time from biopsy to failure/censoring (days): 379;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534153,GPL570,54675,NR,STA,NR,5065d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 529A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 5065;	time from biopsy to failure/censoring (days): 323;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534154,GPL570,54675,R,Mixed,R,793d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 52A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 793;	time from biopsy to failure/censoring (days): 516;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534155,GPL570,54675,NR,STA,NR,898d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 52A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 898;	time from biopsy to failure/censoring (days): 411;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534156,GPL570,54675,NR,STA,NR,4076d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 532A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 4076;	time from biopsy to failure/censoring (days): 361;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534157,GPL570,54675,NR,STA,NR,3233d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 537A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 3233;	time from biopsy to failure/censoring (days): 225;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534158,GPL570,54675,R,Mixed,R,3499d,,1,,,,,,,"renal allograft biopsy,  (Minnesota) 544A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3499;	time from biopsy to failure/censoring (days): 341;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534159,GPL570,54675,NR,STA,NR,7649d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 549A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 7649;	time from biopsy to failure/censoring (days): 583;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534160,GPL570,54675,NR,STA,NR,1029d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 54A2AGX8",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1029;	time from biopsy to failure/censoring (days): 623;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534161,GPL570,54675,NR,STA,NR,1497d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 54A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1497;	time from biopsy to failure/censoring (days): 155;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534162,GPL570,54675,R,Mixed,R,762d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 55A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 762;	time from biopsy to failure/censoring (days): 1588;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534163,GPL570,54675,NR,STA,NR,14d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 56A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 14;	time from biopsy to failure/censoring (days): 1574;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534164,GPL570,54675,NR,STA,NR,26d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 56A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 26;	time from biopsy to failure/censoring (days): 1302;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534165,GPL570,54675,NR,STA,NR,1259d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 57A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1259;	time from biopsy to failure/censoring (days): 777;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534166,GPL570,54675,NR,STA,NR,718d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 58A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 718;	time from biopsy to failure/censoring (days): 1505;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534167,GPL570,54675,NR,STA,NR,121d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 59A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 121;	time from biopsy to failure/censoring (days): 1502;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534168,GPL570,54675,NR,STA,NR,23d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 60A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 23;	time from biopsy to failure/censoring (days): 1531;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534169,GPL570,54675,NR,STA,NR,249d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 60A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 249;	time from biopsy to failure/censoring (days): 1068;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534170,GPL570,54675,R,Mixed,R,556d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 61A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 556;	time from biopsy to failure/censoring (days): 1439;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534171,GPL570,54675,R,Mixed,R,606d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 61A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 606;	time from biopsy to failure/censoring (days): 1389;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534172,GPL570,54675,NR,STA,NR,309d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 63A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 309;	time from biopsy to failure/censoring (days): 1550;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534173,GPL570,54675,NR,STA,NR,4434d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 64A1AGX9",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 4434;	time from biopsy to failure/censoring (days): 192;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534174,GPL570,54675,R,Mixed,R,1835d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 65A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1835;	time from biopsy to failure/censoring (days): 1045;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534175,GPL570,54675,R,Mixed,R,1926d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 65A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 1926;	time from biopsy to failure/censoring (days): 954;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534176,GPL570,54675,R,Mixed,R,3717d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 66A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3717;	time from biopsy to failure/censoring (days): 1360;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534177,GPL570,54675,NR,STA,NR,4203d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 67A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 4203;	time from biopsy to failure/censoring (days): 776;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534178,GPL570,54675,NR,STA,NR,3984d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 71A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3984;	time from biopsy to failure/censoring (days): 1454;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534179,GPL570,54675,NR,STA,NR,10d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 72A3AGX9",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 10;	time from biopsy to failure/censoring (days): 259;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534180,GPL570,54675,R,Mixed,R,72d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 72A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 72;	time from biopsy to failure/censoring (days): 197;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534181,GPL570,54675,NR,STA,NR,217d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 72A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 217;	time from biopsy to failure/censoring (days): 52;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534182,GPL570,54675,R,Mixed,R,79d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 73A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 79;	time from biopsy to failure/censoring (days): 1327;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534183,GPL570,54675,R,Mixed,R,118d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 73A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 118;	time from biopsy to failure/censoring (days): 1288;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534184,GPL570,54675,R,Mixed,R,163d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 73A7AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 163;	time from biopsy to failure/censoring (days): 1243;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534185,GPL570,54675,NR,STA,NR,227d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 73A8AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 227;	time from biopsy to failure/censoring (days): 1179;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534186,GPL570,54675,NR,STA,NR,78d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 75A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 78;	time from biopsy to failure/censoring (days): 1251;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534187,GPL570,54675,R,Mixed,R,751d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 76A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 1;	time of biopsy post transplant (days): 751;	time from biopsy to failure/censoring (days): 298;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534188,GPL570,54675,NR,STA,NR,3683d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 77A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 3683;	time from biopsy to failure/censoring (days): 1491;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534189,GPL570,54675,NR,STA,NR,6d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 80A6AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 6;	time from biopsy to failure/censoring (days): 109;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534190,GPL570,54675,R,Mixed,R,113d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 80A7AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 113;	time from biopsy to failure/censoring (days): 2;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534191,GPL570,54675,NR,STA,NR,254d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 82A3AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 254;	time from biopsy to failure/censoring (days): 1152;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534192,GPL570,54675,NR,STA,NR,13d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 82A4AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 13;	time from biopsy to failure/censoring (days): 1393;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534193,GPL570,54675,R,Mixed,R,241d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 82A5AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 241;	time from biopsy to failure/censoring (days): 1165;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534194,GPL570,54675,NR,STA,NR,16d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 84A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 16;	time from biopsy to failure/censoring (days): 1359;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534195,GPL570,54675,R,Mixed,R,76d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 85A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 76;	time from biopsy to failure/censoring (days): 1367;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534196,GPL570,54675,R,Mixed,R,91d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 86A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 91;	time from biopsy to failure/censoring (days): 1322;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534197,GPL570,54675,NR,STA,NR,687d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 89A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 687;	time from biopsy to failure/censoring (days): 1374;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534198,GPL570,54675,NR,STA,NR,5301d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 90A1AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 5301;	time from biopsy to failure/censoring (days): 104;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534199,GPL570,54675,R,Mixed,R,867d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 94A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 867;	time from biopsy to failure/censoring (days): 1441;	rejection/non rejection: rej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534200,GPL570,54675,NR,STA,NR,42d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 95A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 42;	time from biopsy to failure/censoring (days): 1283;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534201,GPL570,54675,NR,STA,NR,310d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 96A6AGX11",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 310;	time from biopsy to failure/censoring (days): 965;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 0",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21374,GSM534202,GPL570,54675,NR,STA,NR,2822d,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago) 97A2AGX7",renal allograft biopsy,"failed=1/non failed=0: 0;	time of biopsy post transplant (days): 2822;	time from biopsy to failure/censoring (days): 1331;	rejection/non rejection: nonrej;	sample included in the main analysis- the first biopsy per patient from the 105 late (> 1 year) patients: 1",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE21785,GSM542661,GPL96,22283,Control,Normal,Control,,1,0,0,35,,,,,Tubulus_LD5,"Transplant Living Donor, microdissected Tubulus from kidney biopsy","gender: female;	age: 35 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542662,GPL96,22283,Control,Normal,Control,,1,0,1,39,,,,,Tubulus_LD6,"Transplant Living Donor, microdissected Tubulus from kidney biopsy","gender: male;	age: 39 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542663,GPL96,22283,Control,Normal,Control,,1,0,0,56,,,,,Tubulus_LD7,"Transplant Living Donor, microdissected Tubulus from kidney biopsy","gender: female;	age: 56 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542664,GPL96,22283,Control,Normal,Control,,1,0,1,41,,,,,Tubulus_LD8,"Transplant Living Donor, microdissected Tubulus from kidney biopsy","gender: male;	age: 41 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542665,GPL96,22283,Control,Normal,Control,,1,0,1,62,,,,,Tubulus_LD9,"Transplant Living Donor, microdissected Tubulus from kidney biopsy","gender: male;	age: 62 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542666,GPL96,22283,Control,Normal,Control,,1,0,0,58,,,,,Tubulus_LD10,"Transplant Living Donor, microdissected Tubulus from kidney biopsy","gender: female;	age: 58 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542667,GPL96,22283,Control,Normal,Control,,1,0,0,35,,,,,Glomerulus_LD5,"Transplant Living Donor, microdissected Glomerulus from kidney biopsy","gender: female;	age: 35 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542668,GPL96,22283,Control,Normal,Control,,1,0,1,39,,,,,Glomerulus_LD6,"Transplant Living Donor, microdissected Glomerulus from kidney biopsy","gender: male;	age: 39 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542669,GPL96,22283,Control,Normal,Control,,1,0,0,56,,,,,Glomerulus_LD7,"Transplant Living Donor, microdissected Glomerulus from kidney biopsy","gender: female;	age: 56 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542670,GPL96,22283,Control,Normal,Control,,1,0,1,41,,,,,Glomerulus_LD8,"Transplant Living Donor, microdissected Glomerulus from kidney biopsy","gender: male;	age: 41 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542671,GPL96,22283,Control,Normal,Control,,1,0,1,62,,,,,Glomerulus_LD9,"Transplant Living Donor, microdissected Glomerulus from kidney biopsy","gender: male;	age: 62 years",,,,,total RNA,Homo sapiens
GSE21785,GSM542672,GPL96,22283,Control,Normal,Control,,1,0,0,58,,,,,Glomerulus_LD10,"Transplant Living Donor, microdissected Glomerulus from kidney biopsy","gender: female;	age: 58 years",,,,,total RNA,Homo sapiens
GSE22459,GSM557856,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm1,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste443-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557857,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm2,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste473-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557858,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm3,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste479-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557859,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm4,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste480-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557860,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm5,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste486-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557861,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm6,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste487-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557862,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm7,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste502-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557863,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm8,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste507-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557864,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm9,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste522-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557865,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm10,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste536-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557866,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm11,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste538-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557867,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm12,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste546-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557868,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm13,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste549-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557869,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm14,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste555-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557870,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm15,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste567-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557871,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm16,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste572-HG-U133_Plus2-2,total RNA,Homo sapiens
GSE22459,GSM557872,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm17,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste579-HG-U133_Plus2-2,total RNA,Homo sapiens
GSE22459,GSM557873,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm18,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste585-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557874,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm19,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste586-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557875,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm20,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste593-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557876,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm21,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste594-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557877,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm22,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste595-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557878,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm23,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste600-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557879,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm24,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste603-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557880,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,T12_KidneyBx_Norm25,Normal,histology: 1yr protocol bx - Banff: i/cg/ci=0,,,,Ste606-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557881,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA1,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste436-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557882,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA2,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste439-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557883,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA3,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste440-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557884,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA4,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste444-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557885,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA5,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste445-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557886,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA6,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste450-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557887,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA7,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste465-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557888,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA8,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste470-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557889,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA9,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste491-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557890,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA10,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste497-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557891,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA11,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste505-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557892,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA12,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste521-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557893,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA13,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste528-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557894,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA14,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste530-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557895,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA15,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste543-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557896,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA16,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste547-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557897,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA17,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste559-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557898,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA18,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste575-HG-U133_Plus2-2,total RNA,Homo sapiens
GSE22459,GSM557899,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA19,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste576-HG-U133_Plus2-2,total RNA,Homo sapiens
GSE22459,GSM557900,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA20,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste584-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557901,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA21,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste588-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557902,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA22,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste590-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557903,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA23,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste591-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557904,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,T12_KidneyBx_IFTA24,IF/TA,histology: 1yr protocol bx - Banff: i/cg=0; ci>0,,,,Ste604-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557905,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i1,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste432-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557906,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i2,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste466-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557907,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i3,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste482-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557908,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i4,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste512-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557909,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i5,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste537-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557910,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i6,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste557-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557911,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i7,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste560-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557912,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i8,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste583-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557913,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i9,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste597-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557914,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i10,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste602-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557915,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i11,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste621-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557916,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i12,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste622-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557917,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i13,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste627-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557918,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i14,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste628-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557919,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i15,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste632-HG-U133_Plus2,total RNA,Homo sapiens
GSE22459,GSM557920,GPL570,54675,CR,CAN,IFTA_i,1y,,1,,,,,,,T12_KidneyBx_IFTA+i16,IFTA_i,histology: 1yr protocol bx - Banff: cg=0; i/ci>0,,,,Ste635-HG-U133_Plus2,total RNA,Homo sapiens
GSE25902,GSM635742,GPL570,54675,AR,TCMR,"TCMR, lowCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT881_09_11_06],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 3;	cadi score: 4;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635745,GPL570,54675,AR,TCMR,"TCMR, highCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT522],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 3;	cadi score: 6;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635749,GPL570,54675,AR,AR+CAN,"TCMR, IFTA, highCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT697],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 3;	cadi score: 10;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635752,GPL570,54675,AR,TCMR,"TCMR, IFTA, highCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT499_09_11_06],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 3;	cadi score: 9;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635753,GPL570,54675,AR,TCMR,"TCMR, lowCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT777],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 3;	cadi score: 3;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635754,GPL570,54675,AR,TCMR,"TCMR, lowCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT811],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 2;	cadi score: 1;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635755,GPL570,54675,AR,TCMR,"TCMR, lowCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT941_09_12_06],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 3;	cadi score: 3;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635758,GPL570,54675,AR,TCMR,"TCMR, lowCADI",Indication,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Post-transplant rejection (Project 4) [KT821],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 3;	cadi score: 4;	time point: Indication",Tacrolimus-Mycophenolate mofetil,,,Post-transplant rejection (Project 4),total RNA,Homo sapiens
GSE25902,GSM635759,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT707_1_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635760,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1207_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635761,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT820_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 1;	cadi score: 2;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635762,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1383_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 2;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635763,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT1018_B_2_24_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635764,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT1118_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635765,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT1113_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635766,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT944_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635767,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1385_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 2;	total i score: 0;	cadi score: 0;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635768,GPL570,54675,NR,STA,nonprogressive,6m,0,1,1,25,1,16,White,Steroid-based,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT973_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 2;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635769,GPL570,54675,Control,Normal,Baseline,0,0,1,1,25,1,18,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT814_05_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635770,GPL570,54675,NR,IFTA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1289_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 2;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635771,GPL570,54675,NR,STA,nonprogressive,6m,0,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT977_06_28_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635772,GPL570,54675,Control,Normal,Baseline,0,0,1,1,21,1,9.3,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT819_06_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635773,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1349_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 2;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635774,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1314_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 2;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635775,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT790_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635776,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT903_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635777,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1374_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635778,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT897_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635779,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT1026_2_18_09_2],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635780,GPL570,54675,CNIT,CAN,nonprogressive. Acute CNIT,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT1042_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635781,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT861_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635782,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1336_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635783,GPL570,54675,Control,Normal,Baseline,0,1,1,1,21,1,17.8,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT616_06_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635784,GPL570,54675,NR,STA,nonprogressive,6m,1,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT702_06_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635785,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1098_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 1;	cadi score: 3;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635786,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT839_06_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635787,GPL570,54675,Control,Normal,Baseline,0,1,1,0,54,0,2.4,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT738_06_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635788,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1238_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635789,GPL570,54675,Control,Normal,Baseline,0,0,1,1,16,0,2.6,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT832_06_28_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635790,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT961_06_28_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635791,GPL570,54675,NR,CAN,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1300_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 2;	cadi score: 5;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635792,GPL570,54675,NR,STA,nonprogressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Non-progressive CADI score (Project 2 and Project 3) [KT967_06_28_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Non-progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635793,GPL570,54675,Control,Normal,Baseline,0,0,1,0,31,1,17.1,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Non-progressive CADI score (Project 2) [KT818_05_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Non-progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635794,GPL570,54675,NR,STA,lowCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2) [KT1313_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 3;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set low CADI score (Project 1 and Project 4) and 24 months low CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635795,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT778_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 0;	cadi score: 2;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635796,GPL570,54675,NR,IFTA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT930_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 2;	cadi score: 5;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635797,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1284_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 2;	cadi score: 8;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635798,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT783_1_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 2;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635799,GPL570,54675,NR,STA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT932_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635800,GPL570,54675,CR,TCMR,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1287_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 3;	cadi score: 7;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635801,GPL570,54675,Control,Normal,Baseline,0,1,1,1,36,1,14.3,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT752_06_25_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635802,GPL570,54675,NR,STA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT847_06_28_07],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 3;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635803,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1232_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 2;	total i score: 2;	cadi score: 8;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635804,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT754_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635805,GPL570,54675,NR,CAN,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT894_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 1;	cadi score: 3;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635806,GPL570,54675,CR,BL+CAN,"IFTA, lowCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1446_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 2;	total i score: 2;	cadi score: 4;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635807,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT923_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635808,GPL570,54675,CR,IFTA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT1183_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 2;	cadi score: 6;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635809,GPL570,54675,CR,IFTA,highCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1371_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 2;	cadi score: 9;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635810,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT764_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635811,GPL570,54675,NR,CAN,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT855_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 1;	cadi score: 4;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635812,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1316_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 3;	cadi score: 7;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635813,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT849_1_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635814,GPL570,54675,CR,CAN,highCADI,24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1328_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 1;	cadi score: 6;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635815,GPL570,54675,NR,TCMR,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT1010_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 3;	cadi score: 3;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635816,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT609_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 4;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635817,GPL570,54675,NR,STA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT675_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 5;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635818,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1065_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 2;	cadi score: 10;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635819,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT859_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635820,GPL570,54675,CR,IFTA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT1040_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 1;	cadi score: 3;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635821,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1331_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 2;	total i score: 2;	cadi score: 6;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635822,GPL570,54675,NR,STA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT860_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635823,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT766_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635824,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1255_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 2;	total i score: 2;	cadi score: 6;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635825,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT858_2_6_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 3;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635826,GPL570,54675,CR,IFTA,progressive,6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT1034_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 1;	total i score: 1;	cadi score: 4;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635827,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1325_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 3;	cadi score: 8;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635828,GPL570,54675,Control,Normal,Baseline,0,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Baseline (0 months) - Progressive CADI score (Project 2) [KT949_2_16_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 0;	time point: 00 months",Tacrolimus-Mycophenolate mofetil,,,Baseline (0 months) - Progressive CADI score (Project 2),total RNA,Homo sapiens
GSE25902,GSM635829,GPL570,54675,CAN,CAN,"progressive, Acute CNIT",6m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,6 months - Progressive CADI score (Project 2 and Project 3) [KT1115_2_18_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 0;	total i score: 0;	cadi score: 1;	time point: 06 months",Tacrolimus-Mycophenolate mofetil,,,6 months - Progressive CADI score (Project 2 and Project 3),total RNA,Homo sapiens
GSE25902,GSM635830,GPL570,54675,CR,CAN,"IFTA, highCADI",24m,,1,,,,,,Tacrolimus-Mycophenolate mofetil,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2) [KT1384_2_20_09],Kidney transplant biopsy,"tissue: Kidney transplant biopsy;	i-ifta grade: 3;	total i score: 3;	cadi score: 8;	time point: 24 months",Tacrolimus-Mycophenolate mofetil,,,Validation set high CADI score (Project 1 + Project 4) and 24 months high CADI score (Project 2),total RNA,Homo sapiens
GSE26578,GSM654300,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR1_Rep1,kidney,"condition_sample_id: AR1;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654301,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR1_Rep2,kidney,"condition_sample_id: AR1;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654302,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR2_Rep1,kidney,"condition_sample_id: AR2;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654303,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR2_Rep2,kidney,"condition_sample_id: AR2;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654304,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR3_Rep1,kidney,"condition_sample_id: AR3;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654305,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR3_Rep2,kidney,"condition_sample_id: AR3;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654306,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR4_Rep1,kidney,"condition_sample_id: AR4;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654307,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR4_Rep2,kidney,"condition_sample_id: AR4;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654308,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR5_Rep1,kidney,"condition_sample_id: AR5;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654309,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR5_Rep2,kidney,"condition_sample_id: AR5;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654310,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR6_Rep1,kidney,"condition_sample_id: AR6;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654311,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR6_Rep2,kidney,"condition_sample_id: AR6;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654312,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR7_Rep1,kidney,"condition_sample_id: AR7;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654313,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR7_Rep2,kidney,"condition_sample_id: AR7;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654314,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR8_Rep1,kidney,"condition_sample_id: AR8;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654315,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR8_Rep2,kidney,"condition_sample_id: AR8;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654316,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR9_Rep1,kidney,"condition_sample_id: AR9;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654317,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR9_Rep2,kidney,"condition_sample_id: AR9;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654318,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR10_Rep1,kidney,"condition_sample_id: AR10;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654319,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR10_Rep2,kidney,"condition_sample_id: AR10;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654320,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR11_Rep1,kidney,"condition_sample_id: AR11;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654321,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR11_Rep2,kidney,"condition_sample_id: AR11;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654322,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR12_Rep1,kidney,"condition_sample_id: AR12;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654323,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR12_Rep2,kidney,"condition_sample_id: AR12;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654324,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR13_Rep1,kidney,"condition_sample_id: AR13;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654325,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR13_Rep2,kidney,"condition_sample_id: AR13;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654326,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR14_Rep1,kidney,"condition_sample_id: AR14;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654327,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR14_Rep2,kidney,"condition_sample_id: AR14;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654328,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR15_Rep1,kidney,"condition_sample_id: AR15;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654329,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR15_Rep2,kidney,"condition_sample_id: AR15;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654330,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR16_Rep1,kidney,"condition_sample_id: AR16;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654331,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR16_Rep2,kidney,"condition_sample_id: AR16;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654332,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR17_Rep1,kidney,"condition_sample_id: AR17;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654333,GPL9301,1347,AR,Mixed,AR,,,1,,,,,,,AR17_Rep2,kidney,"condition_sample_id: AR17;	tissue: kidney;	disease status: acute rejection",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654334,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN1_Rep1,kidney,"condition_sample_id: ATN1;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654335,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN1_Rep2,kidney,"condition_sample_id: ATN1;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654336,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN2_Rep1,kidney,"condition_sample_id: ATN2;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654337,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN2_Rep2,kidney,"condition_sample_id: ATN2;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654338,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN3_Rep1,kidney,"condition_sample_id: ATN3;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654339,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN3_Rep2,kidney,"condition_sample_id: ATN3;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654340,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN4_Rep1,kidney,"condition_sample_id: ATN4;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654341,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN4_Rep2,kidney,"condition_sample_id: ATN4;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654342,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN5_Rep1,kidney,"condition_sample_id: ATN5;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654343,GPL9301,1347,,DGF,ATN,,,1,,,,,,,ATN5_Rep2,kidney,"condition_sample_id: ATN5;	tissue: kidney;	disease status: acute tubular necrosis",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654344,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx1_Rep1,kidney,"condition_sample_id: Tx1;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654345,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx1_Rep2,kidney,"condition_sample_id: Tx1;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654346,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx2_Rep1,kidney,"condition_sample_id: Tx2;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654347,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx2_Rep2,kidney,"condition_sample_id: Tx2;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654348,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx3_Rep1,kidney,"condition_sample_id: Tx3;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654349,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx3_Rep2,kidney,"condition_sample_id: Tx3;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654350,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx4_Rep1,kidney,"condition_sample_id: Tx4;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654351,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx4_Rep2,kidney,"condition_sample_id: Tx4;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654352,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx5_Rep1,kidney,"condition_sample_id: Tx5;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654353,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx5_Rep2,kidney,"condition_sample_id: Tx5;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654354,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx6_Rep1,kidney,"condition_sample_id: Tx6;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654355,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx6_Rep2,kidney,"condition_sample_id: Tx6;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654356,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx7_Rep1,kidney,"condition_sample_id: Tx7;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654357,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx7_Rep2,kidney,"condition_sample_id: Tx7;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654358,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx8_Rep1,kidney,"condition_sample_id: Tx8;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654359,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx8_Rep2,kidney,"condition_sample_id: Tx8;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654360,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx9_Rep1,kidney,"condition_sample_id: Tx9;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654361,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx9_Rep2,kidney,"condition_sample_id: Tx9;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654362,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx10_Rep1,kidney,"condition_sample_id: Tx10;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654363,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx10_Rep2,kidney,"condition_sample_id: Tx10;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654364,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx11_Rep1,kidney,"condition_sample_id: Tx11;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654365,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx11_Rep2,kidney,"condition_sample_id: Tx11;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654366,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx12_Rep1,kidney,"condition_sample_id: Tx12;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654367,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx13_Rep1,kidney,"condition_sample_id: Tx13;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654368,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx13_Rep2,kidney,"condition_sample_id: Tx13;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654369,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx14_Rep1,kidney,"condition_sample_id: Tx14;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654370,GPL9301,1347,NR,STA,STA,,,1,,,,,,,Tx14_Rep2,kidney,"condition_sample_id: Tx14;	tissue: kidney;	disease status: stable renal function",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654371,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD1_Rep1,kidney,"condition_sample_id: TD1;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654372,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD1_Rep2,kidney,"condition_sample_id: TD1;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654373,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD2_Rep1,kidney,"condition_sample_id: TD2;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654374,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD2_Rep2,kidney,"condition_sample_id: TD2;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654375,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD3_Rep1,kidney,"condition_sample_id: TD3;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654376,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD3_Rep2,kidney,"condition_sample_id: TD3;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654377,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD4_Rep1,kidney,"condition_sample_id: TD4;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654378,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD4_Rep2,kidney,"condition_sample_id: TD4;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654379,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD5_Rep1,kidney,"condition_sample_id: TD5;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654380,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD5_Rep2,kidney,"condition_sample_id: TD5;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654381,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD6_Rep1,kidney,"condition_sample_id: TD6;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654382,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD6_Rep2,kidney,"condition_sample_id: TD6;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654383,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD7_Rep1,kidney,"condition_sample_id: TD7;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654384,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD7_Rep2,kidney,"condition_sample_id: TD7;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654385,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD8_Rep1,kidney,"condition_sample_id: TD8;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654386,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD8_Rep2,kidney,"condition_sample_id: TD8;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654387,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD9_Rep1,kidney,"condition_sample_id: TD9;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654388,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD9_Rep2,kidney,"condition_sample_id: TD9;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654389,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD10_Rep1,kidney,"condition_sample_id: TD10;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654390,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD10_Rep2,kidney,"condition_sample_id: TD10;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654391,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD11_Rep1,kidney,"condition_sample_id: TD11;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654392,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD11_Rep2,kidney,"condition_sample_id: TD11;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654393,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD12_Rep1,kidney,"condition_sample_id: TD12;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654394,GPL9301,1347,NR,STA,STA,,,1,,,,,,,TD12_Rep2,kidney,"condition_sample_id: TD12;	tissue: kidney;	disease status: donor tissue with stable function early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654395,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD13_Rep1,kidney,"condition_sample_id: TD13;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654396,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD13_Rep2,kidney,"condition_sample_id: TD13;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654397,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD14_Rep1,kidney,"condition_sample_id: TD14;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654398,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD14_Rep2,kidney,"condition_sample_id: TD14;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654399,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD15_Rep1,kidney,"condition_sample_id: TD15;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654400,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD15_Rep2,kidney,"condition_sample_id: TD15;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654401,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD16_Rep1,kidney,"condition_sample_id: TD16;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654402,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD16_Rep2,kidney,"condition_sample_id: TD16;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654403,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD17_Rep1,kidney,"condition_sample_id: TD17;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654404,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD17_Rep2,kidney,"condition_sample_id: TD17;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654405,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD18_Rep1,kidney,"condition_sample_id: TD18;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654406,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD18_Rep2,kidney,"condition_sample_id: TD18;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654407,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD19_Rep1,kidney,"condition_sample_id: TD19;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654408,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD19_Rep2,kidney,"condition_sample_id: TD19;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654409,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD20_Rep1,kidney,"condition_sample_id: TD20;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654410,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD20_Rep2,kidney,"condition_sample_id: TD20;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654411,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD21_Rep1,kidney,"condition_sample_id: TD21;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE26578,GSM654412,GPL9301,1347,,DGF,Dysf,,,1,,,,,,,TD21_Rep2,kidney,"condition_sample_id: TD21;	tissue: kidney;	disease status: donor tissue with renal dysfunction early after transplantation",,,,"PBMC samples from acute rejection, acute tubule necrosis, renal recipients with stable function, donor tissue with stable function early after transplantation and donor tissue with stable function early after transplantation.",total RNA,Homo sapiens
GSE30122,GSM756992,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 40, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 40",,,,"HK40G;	KS1-HG_U133A_2-2757",total RNA,Homo sapiens
GSE30122,GSM756993,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 48, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 48",,,,"HK48G;	KS1-HG_U133A_2-2871",total RNA,Homo sapiens
GSE30122,GSM756994,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 62, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 62",,,,"HK62G;	KS1-HG_U133A_2-2901",total RNA,Homo sapiens
GSE30122,GSM756995,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 67, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 67",,,,"HK67G;	KS1-HG_U133A_2-2905",total RNA,Homo sapiens
GSE30122,GSM756996,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 151, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 151",,,,"HK151G;	KS1-HG_U133A_2-5117",total RNA,Homo sapiens
GSE30122,GSM756997,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 158, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 158",,,,"HK158G;	KS1-HG_U133A_2-6372",total RNA,Homo sapiens
GSE30122,GSM756998,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 164, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 164",,,,"HK164G;	KS1-HG_U133A_2-6393",total RNA,Homo sapiens
GSE30122,GSM756999,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 168, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 168",,,,"HK168G;	KS1-HG_U133A_2-6395",total RNA,Homo sapiens
GSE30122,GSM757000,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 178, Glomeruli",Glomerulus of DKD kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: diabetic kidney disease (DKD);	individual: 178",,,,"HK178G;	KS1-HG_U133A_2-6574",total RNA,Homo sapiens
GSE30122,GSM757001,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 33, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 33",,,,"HK33G;	KS1-HG_U133A_2-2772",total RNA,Homo sapiens
GSE30122,GSM757002,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 34, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 34",,,,"HK34G;	KS1-HG_U133A_2-2784",total RNA,Homo sapiens
GSE30122,GSM757003,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 76, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 76",,,,"HK76G;	KS1-HG_U133A_2-2911",total RNA,Homo sapiens
GSE30122,GSM757004,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 77, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 77",,,,"HK77G;	KS1-HG_U133A_2-2913",total RNA,Homo sapiens
GSE30122,GSM757005,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 81, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 81",,,,"HK81G;	KS1-HG_U133A_2-2919",total RNA,Homo sapiens
GSE30122,GSM757006,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 82, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 82",,,,"HK82G;	KS1-HG_U133A_2-2921",total RNA,Homo sapiens
GSE30122,GSM757007,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 83, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 83",,,,"HK83G;	KS1-HG_U133A_2-2923",total RNA,Homo sapiens
GSE30122,GSM757008,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 100, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 100",,,,"HK100G;	KS1-HG_U133A_2-3427",total RNA,Homo sapiens
GSE30122,GSM757009,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 110, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 110",,,,"HK110G;	KS1-HG_U133A_2-3467",total RNA,Homo sapiens
GSE30122,GSM757010,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 119, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 119",,,,"HK119G;	KS1-HG_U133A_2-3470",total RNA,Homo sapiens
GSE30122,GSM757011,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 123, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 123",,,,"HK123G;	KS1-HG_U133A_2-5111",total RNA,Homo sapiens
GSE30122,GSM757012,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 150, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 150",,,,"HK150G;	KS1-HG_U133A_2-5116",total RNA,Homo sapiens
GSE30122,GSM757013,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 154, Glomeruli",Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 154",,,,"HK154G;	KS1-HG_U133A_2-5118",total RNA,Homo sapiens
GSE30122,GSM757014,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 43, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK43T;	KS1-HG_U133A_2-2765",total RNA,Homo sapiens
GSE30122,GSM757015,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 62, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK62T;	KS1-HG_U133A_2-2902",total RNA,Homo sapiens
GSE30122,GSM757016,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 67, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK67T;	KS1-HG_U133A_2-2876",total RNA,Homo sapiens
GSE30122,GSM757017,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 120, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK120T;	KS1-HG_U133A_2-9417",total RNA,Homo sapiens
GSE30122,GSM757018,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 148, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK148T;	KS1-HG_U133A_2-7680",total RNA,Homo sapiens
GSE30122,GSM757019,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 162, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK162T;	KS1-HG_U133A_2-6377",total RNA,Homo sapiens
GSE30122,GSM757020,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 164, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK164T;	KS1-HG_U133A_2-6394",total RNA,Homo sapiens
GSE30122,GSM757021,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 168, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK168T;	KS1-HG_U133A_2-6396",total RNA,Homo sapiens
GSE30122,GSM757022,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 178, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK178T;	KS1-HG_U133A_2-6575",total RNA,Homo sapiens
GSE30122,GSM757023,GPL571,22277,,noIMD,DKD,,,0,,,,,,,"Diabetic Human Kidney 187, Tubuli",Tubuli of DKD kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: diabetic kidney disease (DKD)",,,,"HK187T;	KS1-HG_U133A_2-7682",total RNA,Homo sapiens
GSE30122,GSM757024,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 17, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK17T;	KS1-HG_U133A_2-2898",total RNA,Homo sapiens
GSE30122,GSM757025,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 37, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK37T;	KS1-HG_U133A_2-2868",total RNA,Homo sapiens
GSE30122,GSM757026,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 53, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK53T;	KS1-HG_U133A_2-2741",total RNA,Homo sapiens
GSE30122,GSM757027,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 64, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK64T;	KS1-HG_U133A_2-2903",total RNA,Homo sapiens
GSE30122,GSM757028,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 70, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK70T;	KS1-HG_U133A_2-2906",total RNA,Homo sapiens
GSE30122,GSM757029,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 76, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK76T;	KS1-HG_U133A_2-2912",total RNA,Homo sapiens
GSE30122,GSM757030,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 77, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK77T;	KS1-HG_U133A_2-2914",total RNA,Homo sapiens
GSE30122,GSM757031,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 81, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK81T;	KS1-HG_U133A_2-2920",total RNA,Homo sapiens
GSE30122,GSM757032,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 82, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK82T;	KS1-HG_U133A_2-2922",total RNA,Homo sapiens
GSE30122,GSM757033,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 160, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK160T;	KS1-HG_U133A_2-6375",total RNA,Homo sapiens
GSE30122,GSM757034,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 172, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK172T;	KS1-HG_U133A_2-6466",total RNA,Homo sapiens
GSE30122,GSM757035,GPL571,22277,Control,Normal,Control,,,0,,,,,,,"Control Human Kidney 177, Tubuli",Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubules;	disease state: control",,,,"HK177T;	KS1-HG_U133A_2-6573",total RNA,Homo sapiens
GSE30122,GSM758485,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 33,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 33",,,,"HK33G;	KS1-HG_U133A_2-2772",total RNA,Homo sapiens
GSE30122,GSM758486,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 34,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 34",,,,"HK34G;	KS1-HG_U133A_2-2784",total RNA,Homo sapiens
GSE30122,GSM758487,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 76,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 76",,,,"HK76G;	KS1-HG_U133A_2-2911",total RNA,Homo sapiens
GSE30122,GSM758488,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 77,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 77",,,,"HK77G;	KS1-HG_U133A_2-2913",total RNA,Homo sapiens
GSE30122,GSM758489,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 81,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 81",,,,"HK81G;	KS1-HG_U133A_2-2919",total RNA,Homo sapiens
GSE30122,GSM758490,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 82,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 82",,,,"HK82G;	KS1-HG_U133A_2-2921",total RNA,Homo sapiens
GSE30122,GSM758491,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 83,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 83",,,,"HK83G;	KS1-HG_U133A_2-2923",total RNA,Homo sapiens
GSE30122,GSM758492,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 100,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 100",,,,"HK100G;	KS1-HG_U133A_2-3427",total RNA,Homo sapiens
GSE30122,GSM758493,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 110,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 110",,,,"HK110G;	KS1-HG_U133A_2-3467",total RNA,Homo sapiens
GSE30122,GSM758494,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 119,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 119",,,,"HK119G;	KS1-HG_U133A_2-3470",total RNA,Homo sapiens
GSE30122,GSM758495,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 123,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 123",,,,"HK123G;	KS1-HG_U133A_2-5111",total RNA,Homo sapiens
GSE30122,GSM758496,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 150,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 150",,,,"HK150G;	KS1-HG_U133A_2-5116",total RNA,Homo sapiens
GSE30122,GSM758497,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Glomeruli 154,Glomerulus of control kidney,"tissue: kidney;	tissue subregion: glomerulus;	disease state: control;	individual: 154",,,,"HK154G;	KS1-HG_U133A_2-5118",total RNA,Homo sapiens
GSE30122,GSM758498,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 17,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 17",,,,"HK17T;	KS1-HG_U133A_2-2898",total RNA,Homo sapiens
GSE30122,GSM758499,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 37,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 37",,,,"HK37T;	KS1-HG_U133A_2-2868",total RNA,Homo sapiens
GSE30122,GSM758500,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 53,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 53",,,,"HK53T;	KS1-HG_U133A_2-2741",total RNA,Homo sapiens
GSE30122,GSM758501,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 64,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 64",,,,"HK64T;	KS1-HG_U133A_2-2903",total RNA,Homo sapiens
GSE30122,GSM758502,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 70,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 70",,,,"HK70T;	KS1-HG_U133A_2-2906",total RNA,Homo sapiens
GSE30122,GSM758503,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 76,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 76",,,,"HK76T;	KS1-HG_U133A_2-2912",total RNA,Homo sapiens
GSE30122,GSM758504,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 77,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 77",,,,"HK77T;	KS1-HG_U133A_2-2914",total RNA,Homo sapiens
GSE30122,GSM758505,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 81,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 81",,,,"HK81T;	KS1-HG_U133A_2-2920",total RNA,Homo sapiens
GSE30122,GSM758506,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 82,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 82",,,,"HK82T;	KS1-HG_U133A_2-2922",total RNA,Homo sapiens
GSE30122,GSM758507,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 160,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 160",,,,"HK160T;	KS1-HG_U133A_2-6375",total RNA,Homo sapiens
GSE30122,GSM758508,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 172,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 172",,,,"HK172T;	KS1-HG_U133A_2-6466",total RNA,Homo sapiens
GSE30122,GSM758509,GPL571,22277,Control,Normal,Control,,,0,,,,,,,Control Human Tubuli 177,Tubuli of control kidney,"tissue: kidney;	tissue subregion: tubulus;	disease state: control;	individual: 177",,,,"HK177T;	KS1-HG_U133A_2-6573",total RNA,Homo sapiens
GSE30718,GSM761735,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH1,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761736,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH2,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761737,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH3,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761738,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH4,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761739,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH5,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761740,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH6,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761741,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH7,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761742,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy NEPH8,nephrectomy,"diagnosis: Nephrectomy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761743,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB1,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761744,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB2,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761745,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB3,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761746,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB4,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761747,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB5,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761748,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB6,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761749,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB7,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761750,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB8,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761751,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB9,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761752,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB10,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE30718,GSM761753,GPL570,54675,NR,STA,Stable,,,1,,,,,,,pristine protocol biopsy pPB11,protocol biopsy,"diagnosis: pristine protocol biopsy;	tissue: kidney",The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,"Samples with the same initial numbers in the sample names are replicates from the same patient. For the main analysis, only the earliest biopsy per patient was used, and only in those patients with a biopsy taken > 1 year post-transplant",total RNA,Homo sapiens
GSE32591,GSM807842,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_301,Tubulointerstitium from LN patient,"patient number: 1;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807843,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_302,Tubulointerstitium from LN patient,"patient number: 2;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807844,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_304,Tubulointerstitium from LN patient,"patient number: 3;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807845,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_305,Tubulointerstitium from LN patient,"patient number: 4;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807846,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_306,Tubulointerstitium from LN patient,"patient number: 5;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807847,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_307,Tubulointerstitium from LN patient,"patient number: 6;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807848,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_308,Tubulointerstitium from LN patient,"patient number: 7;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807849,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_309,Tubulointerstitium from LN patient,"patient number: 8;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807850,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_310,Tubulointerstitium from LN patient,"patient number: 9;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807851,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_311,Tubulointerstitium from LN patient,"patient number: 10;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807852,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_312,Tubulointerstitium from LN patient,"patient number: 11;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807853,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_313,Tubulointerstitium from LN patient,"patient number: 12;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807854,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_314,Tubulointerstitium from LN patient,"patient number: 13;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807855,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_318,Tubulointerstitium from LN patient,"patient number: 14;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807856,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_319,Tubulointerstitium from LN patient,"patient number: 15;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807857,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_323,Tubulointerstitium from LN patient,"patient number: 16;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807858,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_329,Tubulointerstitium from LN patient,"patient number: 17;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807859,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_336,Tubulointerstitium from LN patient,"patient number: 18;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807860,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_338,Tubulointerstitium from LN patient,"patient number: 19;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807861,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_340,Tubulointerstitium from LN patient,"patient number: 20;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807862,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_342,Tubulointerstitium from LN patient,"patient number: 21;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807863,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_343,Tubulointerstitium from LN patient,"patient number: 22;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807864,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_346,Tubulointerstitium from LN patient,"patient number: 23;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807865,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_348,Tubulointerstitium from LN patient,"patient number: 24;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807866,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_349,Tubulointerstitium from LN patient,"patient number: 25;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807867,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_352,Tubulointerstitium from LN patient,"patient number: 26;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807868,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_357,Tubulointerstitium from LN patient,"patient number: 27;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807869,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_358,Tubulointerstitium from LN patient,"patient number: 28;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807870,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_359,Tubulointerstitium from LN patient,"patient number: 29;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807871,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_360,Tubulointerstitium from LN patient,"patient number: 30;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807872,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_361,Tubulointerstitium from LN patient,"patient number: 31;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807873,GPL14663,12029,,IMD,LN,,,0,,,,,,,Tub_LN_362,Tubulointerstitium from LN patient,"patient number: 32;	disease status: LN patient;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807874,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_363,Tubulointerstitium from control living donor,"patient number: 1;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807875,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_364,Tubulointerstitium from control living donor,"patient number: 2;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807876,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_365,Tubulointerstitium from control living donor,"patient number: 3;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807877,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_366,Tubulointerstitium from control living donor,"patient number: 4;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807878,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_367,Tubulointerstitium from control living donor,"patient number: 5;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807879,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_368,Tubulointerstitium from control living donor,"patient number: 6;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807880,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_369,Tubulointerstitium from control living donor,"patient number: 7;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807881,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_370,Tubulointerstitium from control living donor,"patient number: 8;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807882,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_371,Tubulointerstitium from control living donor,"patient number: 9;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807883,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_373,Tubulointerstitium from control living donor,"patient number: 10;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807884,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_374,Tubulointerstitium from control living donor,"patient number: 11;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807885,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_375,Tubulointerstitium from control living donor,"patient number: 12;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807886,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_376,Tubulointerstitium from control living donor,"patient number: 13;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807887,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_377,Tubulointerstitium from control living donor,"patient number: 14;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807888,GPL14663,12029,Control,Normal,Control,,1,0,,,,,,,Tub_LD_378,Tubulointerstitium from control living donor,"patient number: 15;	disease status: control;	tissue: Tubulointerstitium from kidney biopsy",,,,Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807889,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_401,Glomeruli from LN patient,"patient number: 1;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807890,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_402,Glomeruli from LN patient,"patient number: 2;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807891,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_404,Glomeruli from LN patient,"patient number: 3;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807892,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_405,Glomeruli from LN patient,"patient number: 4;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807893,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_406,Glomeruli from LN patient,"patient number: 5;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807894,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_407,Glomeruli from LN patient,"patient number: 6;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807895,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_408,Glomeruli from LN patient,"patient number: 7;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807896,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_409,Glomeruli from LN patient,"patient number: 8;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807897,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_410,Glomeruli from LN patient,"patient number: 9;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807898,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_411,Glomeruli from LN patient,"patient number: 10;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807899,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_412,Glomeruli from LN patient,"patient number: 11;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807900,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_413,Glomeruli from LN patient,"patient number: 12;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807901,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_414,Glomeruli from LN patient,"patient number: 13;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807902,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_418,Glomeruli from LN patient,"patient number: 14;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807903,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_419,Glomeruli from LN patient,"patient number: 15;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807904,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_423,Glomeruli from LN patient,"patient number: 16;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807905,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_430,Glomeruli from LN patient,"patient number: 17;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807906,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_438,Glomeruli from LN patient,"patient number: 18;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807907,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_440,Glomeruli from LN patient,"patient number: 19;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807908,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_442,Glomeruli from LN patient,"patient number: 20;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807909,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_444,Glomeruli from LN patient,"patient number: 21;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807910,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_445,Glomeruli from LN patient,"patient number: 22;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807911,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_448,Glomeruli from LN patient,"patient number: 23;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807912,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_450,Glomeruli from LN patient,"patient number: 24;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807913,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_451,Glomeruli from LN patient,"patient number: 25;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807914,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_454,Glomeruli from LN patient,"patient number: 26;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807915,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_462,Glomeruli from LN patient,"patient number: 27;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807916,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_463,Glomeruli from LN patient,"patient number: 28;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807917,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_464,Glomeruli from LN patient,"patient number: 29;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807918,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_465,Glomeruli from LN patient,"patient number: 30;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807919,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_466,Glomeruli from LN patient,"patient number: 31;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807920,GPL14663,12028,,IMD,LN,,,0,,,,,,,Glom_LN_467,Glomeruli from LN patient,"patient number: 32;	disease status: LN patient;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human LN kidney,total RNA,Homo sapiens
GSE32591,GSM807921,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_468,Glomeruli from control living donor,"patient number: 1;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807922,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_469,Glomeruli from control living donor,"patient number: 2;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807923,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_470,Glomeruli from control living donor,"patient number: 3;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807924,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_471,Glomeruli from control living donor,"patient number: 4;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807925,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_472,Glomeruli from control living donor,"patient number: 5;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807926,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_473,Glomeruli from control living donor,"patient number: 6;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807927,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_474,Glomeruli from control living donor,"patient number: 7;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807928,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_475,Glomeruli from control living donor,"patient number: 8;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807929,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_476,Glomeruli from control living donor,"patient number: 9;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807930,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_478,Glomeruli from control living donor,"patient number: 10;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807931,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_479,Glomeruli from control living donor,"patient number: 11;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807932,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_480,Glomeruli from control living donor,"patient number: 13;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807933,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_481,Glomeruli from control living donor,"patient number: 14;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE32591,GSM807934,GPL14663,12028,Control,Normal,Control,,1,0,,,,,,,Glom_LD_482,Glomeruli from control living donor,"patient number: 15;	disease status: control;	tissue: Glomeruli from kidney biopsy",,,,Gene expression data from the glomerular compartment of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE343_A,GSM4776,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT1002a_DT,CRG,CRG,,KT27,KT27,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14313.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4777,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT1002_N,CRG,CRG,,KT44,KT44,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14315.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4778,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT1002c_CAN,CRG,CRG,,KT57,KT57,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14318.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4779,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT1002b_N,CRG,CRG,,KT88,KT88,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14321.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4780,GPL271,28032,AR,TCMR, AR type III,,,1,,,,,,,KT3_AR3,CRG,CRG,,KT3,KT3,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14324.gif;	Disease State: Acute rejection type III",total RNA,Homo sapiens
GSE343_A,GSM4781,GPL271,28032,AR,AR+CAN, AR type III/CAN,,,1,,,,,,,KT12_CAN/AR3,CRG,CRG,,KT12,KT12,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14326.gif;	Disease State: Acute rejection type III/Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4782,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT1001a(2)_AR1,CRG,CRG,,KT33,KT33,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14373.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4783,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT1001_CAN,CRG,CRG,,KT41,KT41,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14375.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4784,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT1001b_N,CRG,CRG,,KT50,KT50,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14376.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4785,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT1001d_CAN,CRG,CRG,,KT97,KT97,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14378.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4786,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT28_N,CRG,CRG,,KT28,KT28,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14438.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4787,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT30_CAN,CRG,CRG,,KT30,KT30,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14439.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4788,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT31_N,CRG,CRG,,KT31,KT31,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14440.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4789,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT32_N,CRG,CRG,,KT32,KT32,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14512.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4790,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT87b_N,CRG,CRG,,KT35,KT35,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14514.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4791,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT36_N,CRG,CRG,,KT36,KT36,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14515.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4792,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT38b_N,CRG,CRG,,KT38,KT38,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14517.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4793,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT18_N,CRG,CRG,,KT6,KT6,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14537.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4794,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT78b_DT,CRG,CRG,,KT71,KT71,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14721.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4795,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT72_DT,CRG,CRG,,KT72 (DT),KT72 (DT),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14723.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4796,GPL271,28032,,CAN, Nephrotoxic of drugs/Infection,,,1,,,,,,,KT1009a_DT/IN,CRG,CRG,,KT75,KT75,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14725.gif;	Disease State: Nephrotoxic effects of drugs/Infection",total RNA,Homo sapiens
GSE343_A,GSM4797,GPL271,28032,AR,AR+CAN, AR type II/DT/Infection,,,1,,,,,,,KT76_AR2/DT/IN,CRG,CRG,,KT#76 (DT),KT#76 (DT),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14726.gif;	Disease State: Acute rejection type II/DT/Infection",total RNA,Homo sapiens
GSE343_A,GSM4798,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT80_AR1,CRG,CRG,,KT80 (AR Rx),KT80 (AR Rx),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14727.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4799,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT1007a_N,CRG,CRG,,KT90,KT90,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14728.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4800,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT1008a_N,CRG,CRG,,KT91,KT91,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14730.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4801,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT1006c_DT,CRG,CRG,,KT105,KT105,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14818.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4802,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT1003d_CAN,CRG,CRG,,KT77,KT77,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14819.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4803,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT1009_N,CRG,CRG,,KT61,KT61,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14824.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4804,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT1013_N,CRG,CRG,,KT108,KT108,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14827.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4805,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT26b_CAN,CRG,CRG,,KT37,KT37,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14919.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4806,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT9_CAN,CRG,CRG,,KT9,KT9,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14921.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4807,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT10_AR1,CRG,CRG,,KT10,KT10,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14924.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4808,GPL271,28032,Control,Normal, Normal,,,1,,,,,,,KT14_N,CRG,CRG,,KT14,KT14,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14926.gif;	Disease State: Normal kidney",total RNA,Homo sapiens
GSE343_A,GSM4809,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT15_DT,CRG,CRG,,KT15,KT15,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-03/14929.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4810,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT40_CAN,CRG,CRG,,KT40,KT40,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15225.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4811,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT38_CAN,CRG,CRG,,KT43,KT43,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15226.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4812,GPL271,28032,AR,TCMR, AR type II,,,1,,,,,,,KT63_AR2,CRG,CRG,,KT63,KT63,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15229.gif;	Disease State: Acute rejection type II",total RNA,Homo sapiens
GSE343_A,GSM4813,GPL271,28032,AR,TCMR, AR type II,,,1,,,,,,,KT25b_AR2,CRG,CRG,,KT67,KT67,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15230.gif;	Disease State: Acute rejection type II",total RNA,Homo sapiens
GSE343_A,GSM4814,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT28c_CAN,CRG,CRG,,KT68,KT68,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15300.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4815,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT126b_AR1,CRG,CRG,,KT74,KT74,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15304.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4816,GPL271,28032,AR,AR+CAN, AR type II/DT/Infection,,,1,,,,,,,KT84_AR2/DT/IN,CRG,CRG,,KT84,KT84,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15307.gif;	Disease State: Acute rejection type II/DT/Infection",total RNA,Homo sapiens
GSE343_A,GSM4817,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT86_AR1,CRG,CRG,,KT86,KT86,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15420.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4818,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT87_AR1,CRG,CRG,,KT87,KT87,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15976.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4819,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT86b_CAN,CRG,CRG,,KT92,KT92,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15979.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4820,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT95_CAN,CRG,CRG,,KT95,KT95,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15982.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4821,GPL271,28032,AR,AR+CAN, AR type III/CAN,,,1,,,,,,,KT99_CAN/AR3,CRG,CRG,,KT99,KT99,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15986.gif;	Disease State: Acute rejection type III/Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4822,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT100_CAN,CRG,CRG,,KT100,KT100,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/15988.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4823,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT65_DT,CRG,CRG,,KT65 (DT/D),KT65 (DT/D),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-04/16249.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4824,GPL271,28032,AR,AR+CAN, AR type II/DT/Infection,,,1,,,,,,,KT12b_AR2/DT/IN,CRG,CRG,,KT69,KT69,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-05/16325.gif;	Disease State: Acute rejection type II/DT/Infection",total RNA,Homo sapiens
GSE343_A,GSM4825,GPL271,28032,AR,TCMR, AR type II,,,1,,,,,,,KT34b_AR2,CRG,CRG,,KT70,KT70,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-05/16326.gif;	Disease State: Acute rejection type II",total RNA,Homo sapiens
GSE343_A,GSM4826,GPL271,28032,AR,TCMR, AR type II,,,1,,,,,,,KT89_AR2,CRG,CRG,,KT89,KT89,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-05/16327.gif;	Disease State: Acute rejection type II",total RNA,Homo sapiens
GSE343_A,GSM4827,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT82_DT,CRG,CRG,,KT82,KT82,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-05/16328.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4828,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT94_AR1,CRG,CRG,,KT94,KT94,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-05/16329.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4829,GPL271,28032,AR,AR+CAN, AR type II/DT/Infection,,,1,,,,,,,KT95b_AR2/DT/IN,CRG,CRG,,KT95b,KT95b,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-05/16330.gif;	Disease State: Acute rejection type II/DT/Infection",total RNA,Homo sapiens
GSE343_A,GSM4830,GPL271,28032,AR,AR+CAN, AR type II/DT/Infection,,,1,,,,,,,KT96_AR2/DT/IN,CRG,CRG,,KT#96 (DT),KT#96 (DT),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17248.gif;	Disease State: Acute rejection type II/DT/Infection",total RNA,Homo sapiens
GSE343_A,GSM4831,GPL271,28032,,CAN, Nephrotoxic of drugs,,,1,,,,,,,KT102_DT,CRG,CRG,,KT#102 (AR),KT#102 (AR),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17251.gif;	Disease State: Nephrotoxic effects of drugs",total RNA,Homo sapiens
GSE343_A,GSM4832,GPL271,28032,AR,TCMR, AR type III/CAN,,,1,,,,,,,KT84b_CAN/AR3,CRG,CRG,,KT#84b (DT/CR),KT#84b (DT/CR),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17253.gif;	Disease State: Acute rejection type III/Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4833,GPL271,28032,,CAN, Nephrotoxic of drugs/Infection,,,1,,,,,,,KT1008c_DT/IN,CRG,CRG,,SFK8-6M,SFK8-6M,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17264.gif;	Disease State: Nephrotoxic effects of drugs/Infection",total RNA,Homo sapiens
GSE343_A,GSM4834,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT138b_AR1,CRG,CRG,,KT#138b(RxAR),KT#138b(RxAR),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17294.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4835,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT1007c_CAN,CRG,CRG,,SFK7-6M,SFK7-6M,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17296.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4836,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT116_AR1,CRG,CRG,,KT#116 (DT),KT#116 (DT),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17329.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4837,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT1021b_CAN,CRG,CRG,,SFK21-3M,SFK21-3M,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17330.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4838,GPL271,28032,AR,TCMR, AR type III,,,1,,,,,,,KT1027_AR3,CRG,CRG,,SFK27-2W (AR),SFK27-2W (AR),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17333.gif;	Disease State: Acute rejection type III",total RNA,Homo sapiens
GSE343_A,GSM4839,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT126_AR1,CRG,CRG,,KT#126 (AR),KT#126 (AR),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17444.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_A,GSM4840,GPL271,28032,CR,CAN, CAN,,,1,,,,,,,KT1023a_CAN,CRG,CRG,,SFK23-1M,SFK23-1M,"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17448.gif;	Disease State: Chronic allograft nephropathy",total RNA,Homo sapiens
GSE343_A,GSM4841,GPL271,28032,AR,TCMR, AR type I,,,1,,,,,,,KT138_AR1,CRG,CRG,,KT#138 (AR),KT#138 (AR),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-06/17450.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE343_B,GSM4842,GPL272,37632,AR,TCMR, AR type I,,,1,,,,,,,KT1001a_AR1,CRG,CRG,,SFK1-1M (SAR),SFK1-1M (SAR),"Simple annotation: Tissue Rejection, Kidney;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-10/20900.gif;	Disease State: Acute rejection type I",total RNA,Homo sapiens
GSE34437,GSM849032,GPL570,54675,AR,TCMR,ARIA+GN,,,1,,,,,,,ARIA+GN*,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIA",,,,KT979,total RNA,Homo sapiens
GSE34437,GSM849033,GPL570,54675,AR,TCMR,ARIA,,,1,,,,,,,ARIA4,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIA",,,,KT496,total RNA,Homo sapiens
GSE34437,GSM849034,GPL570,54675,AR,TCMR,ARIA,,,1,,,,,,,ARIA6,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIA",,,,KT1043,total RNA,Homo sapiens
GSE34437,GSM849035,GPL570,54675,AR,TCMR,ARIA,,,1,,,,,,,ARIA9,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIA",,,,KT1100,total RNA,Homo sapiens
GSE34437,GSM849036,GPL570,54675,AR,TCMR,ARIA,,,1,,,,,,,ARIA3,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIA",,,,KT863,total RNA,Homo sapiens
GSE34437,GSM849037,GPL570,54675,AR,TCMR,ARIA,,,1,,,,,,,ARIA11,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIA",,,,KT775,total RNA,Homo sapiens
GSE34437,GSM849038,GPL570,54675,AR,TCMR,ARIA,,,1,,,,,,,ARIA12*,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIA",,,,KT1086,total RNA,Homo sapiens
GSE34437,GSM849039,GPL570,54675,AR,TCMR,ARIB,,,1,,,,,,,ARIB6*,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIB",,,,KT1045,total RNA,Homo sapiens
GSE34437,GSM849040,GPL570,54675,AR,TCMR,ARIB,,,1,,,,,,,ARIB1,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIB",,,,KT942,total RNA,Homo sapiens
GSE34437,GSM849041,GPL570,54675,AR,TCMR,ARIB,,,1,,,,,,,ARIB2*,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIB",,,,KT725,total RNA,Homo sapiens
GSE34437,GSM849042,GPL570,54675,AR,TCMR,ARIB,,,1,,,,,,,ARIB3,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIB",,,,KT543,total RNA,Homo sapiens
GSE34437,GSM849043,GPL570,54675,AR,TCMR,ARIB,,,1,,,,,,,ARIB4**,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIB",,,,KT1070,total RNA,Homo sapiens
GSE34437,GSM849044,GPL570,54675,AR,TCMR,ARIB,,,1,,,,,,,ARIB5*,kidney allograft biopsy; post transplant,"disease status: acute renal allograft rejection, ARIB",,,,KT649,total RNA,Homo sapiens
GSE34437,GSM849045,GPL570,54675,AR,BL,BL,,,1,,,,,,,BL1,kidney allograft biopsy; post transplant,disease status: borderline acute renal allograft rejection,,,,KT673,total RNA,Homo sapiens
GSE34437,GSM849046,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,BL4,kidney allograft biopsy; post transplant,disease status: borderline acute renal allograft rejection,,,,KT578,total RNA,Homo sapiens
GSE34437,GSM849047,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,BL5,kidney allograft biopsy; post transplant,disease status: borderline acute renal allograft rejection,,,,KT951,total RNA,Homo sapiens
GSE34437,GSM849048,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,BL6+CNIT,kidney allograft biopsy; post transplant,disease status: borderline acute renal allograft rejection,,,,KT559,total RNA,Homo sapiens
GSE34437,GSM849050,GPL570,54675,,STA,STA,,,1,,,,,,,STA19,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT1239,total RNA,Homo sapiens
GSE34437,GSM849051,GPL570,54675,,STA,STA,,,1,,,,,,,STA1,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT641,total RNA,Homo sapiens
GSE34437,GSM849053,GPL570,54675,,STA,STA,,,1,,,,,,,STA2,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT901,total RNA,Homo sapiens
GSE34437,GSM849054,GPL570,54675,,STA,STA,,,1,,,,,,,STA4,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT905,total RNA,Homo sapiens
GSE34437,GSM849055,GPL570,54675,,STA,STA,,,1,,,,,,,STA5,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT417,total RNA,Homo sapiens
GSE34437,GSM849061,GPL570,54675,,CAN,IFTA,6m,0,1,0,20,1,17,Other,Steroid-based,STA12,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT929,total RNA,Homo sapiens
GSE34437,GSM849063,GPL570,54675,,STA,STA,,,1,,,,,,,STA15,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT540,total RNA,Homo sapiens
GSE34437,GSM849064,GPL570,54675,,STA,STA,,,1,,,,,,,STA16*,kidney allograft biopsy; post transplant,disease status: no significant abnormalities,,,,KT612,total RNA,Homo sapiens
GSE34437,GSM849068,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 13,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT623,total RNA,Homo sapiens
GSE34437,GSM849071,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 16,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT651,total RNA,Homo sapiens
GSE34437,GSM849072,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 17,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT690-2,total RNA,Homo sapiens
GSE34437,GSM849073,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 18,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT707-1,total RNA,Homo sapiens
GSE34437,GSM849074,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 20,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT717,total RNA,Homo sapiens
GSE34437,GSM849081,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 3,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT1018 B,total RNA,Homo sapiens
GSE34437,GSM849085,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 33,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT783-1,total RNA,Homo sapiens
GSE34437,GSM849099,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 5,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT1422,total RNA,Homo sapiens
GSE34437,GSM849105,GPL570,54675,,Normal,Normal,,,1,,,,,,,D0 6,"kidney allograft biopsy, baseline, living donor","disease status: baseline, living donor",,,,KT1441,total RNA,Homo sapiens
GSE34748,GSM854492,GPL570,54675,,CAN+TGP,XM/TG,4m,,1,,,,,,,XM/TG_Biopsy1_Pt1,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854493,GPL570,54675,,CAN+TGP,XM/TG,3m,,1,,,,,,,XM/TG_Biopsy1_Pt2,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854494,GPL570,54675,,CAN+TGP,XM/TG,4m,,1,,,,,,,XM/TG_Biopsy1_Pt3,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854495,GPL570,54675,,CAN+TGP,XM/TG,13m,,1,,,,,,,XM/TG_Biopsy1_Pt4,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854496,GPL570,54675,,CAN+TGP,XM/TG,14m,,1,,,,,,,XM/TG_Biopsy1_Pt5,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854497,GPL570,54675,,CAN+TGP,XM/TG,13m,,1,,,,,,,XM/TG_Biopsy1_Pt6,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854498,GPL570,54675,,CAN+TGP,XM/TG,12m,,1,,,,,,,XM/TG_Biopsy1_Pt7,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854499,GPL570,54675,,CAN+TGP,XM/TG,4m,,1,,,,,,,XM/TG_Biopsy1_Pt8,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854500,GPL570,54675,,CAN+TGP,XM/TG,13m,,1,,,,,,,XM/TG_Biopsy1_Pt9,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854501,GPL570,54675,,CAN+TGP,XM/TG,4m,,1,,,,,,,XM/TG_Biopsy1_Pt10,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854502,GPL570,54675,,CAN+TGP,XM/TG,12m,,1,,,,,,,XM/TG_Biopsy2_Pt1,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854503,GPL570,54675,,CAN+TGP,XM/TG,15m,,1,,,,,,,XM/TG_Biopsy2_Pt2,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854504,GPL570,54675,,CAN+TGP,XM/TG,12m,,1,,,,,,,XM/TG_Biopsy2_Pt3,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854505,GPL570,54675,,CAN+TGP,XM/TG,28m,,1,,,,,,,XM/TG_Biopsy2_Pt4,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854506,GPL570,54675,,CAN+TGP,XM/TG,26m,,1,,,,,,,XM/TG_Biopsy2_Pt5,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854507,GPL570,54675,,CAN+TGP,XM/TG,24m,,1,,,,,,,XM/TG_Biopsy2_Pt6,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854508,GPL570,54675,,CAN+TGP,XM/TG,24m,,1,,,,,,,XM/TG_Biopsy2_Pt7,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854509,GPL570,54675,,CAN+TGP,XM/TG,13m,,1,,,,,,,XM/TG_Biopsy2_Pt8,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854510,GPL570,54675,,CAN+TGP,XM/TG,33m,,1,,,,,,,XM/TG_Biopsy2_Pt9,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854511,GPL570,54675,,CAN+TGP,XM/TG,12m,,1,,,,,,,XM/TG_Biopsy2_Pt10,XM/TG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854512,GPL570,54675,NR,STA,noTG,12m,,1,,,,,,,Control_Biopsy1_Pt36,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854513,GPL570,54675,NR,STA,noTG,13m,,1,,,,,,,Control_Biopsy1_Pt37,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854514,GPL570,54675,NR,STA,noTG,4m,,1,,,,,,,Control_Biopsy1_Pt38,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854515,GPL570,54675,NR,STA,noTG,4m,,1,,,,,,,Control_Biopsy1_Pt39,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854516,GPL570,54675,NR,STA,noTG,3m,,1,,,,,,,Control_Biopsy1_Pt40,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854517,GPL570,54675,NR,STA,noTG,3m,,1,,,,,,,Control_Biopsy1_Pt41,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854518,GPL570,54675,NR,STA,noTG,13m,,1,,,,,,,Control_Biopsy1_Pt42,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854519,GPL570,54675,NR,STA,noTG,4m,,1,,,,,,,Control_Biopsy1_Pt43,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854520,GPL570,54675,NR,STA,noTG,12m,,1,,,,,,,Control_Biopsy1_Pt44,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854521,GPL570,54675,NR,STA,noTG,12m,,1,,,,,,,Control_Biopsy1_Pt45,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854522,GPL570,54675,NR,STA,noTG,25m,,1,,,,,,,Control_Biopsy2_Pt36,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854523,GPL570,54675,NR,STA,noTG,26m,,1,,,,,,,Control_Biopsy2_Pt37,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854524,GPL570,54675,NR,STA,noTG,13m,,1,,,,,,,Control_Biopsy2_Pt38,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854525,GPL570,54675,NR,STA,noTG,14m,,1,,,,,,,Control_Biopsy2_Pt39,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854526,GPL570,54675,NR,STA,noTG,12m,,1,,,,,,,Control_Biopsy2_Pt40,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854527,GPL570,54675,NR,STA,noTG,12m,,1,,,,,,,Control_Biopsy2_Pt41,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854528,GPL570,54675,NR,STA,noTG,25m,,1,,,,,,,Control_Biopsy2_Pt42,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854529,GPL570,54675,NR,STA,noTG,13m,,1,,,,,,,Control_Biopsy2_Pt43,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854530,GPL570,54675,NR,STA,noTG,25m,,1,,,,,,,Control_Biopsy2_Pt44,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854531,GPL570,54675,NR,STA,noTG,25m,,1,,,,,,,Control_Biopsy2_Pt45,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854532,GPL570,54675,NR,STA,noTG,13m,,1,,,,,,,Control_Biopsy2_Pt38_repeat,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854533,GPL570,54675,NR,STA,noTG,14m,,1,,,,,,,Control_Biopsy2_Pt39_repeat,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854534,GPL570,54675,NR,STA,noTG,12m,,1,,,,,,,Control_Biopsy2_Pt40_repeat,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854535,GPL570,54675,NR,STA,noTG,12m,,1,,,,,,,Control_Biopsy2_Pt41_repeat,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854536,GPL570,54675,NR,STA,noTG,25m,,1,,,,,,,Control_Biopsy2_Pt42_repeat,noXM/noTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___1 year biopsy - Banff: cg>0",,,,,total RNA,Homo sapiens
GSE34748,GSM854537,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt1,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854538,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt2,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854539,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt3,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854540,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt4,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854541,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt5,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854542,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt6,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854543,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt7,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854544,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt8,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854545,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt9,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854546,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt10,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE34748,GSM854547,GPL570,54675,NR,STA,noXM/NoTG,,,1,,,,,,,XM/NoTG_Biopsy2_Pt11,XM/NoTG,"tissue: Kidney Allograft Biopsy;	timepoint: ___2 year biopsy - Banff: cg=0",,,,,total RNA,Homo sapiens
GSE35487,GSM869311,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA1 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA1;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869315,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA2 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA2;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869316,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA3 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA3;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869317,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA4 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA4;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869318,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA5 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA5;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869319,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA6 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA6;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869320,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA7 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA7;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869321,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA8 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA8;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869322,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA9 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA9;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869323,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA10 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"TubIgA10;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869324,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA11 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"TubIgA11;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869325,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA12 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"TubIgA12;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869326,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA13 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA13;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869327,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA14 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA14;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869328,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA16 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA16;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869329,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA18 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA18;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869330,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA19 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA19;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869331,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA20 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA20;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869332,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA21 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA21;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869333,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA22 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA22;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869334,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA23 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"TubIgA23;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869335,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA24 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"TubIgA24;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869336,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA25 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"TubIgA25;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869337,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA26 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA26;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869338,GPL96,22283,,IMD,IgAN,,,0,,,,,,,Tubulointerstitium from IgAN patient_IgA27 [HG-U133A],Kidney biopsy from human IgAN,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_IgA27;	Gene expression data from the tubulointerstitial compartment of human IgAN kidney",total RNA,Homo sapiens
GSE35487,GSM869339,GPL96,22283,Control,Normal,Control,,1,0,,,,,,,Tubulointerstitium from control living donor_LD_5 [HG-U133A],Kidney biopsy from human pre-transplant living donor,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_LD5;	Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney",total RNA,Homo sapiens
GSE35487,GSM869340,GPL96,22283,Control,Normal,Control,,1,0,,,,,,,Tubulointerstitium from control living donor_LD_6 [HG-U133A],Kidney biopsy from human pre-transplant living donor,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_LD6;	Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney",total RNA,Homo sapiens
GSE35487,GSM869341,GPL96,22283,Control,Normal,Control,,1,0,,,,,,,Tubulointerstitium from control living donor_LD_7 [HG-U133A],Kidney biopsy from human pre-transplant living donor,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_LD7;	Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney",total RNA,Homo sapiens
GSE35487,GSM869342,GPL96,22283,Control,Normal,Control,,1,0,,,,,,,Tubulointerstitium from control living donor_LD_8 [HG-U133A],Kidney biopsy from human pre-transplant living donor,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_LD8;	Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney",total RNA,Homo sapiens
GSE35487,GSM869343,GPL96,22283,Control,Normal,Control,,1,0,,,,,,,Tubulointerstitium from control living donor_LD_9 [HG-U133A],Kidney biopsy from human pre-transplant living donor,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_LD9;	Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney",total RNA,Homo sapiens
GSE35487,GSM869344,GPL96,22283,Control,Normal,Control,,1,0,,,,,,,Tubulointerstitium from control living donor_LD_10 [HG-U133A],Kidney biopsy from human pre-transplant living donor,tissue: Tubulointerstitium from kidney biopsy,,,,"Tub_LD10;	Gene expression data from the tubulointerstitial compartment of human pre-transplant living donor control kidney",total RNA,Homo sapiens
GSE36059,GSM880204,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting146,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880205,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting63,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880206,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting252,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880207,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting180,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880208,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting181,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880209,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting182,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880210,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting147,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880211,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting183,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880212,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR18,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880213,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting1,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880214,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR19,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880215,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR1,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880216,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR20,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880217,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR21,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880218,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR22,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880219,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting148,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880220,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting2,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880221,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting3,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880222,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting64,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880223,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting184,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880224,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting105,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880225,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting4,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880226,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting185,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880227,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting5,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880228,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed1,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880229,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR23,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880230,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed2,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880231,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting6,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880232,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting65,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880233,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR1,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880234,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR2,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880235,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting186,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880236,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR24,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880237,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR25,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880238,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting149,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880239,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR26,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880240,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR3,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880241,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting150,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880242,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting151,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880243,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting152,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880244,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed3,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880245,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy1,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880246,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy2,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880247,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting106,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880248,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR27,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880249,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR28,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880250,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed4,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880251,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR29,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880252,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting7,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880253,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting66,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880254,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting8,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880255,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting107,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880256,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting108,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880257,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting109,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880258,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR2,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880259,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR30,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880260,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed5,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880261,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed6,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880262,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting110,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880263,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting67,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880264,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR3,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880265,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting153,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880266,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting187,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880267,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting154,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880268,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting111,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880269,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting253,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880270,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR31,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880271,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed7,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880272,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting272,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880273,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed8,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880274,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting188,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880275,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR4,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880276,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR32,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880277,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting155,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880278,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting9,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880279,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting10,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880280,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR4,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880281,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting273,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880282,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting112,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880283,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting11,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880284,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting189,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880285,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting190,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880286,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR33,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880287,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR34,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880288,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR35,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880289,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR36,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880290,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting191,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880291,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR37,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880292,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting156,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880293,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting68,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880294,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR38,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880295,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting113,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880296,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting114,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880297,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR39,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880298,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting69,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880299,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy3,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880300,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting192,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880301,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting274,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880302,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed9,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880303,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting157,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880304,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR40,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880305,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR41,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880306,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR42,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880307,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR5,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880308,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting70,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880309,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR6,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880310,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting193,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880311,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy4,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880312,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting12,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880313,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR43,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880314,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed10,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880315,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting71,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880316,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting72,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880317,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR44,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880318,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy5,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880319,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting13,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880320,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting51,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880321,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting52,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880322,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting14,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880323,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting194,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880324,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting158,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880325,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting73,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880326,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting254,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880327,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting74,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880328,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting195,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880329,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting75,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880330,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting196,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880331,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR7,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880332,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting159,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880333,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR45,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880334,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR46,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880335,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR47,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880336,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting197,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880337,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting198,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880338,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting160,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880339,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting255,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880340,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting199,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880341,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR8,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880342,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting161,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880343,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting15,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880344,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting200,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880345,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR9,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880346,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR10,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880347,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting201,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880348,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting76,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880349,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting115,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880350,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting16,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880351,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting116,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880352,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed11,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880353,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR48,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880354,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting77,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880355,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting117,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880356,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting162,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880357,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting118,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880358,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting119,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880359,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting256,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880360,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting257,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880361,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting17,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880362,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting258,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880363,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting202,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880364,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting120,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880365,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting18,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880366,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting259,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880367,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting260,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880368,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting19,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880369,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting203,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880370,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR5,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880371,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting20,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880372,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR11,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880373,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting21,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880374,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR6,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880375,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting22,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880376,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting204,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880377,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting23,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880378,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting261,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880379,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting205,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880380,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting53,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880381,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting24,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880382,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting25,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880383,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting26,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880384,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting262,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880385,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting206,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880386,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting121,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880387,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting207,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880388,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR12,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880389,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting78,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880390,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting208,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880391,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed12,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880392,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting209,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880393,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting27,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880394,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR13,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880395,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed13,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880396,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting122,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880397,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR49,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880398,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting123,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880399,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR14,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880400,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting124,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880401,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting79,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880402,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting275,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880403,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting210,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880404,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting28,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880405,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR50,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880406,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting276,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880407,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed14,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880408,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR7,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880409,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting277,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880410,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting278,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880411,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR15,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880412,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting211,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880413,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting125,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880414,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting212,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880415,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting126,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880416,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR16,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880417,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting163,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880418,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting127,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880419,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting80,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880420,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR51,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880421,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting81,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880422,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting29,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880423,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting82,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880424,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR52,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880425,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting30,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880426,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR17,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880427,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting213,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880428,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR53,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880429,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR54,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880430,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy6,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880431,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting54,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880432,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting214,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880433,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting215,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880434,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR18,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880435,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting216,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880436,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR8,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880437,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed15,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880438,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting128,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880439,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting129,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880440,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR19,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880441,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting130,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880442,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR55,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880443,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting131,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880444,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting132,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880445,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR20,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880446,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting83,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880447,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy7,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880448,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting84,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880449,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR56,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880450,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting164,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880451,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting279,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880452,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting133,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880453,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR57,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880454,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting31,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880455,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting263,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880456,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR21,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880457,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting134,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880458,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting165,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880459,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed16,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880460,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting135,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880461,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting32,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880462,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting33,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880463,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting85,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880464,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR22,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880465,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR23,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880466,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR9,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880467,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting280,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880468,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting217,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880469,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting86,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880470,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting87,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880471,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting218,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880472,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting55,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880473,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting219,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880474,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting136,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880475,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting137,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880476,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting220,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880477,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR10,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880478,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting221,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880479,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting88,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880480,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting222,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880481,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting223,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880482,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting56,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880483,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting57,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880484,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR24,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880485,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR25,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880486,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting89,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880487,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting90,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880488,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting91,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880489,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting92,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880490,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR26,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880491,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting264,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880492,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR27,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880493,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR28,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880494,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting166,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880495,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting167,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880496,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting224,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880497,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting138,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880498,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting93,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880499,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting34,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880500,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomy8,nephrectomy,diagnosis: Nephrectomy,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880501,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting225,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880502,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed17,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880503,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR11,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880504,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting35,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880505,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed18,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880506,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed19,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880507,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting168,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880508,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting226,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880509,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting36,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880510,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting227,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880511,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting169,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880512,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed20,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880513,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting37,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880514,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting94,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880515,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting170,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880516,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting171,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880517,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR12,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880518,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting228,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880519,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR58,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880520,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting229,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880521,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR59,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880522,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting172,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880523,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting230,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880524,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting95,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880525,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting231,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880526,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting281,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880527,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting232,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880528,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting233,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880529,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR60,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880530,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR29,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880531,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR13,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880532,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting38,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880533,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting234,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880534,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting139,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880535,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR61,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880536,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting235,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880537,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting58,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880538,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting59,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880539,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting60,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880540,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting265,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880541,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting236,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880542,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting237,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880543,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting96,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880544,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting238,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880545,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting61,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880546,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting97,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880547,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting140,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880548,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting141,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880549,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting98,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880550,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting239,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880551,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting142,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880552,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting62,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880553,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting266,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880554,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting267,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880555,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting39,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880556,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting40,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880557,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting41,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880558,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting240,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880559,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting99,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880560,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting173,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880561,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting42,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880562,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting43,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880563,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting44,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880564,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR30,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880565,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR62,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880566,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting174,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880567,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting241,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880568,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting45,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880569,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting242,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880570,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR31,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880571,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting243,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880572,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting244,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880573,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR63,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880574,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting245,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880575,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting246,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880576,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR32,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880577,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting268,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880578,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting46,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880579,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting47,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880580,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting175,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880581,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR33,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880582,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting48,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880583,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting247,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880584,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR34,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880585,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting269,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880586,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting100,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880587,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting248,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880588,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting176,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880589,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting177,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880590,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting178,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880591,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR14,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880592,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting270,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880593,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting249,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880594,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting250,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880595,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting49,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880596,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR15,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880597,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting179,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880598,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting50,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880599,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting251,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880600,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting143,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880601,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed21,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880602,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR64,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880603,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting101,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880604,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting102,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880605,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR16,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880606,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR17,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880607,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting144,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880608,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting145,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880609,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting271,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880611,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,mixed22,renal allograft biopsy,diagnosis: mixed,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880612,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,ABMR65,renal allograft biopsy,diagnosis: ABMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880613,GPL570,54675,NR,STA,NR,,,1,,,,,,,non-rejecting104,renal allograft biopsy,diagnosis: non-rejecting,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE36059,GSM880614,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,TCMR35,renal allograft biopsy,diagnosis: TCMR,The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.,,,,total RNA,Homo sapiens
GSE37463_A,GSM920034,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H1-Tub-LD1],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM920035,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H1-Tub-LD2],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM920036,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H1-Tub-LD3],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920052,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1164],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920053,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1165],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920054,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1166],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920055,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1168],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920056,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1169],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920057,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1170],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920058,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1171],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920059,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1172],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920060,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1173],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920061,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1174],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920062,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1175],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920063,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1177],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920064,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1178],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920065,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1179],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920066,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1180],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920067,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1182],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920068,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1183],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920069,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Tub-LD1184],Kidney Biopsy from Human Healthy Living donor,tissue: Tubulointerstitium from kidney biopsy,,,,Gene expression data from the tubulointerstitium of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM920070,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT1],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920071,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT10],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920072,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT11],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920073,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT12],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920074,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT13],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920075,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT14],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920076,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT15],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920077,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT16],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920078,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT17],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920079,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT18],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920080,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT19],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920081,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT2],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920082,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT20],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920083,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT3],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920084,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT4],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920085,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT5],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920086,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT6],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920087,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT7],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920088,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT8],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920089,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Tub-HT9],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920350,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H1-Glom-LD1],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM920351,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H1-Glom-LD2],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM920352,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H1-Glom-LD3],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM920353,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H1-Glom-LD4],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920368,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD974],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920369,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD975],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920370,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD976],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920371,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD978],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920372,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD979],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920373,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD980],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920374,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD981],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920375,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD982],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920376,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD983],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920377,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD984],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920378,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD985],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920379,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD987],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920380,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD988],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920381,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD989],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920382,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD990],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920383,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD992],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920384,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD993],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_B,GSM920385,GPL11670,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H7-Glom-LD994],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM920386,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT1],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920387,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT11],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920388,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT12],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920389,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT13],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920390,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT14],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920391,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT15],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920392,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT16],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920393,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT18],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920394,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT2],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920395,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT25],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920396,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT4],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920397,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT5],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920398,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT6],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920399,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT7],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920400,GPL14663,12020,,noIMD,HT,,,0,,,,,,,Hypertensive nephropathy [H2-Glom-HT8],Kidney Biopsy from Human Hypertensive nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920401,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA10],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920402,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA11],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920403,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA12],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920404,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA13],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920405,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA14],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920406,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA15],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920407,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA16],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920408,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA17],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920409,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA18],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920410,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA19],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920411,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA1],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920412,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA20],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920413,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA21],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920414,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA22],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920415,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA23],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920416,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA24],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920417,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA25],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920418,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA26],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920419,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA27],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920420,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA2],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920421,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA3],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920422,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA4],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920423,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA5],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920424,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA6],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920425,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA7],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920426,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA8],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM920427,GPL14663,12020,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy [H4-Glom-IgA9],Kidney Biopsy from Human IgA Nephropathy,tissue: Glomeruli from kidney biopsy,,,,Gene Expression data from the glomeruli of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE37463_A,GSM1046922,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H4-Glom-LD10],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM1046923,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H4-Glom-LD5],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM1046924,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H4-Glom-LD7],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM1046925,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H4-Glom-LD8],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE37463_A,GSM1046926,GPL14663,12020,Control,Normal,Healthy,,1,0,,,,,,,Healthy Living donor [H4-Glom-LD9],Kidney Biopsy from Human Healthy Living donor,tissue: Glomeruli from kidney biopsy,,,,Gene expression data from the glomeruli of human pre-transplant living donor control kidney,total RNA,Homo sapiens
GSE3931_A,GSM89935,GPL1282,43008,Control,Normal,Normal,,,0,,,,,,,FT2046 Outer medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,out medulla total RNA","Normal kidney,out medulla total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-12/23317.gif",total RNA,Homo sapiens
GSE3931_B,GSM89936,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1833 Inner cortex,CRG total RNA,CRG total RNA,,"Normal kidney,inner cortex total RNA","Normal kidney,inner cortex total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-10/20843.gif",total RNA,Homo sapiens
GSE3931_B,GSM89937,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1833 Pelvis,CRG total RNA,CRG total RNA,,"Normal kidney,pelvis total RNA","Normal kidney,pelvis total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-10/20860.gif",total RNA,Homo sapiens
GSE3931_C,GSM89938,GPL3040,46464,Control,Normal,Normal,,,0,,,,,,,FT1833 Glomeruli,CRG total RNA,CRG total RNA,,"FT1833g-Normal kidney,glomeruli total RNA","FT1833g-Normal kidney,glomeruli total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-11/21848.gif",total RNA,Homo sapiens
GSE3931_D,GSM89939,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT1835 Outer cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,out cortex-2 total RNA","Normal kidney,out cortex-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-03/25914.gif",total RNA,Homo sapiens
GSE3931_E,GSM89940,GPL3044,43008,Control,Normal,Normal,,,0,,,,,,,FT2449 Papillary tips,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,papillary tips total RNA","Normal kidney,papillary tips total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/24863.gif",total RNA,Homo sapiens
GSE3931_D,GSM89941,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT1835 Inner medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,inner medulla-2 total RNA","Normal kidney,inner medulla-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-03/25916.gif",total RNA,Homo sapiens
GSE3931_D,GSM89942,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT2202 Outer cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,out cortex-2 total RNA","Normal kidney,out cortex-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/25592.gif",total RNA,Homo sapiens
GSE3931_D,GSM89943,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT1835 Pelvis,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,pelvis-2 total RNA","Normal kidney,pelvis-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-03/25917.gif",total RNA,Homo sapiens
GSE3931_A,GSM89944,GPL1282,43008,Control,Normal,Normal,,,0,,,,,,,FT2046 Inner medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,inner medulla total RNA","Normal kidney,inner medulla total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-12/23320.gif",total RNA,Homo sapiens
GSE3931_B,GSM89945,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1835 Outer medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"FT1835c-Normal kidney,out medulla total RNA","FT1835c-Normal kidney,out medulla total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-11/22251.gif",total RNA,Homo sapiens
GSE3931_D,GSM89946,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT2202 Inner cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,inner cortex-2 total RNA","Normal kidney,inner cortex-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/25594.gif",total RNA,Homo sapiens
GSE3931_E,GSM89947,GPL3044,43008,Control,Normal,Normal,,,0,,,,,,,FT2449 Pelvis,Universal Human Reference total RNA,Universal Human Reference total RNA,,"FT2449f-Normal kidney,pelvis total RNA","FT2449f-Normal kidney,pelvis total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/24866.gif",total RNA,Homo sapiens
GSE3931_D,GSM89948,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT2202 Outer medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,out medulla-2 total RNA","Normal kidney,out medulla-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/25595.gif",total RNA,Homo sapiens
GSE3931_D,GSM89949,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT2202 Inner medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,inner medulla-2 total RNA","Normal kidney,inner medulla-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/25596.gif",total RNA,Homo sapiens
GSE3931_E,GSM89950,GPL3044,43008,Control,Normal,Normal,,,0,,,,,,,FT2449 Glomeruli,Universal Human Reference total RNA,Universal Human Reference total RNA,,"FT2449g-Normal kidney,glomeruli total RNA","FT2449g-Normal kidney,glomeruli total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/24867.gif",total RNA,Homo sapiens
GSE3931_D,GSM89951,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT2202 Papillary tips,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,papillary tips-2 total RNA","Normal kidney,papillary tips-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/25597.gif",total RNA,Homo sapiens
GSE3931_D,GSM89952,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT2202 Pelvis,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,pelvis-2 total RNA","Normal kidney,pelvis-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/25598.gif",total RNA,Homo sapiens
GSE3931_B,GSM89953,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1835 Papillary tips,Universal Human Reference total RNA,Universal Human Reference total RNA,,"FT1835e-Normal kidney,papillary tips total RNA","FT1835e-Normal kidney,papillary tips total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-11/22255.gif",total RNA,Homo sapiens
GSE3931_D,GSM89954,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT2202 Glomeruli,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,glomeruli-2 total RNA","Normal kidney,glomeruli-2 total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/25599.gif",total RNA,Homo sapiens
GSE3931_A,GSM89955,GPL1282,43008,Control,Normal,Normal,,,0,,,,,,,FT2046 Papillary tips,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,papillary tips total RNA","Normal kidney,papillary tips total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-12/23327.gif",total RNA,Homo sapiens
GSE3931_A,GSM89956,GPL1282,43008,Control,Normal,Normal,,,0,,,,,,,FT2046 Pelvis,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,pelvis total RNA","Normal kidney,pelvis total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-12/23329.gif",total RNA,Homo sapiens
GSE3931_B,GSM89957,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1833 Outer medulla,CRG total RNA,CRG total RNA,,"Normal kidney,outer medulla total RNA","Normal kidney,outer medulla total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-10/20851.gif",total RNA,Homo sapiens
GSE3931_B,GSM89958,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1833 Outer cortex,CRG total RNA,CRG total RNA,,"Normal kidney,outer cortex total RNA","Normal kidney,outer cortex total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-10/20838.gif",total RNA,Homo sapiens
GSE3931_B,GSM89959,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1833 Inner medulla,CRG total RNA,CRG total RNA,,"Normal kidney,inner medulla total RNA","Normal kidney,inner medulla total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-10/20856.gif",total RNA,Homo sapiens
GSE3931_B,GSM89960,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1833 Papillary tips,CRG total RNA,CRG total RNA,,"Normal kidney,papillary tips total RNA","Normal kidney,papillary tips total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-10/20858.gif",total RNA,Homo sapiens
GSE3931_D,GSM89961,GPL3275,43008,Control,Normal,Normal,,,0,,,,,,,FT1835 Glomeruli,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,glomeruli total RNA","Normal kidney,glomeruli total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-03/25920.gif",total RNA,Homo sapiens
GSE3931_E,GSM89962,GPL3044,43008,Control,Normal,Normal,,,0,,,,,,,FT2449 Outer cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,out cortex total RNA","Normal kidney,out cortex total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/24855.gif",total RNA,Homo sapiens
GSE3931_E,GSM89963,GPL3044,43008,Control,Normal,Normal,,,0,,,,,,,FT2449 Inner cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,inner cortex total RNA","Normal kidney,inner cortex total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/24856.gif",total RNA,Homo sapiens
GSE3931_E,GSM89964,GPL3044,43008,Control,Normal,Normal,,,0,,,,,,,FT2449 Outer medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,out medulla total RNA","Normal kidney,out medulla total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/24857.gif",total RNA,Homo sapiens
GSE3931_A,GSM89965,GPL1282,43008,Control,Normal,Normal,,,0,,,,,,,FT2046 Outer cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,out cortex total RNA","Normal kidney,out cortex total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-12/23315.gif",total RNA,Homo sapiens
GSE3931_E,GSM89966,GPL3044,43008,Control,Normal,Normal,,,0,,,,,,,FT2449 Inner medulla,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,inner medulla total RNA","Normal kidney,inner medulla total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2002-02/24859.gif",total RNA,Homo sapiens
GSE3931_A,GSM89967,GPL1282,43008,Control,Normal,Normal,,,0,,,,,,,FT2046 Inner cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"Normal kidney,inner cortex total RNA","Normal kidney,inner cortex total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-12/23316.gif",total RNA,Homo sapiens
GSE3931_B,GSM89968,GPL2705,43008,Control,Normal,Normal,,,0,,,,,,,FT1835 Inner cortex,Universal Human Reference total RNA,Universal Human Reference total RNA,,"FT1835b-Normal kidney,inner cortex total RNA","FT1835b-Normal kidney,inner cortex total RNA","Simple annotation: Kidney, Normal tissue;	Image: http://smd.stanford.edu/MicroArray/gifs/2001-11/22247.gif",total RNA,Homo sapiens
GSE43974,GSM1075188,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_1,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_A,total RNA,Homo sapiens
GSE43974,GSM1075189,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_1,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311049_B,total RNA,Homo sapiens
GSE43974,GSM1075190,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_1,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311049_C,total RNA,Homo sapiens
GSE43974,GSM1075191,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_1,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_D,total RNA,Homo sapiens
GSE43974,GSM1075192,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_2,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_E,total RNA,Homo sapiens
GSE43974,GSM1075193,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_2,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_F,total RNA,Homo sapiens
GSE43974,GSM1075194,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_1,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311049_G,total RNA,Homo sapiens
GSE43974,GSM1075195,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_1,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311049_H,total RNA,Homo sapiens
GSE43974,GSM1075196,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_2,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_I,total RNA,Homo sapiens
GSE43974,GSM1075197,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_3,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_J,total RNA,Homo sapiens
GSE43974,GSM1075198,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_3,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_K,total RNA,Homo sapiens
GSE43974,GSM1075199,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_2,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311049_L,total RNA,Homo sapiens
GSE43974,GSM1075200,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_2,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311055_A,total RNA,Homo sapiens
GSE43974,GSM1075201,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_3,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311055_B,total RNA,Homo sapiens
GSE43974,GSM1075202,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_1,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311055_C,total RNA,Homo sapiens
GSE43974,GSM1075203,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_2,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311055_D,total RNA,Homo sapiens
GSE43974,GSM1075204,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_2,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311055_E,total RNA,Homo sapiens
GSE43974,GSM1075205,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_4,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311055_F,total RNA,Homo sapiens
GSE43974,GSM1075206,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_3,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311055_G,total RNA,Homo sapiens
GSE43974,GSM1075207,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_3,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311055_H,total RNA,Homo sapiens
GSE43974,GSM1075208,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_3,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311055_J,total RNA,Homo sapiens
GSE43974,GSM1075209,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_4,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311055_K,total RNA,Homo sapiens
GSE43974,GSM1075210,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_4,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311055_L,total RNA,Homo sapiens
GSE43974,GSM1075211,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_5,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311057_B,total RNA,Homo sapiens
GSE43974,GSM1075212,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_3,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311057_C,total RNA,Homo sapiens
GSE43974,GSM1075213,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_5,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311057_D,total RNA,Homo sapiens
GSE43974,GSM1075214,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_5,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311057_F,total RNA,Homo sapiens
GSE43974,GSM1075215,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_4,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311057_G,total RNA,Homo sapiens
GSE43974,GSM1075216,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_4,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311057_H,total RNA,Homo sapiens
GSE43974,GSM1075217,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_4,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311057_I,total RNA,Homo sapiens
GSE43974,GSM1075218,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_1,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311057_J,total RNA,Homo sapiens
GSE43974,GSM1075219,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_5,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311057_K,total RNA,Homo sapiens
GSE43974,GSM1075220,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_5,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311058_B,total RNA,Homo sapiens
GSE43974,GSM1075221,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_6,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_C,total RNA,Homo sapiens
GSE43974,GSM1075222,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_6,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_D,total RNA,Homo sapiens
GSE43974,GSM1075223,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_6,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_E,total RNA,Homo sapiens
GSE43974,GSM1075224,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_7,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_F,total RNA,Homo sapiens
GSE43974,GSM1075225,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_6,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_G,total RNA,Homo sapiens
GSE43974,GSM1075226,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_4,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_H,total RNA,Homo sapiens
GSE43974,GSM1075227,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_5,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311058_I,total RNA,Homo sapiens
GSE43974,GSM1075228,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_7,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_J,total RNA,Homo sapiens
GSE43974,GSM1075229,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_7,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_K,total RNA,Homo sapiens
GSE43974,GSM1075230,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_8,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311058_L,total RNA,Homo sapiens
GSE43974,GSM1075231,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_8,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311059_A,total RNA,Homo sapiens
GSE43974,GSM1075232,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_6,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311059_B,total RNA,Homo sapiens
GSE43974,GSM1075233,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_7,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311059_C,total RNA,Homo sapiens
GSE43974,GSM1075234,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_8,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311059_D,total RNA,Homo sapiens
GSE43974,GSM1075235,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_9,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311059_G,total RNA,Homo sapiens
GSE43974,GSM1075236,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_9,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311059_H,total RNA,Homo sapiens
GSE43974,GSM1075237,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_5,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311059_I,total RNA,Homo sapiens
GSE43974,GSM1075238,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_9,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311059_K,total RNA,Homo sapiens
GSE43974,GSM1075239,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_10,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311062_A,total RNA,Homo sapiens
GSE43974,GSM1075240,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_6,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311062_B,total RNA,Homo sapiens
GSE43974,GSM1075241,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_11,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311062_C,total RNA,Homo sapiens
GSE43974,GSM1075242,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_7,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311062_E,total RNA,Homo sapiens
GSE43974,GSM1075243,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_6,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311062_F,total RNA,Homo sapiens
GSE43974,GSM1075244,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_10,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311062_G,total RNA,Homo sapiens
GSE43974,GSM1075245,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_10,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311062_H,total RNA,Homo sapiens
GSE43974,GSM1075246,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_12,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311062_I,total RNA,Homo sapiens
GSE43974,GSM1075247,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_11,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311062_K,total RNA,Homo sapiens
GSE43974,GSM1075248,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_11,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311062_L,total RNA,Homo sapiens
GSE43974,GSM1075249,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_12,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_A,total RNA,Homo sapiens
GSE43974,GSM1075250,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_13,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_B,total RNA,Homo sapiens
GSE43974,GSM1075251,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_7,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311063_C,total RNA,Homo sapiens
GSE43974,GSM1075252,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_12,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_D,total RNA,Homo sapiens
GSE43974,GSM1075253,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_8,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_E,total RNA,Homo sapiens
GSE43974,GSM1075254,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_8,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_F,total RNA,Homo sapiens
GSE43974,GSM1075255,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_14,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_G,total RNA,Homo sapiens
GSE43974,GSM1075256,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_13,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_H,total RNA,Homo sapiens
GSE43974,GSM1075257,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_13,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_I,total RNA,Homo sapiens
GSE43974,GSM1075258,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_8,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311063_J,total RNA,Homo sapiens
GSE43974,GSM1075259,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_15,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_K,total RNA,Homo sapiens
GSE43974,GSM1075260,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_14,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311063_L,total RNA,Homo sapiens
GSE43974,GSM1075261,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_16,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311066_A,total RNA,Homo sapiens
GSE43974,GSM1075262,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_9,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311066_B,total RNA,Homo sapiens
GSE43974,GSM1075263,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_9,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311066_D,total RNA,Homo sapiens
GSE43974,GSM1075264,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_9,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311066_E,total RNA,Homo sapiens
GSE43974,GSM1075265,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_10,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311066_F,total RNA,Homo sapiens
GSE43974,GSM1075266,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_15,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311066_G,total RNA,Homo sapiens
GSE43974,GSM1075267,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_14,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311066_H,total RNA,Homo sapiens
GSE43974,GSM1075268,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_7,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311066_I,total RNA,Homo sapiens
GSE43974,GSM1075269,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_17,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311066_J,total RNA,Homo sapiens
GSE43974,GSM1075270,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_16,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311066_K,total RNA,Homo sapiens
GSE43974,GSM1075271,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_18,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311066_L,total RNA,Homo sapiens
GSE43974,GSM1075272,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_17,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311067_A,total RNA,Homo sapiens
GSE43974,GSM1075273,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_15,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311067_B,total RNA,Homo sapiens
GSE43974,GSM1075274,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_19,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311067_C,total RNA,Homo sapiens
GSE43974,GSM1075275,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_8,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311067_D,total RNA,Homo sapiens
GSE43974,GSM1075276,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_10,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311067_E,total RNA,Homo sapiens
GSE43974,GSM1075277,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_16,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311067_F,total RNA,Homo sapiens
GSE43974,GSM1075278,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_11,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311067_G,total RNA,Homo sapiens
GSE43974,GSM1075279,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_17,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311067_H,total RNA,Homo sapiens
GSE43974,GSM1075280,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_18,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1",,,,5937311067_I,total RNA,Homo sapiens
GSE43974,GSM1075281,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_18,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311067_J,total RNA,Homo sapiens
GSE43974,GSM1075282,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_10,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311067_K,total RNA,Homo sapiens
GSE43974,GSM1075283,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_20,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311067_L,total RNA,Homo sapiens
GSE43974,GSM1075284,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_19,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311068_E,total RNA,Homo sapiens
GSE43974,GSM1075285,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_2,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311068_F,total RNA,Homo sapiens
GSE43974,GSM1075286,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_20,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311068_G,total RNA,Homo sapiens
GSE43974,GSM1075287,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_3,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311068_H,total RNA,Homo sapiens
GSE43974,GSM1075288,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_21,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311068_I,total RNA,Homo sapiens
GSE43974,GSM1075289,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_21,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311068_J,total RNA,Homo sapiens
GSE43974,GSM1075290,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_19,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311068_K,total RNA,Homo sapiens
GSE43974,GSM1075291,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_22,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311068_L,total RNA,Homo sapiens
GSE43974,GSM1075292,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_4,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311070_A,total RNA,Homo sapiens
GSE43974,GSM1075293,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_23,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311070_B,total RNA,Homo sapiens
GSE43974,GSM1075294,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_12,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311070_C,total RNA,Homo sapiens
GSE43974,GSM1075295,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_20,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311070_D,total RNA,Homo sapiens
GSE43974,GSM1075296,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_22,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311070_E,total RNA,Homo sapiens
GSE43974,GSM1075297,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_24,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1",,,,5937311070_F,total RNA,Homo sapiens
GSE43974,GSM1075298,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_9,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311070_G,total RNA,Homo sapiens
GSE43974,GSM1075299,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_13,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311070_I,total RNA,Homo sapiens
GSE43974,GSM1075300,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_5,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311070_J,total RNA,Homo sapiens
GSE43974,GSM1075301,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_21,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311070_L,total RNA,Homo sapiens
GSE43974,GSM1075302,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_11,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311071_A,total RNA,Homo sapiens
GSE43974,GSM1075303,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_25,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311071_C,total RNA,Homo sapiens
GSE43974,GSM1075304,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_22,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311071_D,total RNA,Homo sapiens
GSE43974,GSM1075305,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_12,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311071_E,total RNA,Homo sapiens
GSE43974,GSM1075306,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_26,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311071_F,total RNA,Homo sapiens
GSE43974,GSM1075307,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_6,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311071_G,total RNA,Homo sapiens
GSE43974,GSM1075308,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_27,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1",,,,5937311071_H,total RNA,Homo sapiens
GSE43974,GSM1075309,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_11,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311071_I,total RNA,Homo sapiens
GSE43974,GSM1075310,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_28,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311071_J,total RNA,Homo sapiens
GSE43974,GSM1075311,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_14,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311071_K,total RNA,Homo sapiens
GSE43974,GSM1075312,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_23,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311071_L,total RNA,Homo sapiens
GSE43974,GSM1075313,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_12,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311072_A,total RNA,Homo sapiens
GSE43974,GSM1075314,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_15,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311072_B,total RNA,Homo sapiens
GSE43974,GSM1075315,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_24,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311072_C,total RNA,Homo sapiens
GSE43974,GSM1075316,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_25,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311072_D,total RNA,Homo sapiens
GSE43974,GSM1075317,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_23,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311072_E,total RNA,Homo sapiens
GSE43974,GSM1075318,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_13,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311072_F,total RNA,Homo sapiens
GSE43974,GSM1075319,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_29,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311072_G,total RNA,Homo sapiens
GSE43974,GSM1075320,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_26,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311072_H,total RNA,Homo sapiens
GSE43974,GSM1075321,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_30,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311072_I,total RNA,Homo sapiens
GSE43974,GSM1075322,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_7,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311073_A,total RNA,Homo sapiens
GSE43974,GSM1075323,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_27,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311073_C,total RNA,Homo sapiens
GSE43974,GSM1075324,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_28,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311073_D,total RNA,Homo sapiens
GSE43974,GSM1075325,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_8,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311073_E,total RNA,Homo sapiens
GSE43974,GSM1075326,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_16,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311073_G,total RNA,Homo sapiens
GSE43974,GSM1075327,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_9,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311073_H,total RNA,Homo sapiens
GSE43974,GSM1075328,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_10,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311073_I,total RNA,Homo sapiens
GSE43974,GSM1075329,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_31,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311073_L,total RNA,Homo sapiens
GSE43974,GSM1075330,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_32,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311074_B,total RNA,Homo sapiens
GSE43974,GSM1075331,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_29,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311074_C,total RNA,Homo sapiens
GSE43974,GSM1075332,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_17,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311074_D,total RNA,Homo sapiens
GSE43974,GSM1075333,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_11,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311074_E,total RNA,Homo sapiens
GSE43974,GSM1075334,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_30,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311074_F,total RNA,Homo sapiens
GSE43974,GSM1075335,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_14,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311074_H,total RNA,Homo sapiens
GSE43974,GSM1075336,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_12,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311074_I,total RNA,Homo sapiens
GSE43974,GSM1075337,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_33,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311074_J,total RNA,Homo sapiens
GSE43974,GSM1075338,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_10,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311074_K,total RNA,Homo sapiens
GSE43974,GSM1075339,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_15,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311074_L,total RNA,Homo sapiens
GSE43974,GSM1075340,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_13,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311075_A,total RNA,Homo sapiens
GSE43974,GSM1075341,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_13,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311075_B,total RNA,Homo sapiens
GSE43974,GSM1075342,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_24,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311075_C,total RNA,Homo sapiens
GSE43974,GSM1075343,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_31,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311075_D,total RNA,Homo sapiens
GSE43974,GSM1075344,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_16,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311075_F,total RNA,Homo sapiens
GSE43974,GSM1075345,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_18,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311075_G,total RNA,Homo sapiens
GSE43974,GSM1075346,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_14,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311075_H,total RNA,Homo sapiens
GSE43974,GSM1075347,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_19,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311075_I,total RNA,Homo sapiens
GSE43974,GSM1075348,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_15,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311075_J,total RNA,Homo sapiens
GSE43974,GSM1075349,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_32,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311075_K,total RNA,Homo sapiens
GSE43974,GSM1075350,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_16,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311075_L,total RNA,Homo sapiens
GSE43974,GSM1075351,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_25,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311076_A,total RNA,Homo sapiens
GSE43974,GSM1075352,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_33,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311076_C,total RNA,Homo sapiens
GSE43974,GSM1075353,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_34,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311076_E,total RNA,Homo sapiens
GSE43974,GSM1075354,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_17,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311076_G,total RNA,Homo sapiens
GSE43974,GSM1075355,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_34,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311076_H,total RNA,Homo sapiens
GSE43974,GSM1075356,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_26,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311076_I,total RNA,Homo sapiens
GSE43974,GSM1075357,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_35,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311076_J,total RNA,Homo sapiens
GSE43974,GSM1075358,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_35,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311076_K,total RNA,Homo sapiens
GSE43974,GSM1075359,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_27,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311076_L,total RNA,Homo sapiens
GSE43974,GSM1075360,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_36,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311078_A,total RNA,Homo sapiens
GSE43974,GSM1075361,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_14,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311078_C,total RNA,Homo sapiens
GSE43974,GSM1075362,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_15,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311078_E,total RNA,Homo sapiens
GSE43974,GSM1075363,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_20,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311078_G,total RNA,Homo sapiens
GSE43974,GSM1075364,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_18,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311078_I,total RNA,Homo sapiens
GSE43974,GSM1075365,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_17,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311078_K,total RNA,Homo sapiens
GSE43974,GSM1075366,GPL10558,47323,,DGF,DGF,1h,1,1,,,,,,,Kidney_donor_Living_T3_11,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311079_A,total RNA,Homo sapiens
GSE43974,GSM1075367,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_37,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311079_B,total RNA,Homo sapiens
GSE43974,GSM1075368,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_28,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311079_C,total RNA,Homo sapiens
GSE43974,GSM1075369,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_36,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311079_D,total RNA,Homo sapiens
GSE43974,GSM1075370,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_12,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311079_F,total RNA,Homo sapiens
GSE43974,GSM1075371,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_18,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311079_G,total RNA,Homo sapiens
GSE43974,GSM1075372,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_29,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311079_H,total RNA,Homo sapiens
GSE43974,GSM1075373,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_19,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311079_J,total RNA,Homo sapiens
GSE43974,GSM1075374,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_30,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311079_K,total RNA,Homo sapiens
GSE43974,GSM1075375,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_37,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311079_L,total RNA,Homo sapiens
GSE43974,GSM1075376,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_38,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_A,total RNA,Homo sapiens
GSE43974,GSM1075377,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_20,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_B,total RNA,Homo sapiens
GSE43974,GSM1075378,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_16,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_C,total RNA,Homo sapiens
GSE43974,GSM1075379,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_31,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_D,total RNA,Homo sapiens
GSE43974,GSM1075380,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_32,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_E,total RNA,Homo sapiens
GSE43974,GSM1075381,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_39,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_F,total RNA,Homo sapiens
GSE43974,GSM1075382,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_19,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311080_G,total RNA,Homo sapiens
GSE43974,GSM1075383,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_40,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_H,total RNA,Homo sapiens
GSE43974,GSM1075384,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_41,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_I,total RNA,Homo sapiens
GSE43974,GSM1075385,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_21,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311080_J,total RNA,Homo sapiens
GSE43974,GSM1075386,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_33,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311080_K,total RNA,Homo sapiens
GSE43974,GSM1075387,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_21,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311080_L,total RNA,Homo sapiens
GSE43974,GSM1075388,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_20,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311081_A,total RNA,Homo sapiens
GSE43974,GSM1075389,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_38,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311081_B,total RNA,Homo sapiens
GSE43974,GSM1075390,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_34,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311081_C,total RNA,Homo sapiens
GSE43974,GSM1075391,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_35,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311081_D,total RNA,Homo sapiens
GSE43974,GSM1075392,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_42,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311081_E,total RNA,Homo sapiens
GSE43974,GSM1075393,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_13,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311081_F,total RNA,Homo sapiens
GSE43974,GSM1075394,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_14,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3",,,,5937311081_H,total RNA,Homo sapiens
GSE43974,GSM1075395,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_43,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311081_I,total RNA,Homo sapiens
GSE43974,GSM1075396,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_15,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311081_J,total RNA,Homo sapiens
GSE43974,GSM1075397,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_22,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311081_K,total RNA,Homo sapiens
GSE43974,GSM1075398,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_44,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311081_L,total RNA,Homo sapiens
GSE43974,GSM1075399,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_23,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311082_A,total RNA,Homo sapiens
GSE43974,GSM1075400,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_45,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1",,,,5937311082_C,total RNA,Homo sapiens
GSE43974,GSM1075401,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_46,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311082_D,total RNA,Homo sapiens
GSE43974,GSM1075402,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_39,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311082_E,total RNA,Homo sapiens
GSE43974,GSM1075403,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_24,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311082_F,total RNA,Homo sapiens
GSE43974,GSM1075404,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_36,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311082_G,total RNA,Homo sapiens
GSE43974,GSM1075405,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_40,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311082_I,total RNA,Homo sapiens
GSE43974,GSM1075406,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_37,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311082_J,total RNA,Homo sapiens
GSE43974,GSM1075407,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_22,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311082_K,total RNA,Homo sapiens
GSE43974,GSM1075408,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_38,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311082_L,total RNA,Homo sapiens
GSE43974,GSM1075409,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_41,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311083_A,total RNA,Homo sapiens
GSE43974,GSM1075410,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_47,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311083_C,total RNA,Homo sapiens
GSE43974,GSM1075411,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_21,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311083_D,total RNA,Homo sapiens
GSE43974,GSM1075412,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_42,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311083_E,total RNA,Homo sapiens
GSE43974,GSM1075413,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_48,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311083_F,total RNA,Homo sapiens
GSE43974,GSM1075414,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_49,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311083_G,total RNA,Homo sapiens
GSE43974,GSM1075415,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_43,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311083_H,total RNA,Homo sapiens
GSE43974,GSM1075416,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_44,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311083_I,total RNA,Homo sapiens
GSE43974,GSM1075417,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_39,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311083_J,total RNA,Homo sapiens
GSE43974,GSM1075418,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_25,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311083_K,total RNA,Homo sapiens
GSE43974,GSM1075419,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_16,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311083_L,total RNA,Homo sapiens
GSE43974,GSM1075420,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_50,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1",,,,5937311085_A,total RNA,Homo sapiens
GSE43974,GSM1075421,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_22,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311085_B,total RNA,Homo sapiens
GSE43974,GSM1075422,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_23,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311085_C,total RNA,Homo sapiens
GSE43974,GSM1075423,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_45,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311085_D,total RNA,Homo sapiens
GSE43974,GSM1075424,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_23,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311085_E,total RNA,Homo sapiens
GSE43974,GSM1075425,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_40,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311085_G,total RNA,Homo sapiens
GSE43974,GSM1075426,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_41,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311085_H,total RNA,Homo sapiens
GSE43974,GSM1075427,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_42,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311085_I,total RNA,Homo sapiens
GSE43974,GSM1075428,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_17,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311085_J,total RNA,Homo sapiens
GSE43974,GSM1075429,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_43,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311085_K,total RNA,Homo sapiens
GSE43974,GSM1075430,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_51,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311085_L,total RNA,Homo sapiens
GSE43974,GSM1075431,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_17,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311087_A,total RNA,Homo sapiens
GSE43974,GSM1075432,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_44,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311087_B,total RNA,Homo sapiens
GSE43974,GSM1075433,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_18,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311087_C,total RNA,Homo sapiens
GSE43974,GSM1075434,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_24,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311087_E,total RNA,Homo sapiens
GSE43974,GSM1075435,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_18,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311087_F,total RNA,Homo sapiens
GSE43974,GSM1075436,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_46,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311087_G,total RNA,Homo sapiens
GSE43974,GSM1075437,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_19,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311087_H,total RNA,Homo sapiens
GSE43974,GSM1075438,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_20,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311087_I,total RNA,Homo sapiens
GSE43974,GSM1075439,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_19,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311087_J,total RNA,Homo sapiens
GSE43974,GSM1075440,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_24,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311087_K,total RNA,Homo sapiens
GSE43974,GSM1075441,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_26,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311087_L,total RNA,Homo sapiens
GSE43974,GSM1075442,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_25,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311089_A,total RNA,Homo sapiens
GSE43974,GSM1075443,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_47,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311089_B,total RNA,Homo sapiens
GSE43974,GSM1075444,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_26,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311089_D,total RNA,Homo sapiens
GSE43974,GSM1075445,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_52,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311089_E,total RNA,Homo sapiens
GSE43974,GSM1075446,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_27,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311089_G,total RNA,Homo sapiens
GSE43974,GSM1075447,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_48,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311089_I,total RNA,Homo sapiens
GSE43974,GSM1075448,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_53,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311089_J,total RNA,Homo sapiens
GSE43974,GSM1075449,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_54,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311089_K,total RNA,Homo sapiens
GSE43974,GSM1075450,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_55,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1",,,,5937311091_A,total RNA,Homo sapiens
GSE43974,GSM1075451,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_49,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311091_B,total RNA,Homo sapiens
GSE43974,GSM1075452,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_28,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311091_C,total RNA,Homo sapiens
GSE43974,GSM1075453,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_45,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311091_D,total RNA,Homo sapiens
GSE43974,GSM1075454,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_46,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311091_E,total RNA,Homo sapiens
GSE43974,GSM1075455,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_47,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311091_F,total RNA,Homo sapiens
GSE43974,GSM1075456,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_27,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311091_I,total RNA,Homo sapiens
GSE43974,GSM1075457,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_50,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311091_K,total RNA,Homo sapiens
GSE43974,GSM1075458,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_56,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311092_A,total RNA,Homo sapiens
GSE43974,GSM1075459,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_57,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311092_B,total RNA,Homo sapiens
GSE43974,GSM1075460,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_25,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311092_D,total RNA,Homo sapiens
GSE43974,GSM1075461,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_26,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311092_E,total RNA,Homo sapiens
GSE43974,GSM1075462,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_51,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311092_F,total RNA,Homo sapiens
GSE43974,GSM1075463,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_28,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311092_G,total RNA,Homo sapiens
GSE43974,GSM1075464,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_27,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311092_H,total RNA,Homo sapiens
GSE43974,GSM1075465,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_52,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311092_I,total RNA,Homo sapiens
GSE43974,GSM1075466,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_53,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311092_K,total RNA,Homo sapiens
GSE43974,GSM1075467,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_29,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311092_L,total RNA,Homo sapiens
GSE43974,GSM1075468,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_54,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311093_B,total RNA,Homo sapiens
GSE43974,GSM1075469,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_29,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311093_D,total RNA,Homo sapiens
GSE43974,GSM1075470,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_20,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311093_E,total RNA,Homo sapiens
GSE43974,GSM1075471,GPL10558,47323,,DGF,DGF,1h,1,1,,,,,,,Kidney_donor_Living_T3_21,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311093_F,total RNA,Homo sapiens
GSE43974,GSM1075472,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_48,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311093_G,total RNA,Homo sapiens
GSE43974,GSM1075473,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_58,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311093_H,total RNA,Homo sapiens
GSE43974,GSM1075474,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_49,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311093_I,total RNA,Homo sapiens
GSE43974,GSM1075475,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_30,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311093_J,total RNA,Homo sapiens
GSE43974,GSM1075476,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_21,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311093_K,total RNA,Homo sapiens
GSE43974,GSM1075477,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_30,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311093_L,total RNA,Homo sapiens
GSE43974,GSM1075478,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_22,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_A,total RNA,Homo sapiens
GSE43974,GSM1075479,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_59,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_B,total RNA,Homo sapiens
GSE43974,GSM1075480,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_50,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_C,total RNA,Homo sapiens
GSE43974,GSM1075481,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_31,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_D,total RNA,Homo sapiens
GSE43974,GSM1075482,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_23,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_E,total RNA,Homo sapiens
GSE43974,GSM1075483,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_28,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311094_F,total RNA,Homo sapiens
GSE43974,GSM1075484,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_32,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311094_G,total RNA,Homo sapiens
GSE43974,GSM1075485,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_55,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_H,total RNA,Homo sapiens
GSE43974,GSM1075486,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_24,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_J,total RNA,Homo sapiens
GSE43974,GSM1075487,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_29,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_K,total RNA,Homo sapiens
GSE43974,GSM1075488,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_60,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311094_L,total RNA,Homo sapiens
GSE43974,GSM1075489,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_61,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_B,total RNA,Homo sapiens
GSE43974,GSM1075490,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_56,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_C,total RNA,Homo sapiens
GSE43974,GSM1075491,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_51,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_D,total RNA,Homo sapiens
GSE43974,GSM1075492,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_57,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_F,total RNA,Homo sapiens
GSE43974,GSM1075493,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_62,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311095_G,total RNA,Homo sapiens
GSE43974,GSM1075494,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_58,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_I,total RNA,Homo sapiens
GSE43974,GSM1075495,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_59,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_J,total RNA,Homo sapiens
GSE43974,GSM1075496,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_52,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_K,total RNA,Homo sapiens
GSE43974,GSM1075497,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_63,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311095_L,total RNA,Homo sapiens
GSE43974,GSM1075498,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_60,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311096_A,total RNA,Homo sapiens
GSE43974,GSM1075499,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_64,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311096_B,total RNA,Homo sapiens
GSE43974,GSM1075500,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_53,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311096_C,total RNA,Homo sapiens
GSE43974,GSM1075501,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_33,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311096_D,total RNA,Homo sapiens
GSE43974,GSM1075502,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_54,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311096_E,total RNA,Homo sapiens
GSE43974,GSM1075503,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_65,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311096_F,total RNA,Homo sapiens
GSE43974,GSM1075504,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_31,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311096_G,total RNA,Homo sapiens
GSE43974,GSM1075505,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_55,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311096_H,total RNA,Homo sapiens
GSE43974,GSM1075506,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_22,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311096_I,total RNA,Homo sapiens
GSE43974,GSM1075507,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_34,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311096_J,total RNA,Homo sapiens
GSE43974,GSM1075508,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_32,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311096_K,total RNA,Homo sapiens
GSE43974,GSM1075509,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_61,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311096_L,total RNA,Homo sapiens
GSE43974,GSM1075510,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_62,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311097_B,total RNA,Homo sapiens
GSE43974,GSM1075511,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_30,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311097_C,total RNA,Homo sapiens
GSE43974,GSM1075512,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_63,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311097_D,total RNA,Homo sapiens
GSE43974,GSM1075513,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_33,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311097_F,total RNA,Homo sapiens
GSE43974,GSM1075514,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_34,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311097_H,total RNA,Homo sapiens
GSE43974,GSM1075515,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_35,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311097_I,total RNA,Homo sapiens
GSE43974,GSM1075516,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_56,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311097_K,total RNA,Homo sapiens
GSE43974,GSM1075517,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_35,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311097_L,total RNA,Homo sapiens
GSE43974,GSM1075518,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_23,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311098_A,total RNA,Homo sapiens
GSE43974,GSM1075519,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_31,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311098_B,total RNA,Homo sapiens
GSE43974,GSM1075520,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_64,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311098_C,total RNA,Homo sapiens
GSE43974,GSM1075521,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_57,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311098_D,total RNA,Homo sapiens
GSE43974,GSM1075522,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_66,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311098_E,total RNA,Homo sapiens
GSE43974,GSM1075523,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_67,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311098_F,total RNA,Homo sapiens
GSE43974,GSM1075524,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_36,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311098_G,total RNA,Homo sapiens
GSE43974,GSM1075525,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_58,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311098_H,total RNA,Homo sapiens
GSE43974,GSM1075526,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_59,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311098_I,total RNA,Homo sapiens
GSE43974,GSM1075527,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_25,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311098_J,total RNA,Homo sapiens
GSE43974,GSM1075528,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_68,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311098_K,total RNA,Homo sapiens
GSE43974,GSM1075529,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_65,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311098_L,total RNA,Homo sapiens
GSE43974,GSM1075530,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_66,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311100_A,total RNA,Homo sapiens
GSE43974,GSM1075531,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_37,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311100_B,total RNA,Homo sapiens
GSE43974,GSM1075532,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_38,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937311100_C,total RNA,Homo sapiens
GSE43974,GSM1075533,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_67,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311100_E,total RNA,Homo sapiens
GSE43974,GSM1075534,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_60,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311100_G,total RNA,Homo sapiens
GSE43974,GSM1075535,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_68,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311100_H,total RNA,Homo sapiens
GSE43974,GSM1075536,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_69,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311100_I,total RNA,Homo sapiens
GSE43974,GSM1075537,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_61,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311100_J,total RNA,Homo sapiens
GSE43974,GSM1075538,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_69,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937311100_K,total RNA,Homo sapiens
GSE43974,GSM1075539,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_62,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311100_L,total RNA,Homo sapiens
GSE43974,GSM1075540,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_39,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311101_A,total RNA,Homo sapiens
GSE43974,GSM1075541,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_32,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311101_B,total RNA,Homo sapiens
GSE43974,GSM1075542,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_36,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311101_C,total RNA,Homo sapiens
GSE43974,GSM1075543,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_63,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311101_E,total RNA,Homo sapiens
GSE43974,GSM1075544,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_70,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937311101_F,total RNA,Homo sapiens
GSE43974,GSM1075545,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_24,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311101_G,total RNA,Homo sapiens
GSE43974,GSM1075546,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_64,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311101_H,total RNA,Homo sapiens
GSE43974,GSM1075547,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_40,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937311101_I,total RNA,Homo sapiens
GSE43974,GSM1075548,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_65,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937311101_J,total RNA,Homo sapiens
GSE43974,GSM1075549,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_71,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311101_K,total RNA,Homo sapiens
GSE43974,GSM1075550,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_72,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937311101_L,total RNA,Homo sapiens
GSE43974,GSM1075551,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_70,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329001_A,total RNA,Homo sapiens
GSE43974,GSM1075552,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_66,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329001_B,total RNA,Homo sapiens
GSE43974,GSM1075553,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_73,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329001_C,total RNA,Homo sapiens
GSE43974,GSM1075554,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_74,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329001_D,total RNA,Homo sapiens
GSE43974,GSM1075555,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_25,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329001_E,total RNA,Homo sapiens
GSE43974,GSM1075556,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_71,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329001_F,total RNA,Homo sapiens
GSE43974,GSM1075557,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_41,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329001_G,total RNA,Homo sapiens
GSE43974,GSM1075558,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_72,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1",,,,5937329001_H,total RNA,Homo sapiens
GSE43974,GSM1075559,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_26,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329001_I,total RNA,Homo sapiens
GSE43974,GSM1075560,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_73,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329001_J,total RNA,Homo sapiens
GSE43974,GSM1075561,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_33,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329001_K,total RNA,Homo sapiens
GSE43974,GSM1075562,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_75,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329001_L,total RNA,Homo sapiens
GSE43974,GSM1075563,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_67,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329003_A,total RNA,Homo sapiens
GSE43974,GSM1075564,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_27,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329003_B,total RNA,Homo sapiens
GSE43974,GSM1075565,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_68,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329003_C,total RNA,Homo sapiens
GSE43974,GSM1075566,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_34,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329003_D,total RNA,Homo sapiens
GSE43974,GSM1075567,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_37,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329003_E,total RNA,Homo sapiens
GSE43974,GSM1075568,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_28,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329003_F,total RNA,Homo sapiens
GSE43974,GSM1075569,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_42,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329003_G,total RNA,Homo sapiens
GSE43974,GSM1075570,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_76,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329003_H,total RNA,Homo sapiens
GSE43974,GSM1075571,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_69,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329003_I,total RNA,Homo sapiens
GSE43974,GSM1075572,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_43,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329003_J,total RNA,Homo sapiens
GSE43974,GSM1075573,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_26,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329003_K,total RNA,Homo sapiens
GSE43974,GSM1075574,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_35,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329004_A,total RNA,Homo sapiens
GSE43974,GSM1075575,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_77,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329004_B,total RNA,Homo sapiens
GSE43974,GSM1075576,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_78,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329004_C,total RNA,Homo sapiens
GSE43974,GSM1075577,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_79,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329004_D,total RNA,Homo sapiens
GSE43974,GSM1075578,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_74,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329004_E,total RNA,Homo sapiens
GSE43974,GSM1075579,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_70,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329004_F,total RNA,Homo sapiens
GSE43974,GSM1075580,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_38,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329004_G,total RNA,Homo sapiens
GSE43974,GSM1075581,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_71,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329004_J,total RNA,Homo sapiens
GSE43974,GSM1075582,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_36,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329004_K,total RNA,Homo sapiens
GSE43974,GSM1075583,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_29,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329004_L,total RNA,Homo sapiens
GSE43974,GSM1075584,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_44,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329005_A,total RNA,Homo sapiens
GSE43974,GSM1075585,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_75,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329005_B,total RNA,Homo sapiens
GSE43974,GSM1075586,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_39,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329005_C,total RNA,Homo sapiens
GSE43974,GSM1075587,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_80,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329005_E,total RNA,Homo sapiens
GSE43974,GSM1075588,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_76,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329005_G,total RNA,Homo sapiens
GSE43974,GSM1075589,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_45,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329005_H,total RNA,Homo sapiens
GSE43974,GSM1075590,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_40,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329005_I,total RNA,Homo sapiens
GSE43974,GSM1075591,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_77,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329005_J,total RNA,Homo sapiens
GSE43974,GSM1075592,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_46,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329005_K,total RNA,Homo sapiens
GSE43974,GSM1075593,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_81,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329005_L,total RNA,Homo sapiens
GSE43974,GSM1075594,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_82,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329006_A,total RNA,Homo sapiens
GSE43974,GSM1075595,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_72,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329006_B,total RNA,Homo sapiens
GSE43974,GSM1075596,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_73,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329006_C,total RNA,Homo sapiens
GSE43974,GSM1075597,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_78,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329006_D,total RNA,Homo sapiens
GSE43974,GSM1075598,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_30,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1",,,,5937329006_E,total RNA,Homo sapiens
GSE43974,GSM1075599,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_74,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329006_G,total RNA,Homo sapiens
GSE43974,GSM1075600,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_79,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329006_H,total RNA,Homo sapiens
GSE43974,GSM1075601,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_37,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329006_I,total RNA,Homo sapiens
GSE43974,GSM1075602,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_75,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329006_J,total RNA,Homo sapiens
GSE43974,GSM1075603,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_76,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329006_K,total RNA,Homo sapiens
GSE43974,GSM1075604,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_77,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329006_L,total RNA,Homo sapiens
GSE43974,GSM1075605,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_80,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329007_B,total RNA,Homo sapiens
GSE43974,GSM1075606,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_38,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329007_C,total RNA,Homo sapiens
GSE43974,GSM1075607,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_27,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329007_D,total RNA,Homo sapiens
GSE43974,GSM1075608,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_31,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329007_E,total RNA,Homo sapiens
GSE43974,GSM1075609,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_47,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329007_F,total RNA,Homo sapiens
GSE43974,GSM1075610,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_39,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329007_G,total RNA,Homo sapiens
GSE43974,GSM1075611,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_78,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329007_H,total RNA,Homo sapiens
GSE43974,GSM1075612,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_48,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329007_I,total RNA,Homo sapiens
GSE43974,GSM1075613,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_32,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329007_J,total RNA,Homo sapiens
GSE43974,GSM1075614,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_41,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329007_K,total RNA,Homo sapiens
GSE43974,GSM1075615,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_83,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329007_L,total RNA,Homo sapiens
GSE43974,GSM1075616,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_28,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329008_A,total RNA,Homo sapiens
GSE43974,GSM1075617,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_81,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329008_B,total RNA,Homo sapiens
GSE43974,GSM1075618,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_84,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329008_C,total RNA,Homo sapiens
GSE43974,GSM1075619,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_79,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329008_D,total RNA,Homo sapiens
GSE43974,GSM1075620,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_42,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329008_E,total RNA,Homo sapiens
GSE43974,GSM1075621,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_82,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329008_F,total RNA,Homo sapiens
GSE43974,GSM1075622,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_80,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329008_G,total RNA,Homo sapiens
GSE43974,GSM1075623,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_40,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329008_I,total RNA,Homo sapiens
GSE43974,GSM1075624,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_81,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329008_K,total RNA,Homo sapiens
GSE43974,GSM1075625,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_49,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329008_L,total RNA,Homo sapiens
GSE43974,GSM1075626,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_82,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329012_B,total RNA,Homo sapiens
GSE43974,GSM1075627,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_83,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329012_C,total RNA,Homo sapiens
GSE43974,GSM1075628,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_84,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329012_D,total RNA,Homo sapiens
GSE43974,GSM1075629,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_43,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329012_F,total RNA,Homo sapiens
GSE43974,GSM1075630,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_85,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329012_G,total RNA,Homo sapiens
GSE43974,GSM1075631,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_83,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329012_I,total RNA,Homo sapiens
GSE43974,GSM1075632,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_85,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329012_J,total RNA,Homo sapiens
GSE43974,GSM1075633,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_50,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329012_K,total RNA,Homo sapiens
GSE43974,GSM1075634,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_44,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329012_L,total RNA,Homo sapiens
GSE43974,GSM1075635,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_29,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329013_A,total RNA,Homo sapiens
GSE43974,GSM1075636,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_51,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329013_C,total RNA,Homo sapiens
GSE43974,GSM1075637,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_52,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329013_D,total RNA,Homo sapiens
GSE43974,GSM1075638,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_84,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329013_F,total RNA,Homo sapiens
GSE43974,GSM1075639,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_86,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329013_G,total RNA,Homo sapiens
GSE43974,GSM1075640,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_86,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329013_H,total RNA,Homo sapiens
GSE43974,GSM1075641,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_87,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329013_I,total RNA,Homo sapiens
GSE43974,GSM1075642,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_53,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329013_J,total RNA,Homo sapiens
GSE43974,GSM1075643,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_30,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329013_K,total RNA,Homo sapiens
GSE43974,GSM1075644,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_45,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329013_L,total RNA,Homo sapiens
GSE43974,GSM1075645,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_85,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329014_A,total RNA,Homo sapiens
GSE43974,GSM1075646,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_86,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329014_B,total RNA,Homo sapiens
GSE43974,GSM1075647,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_41,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329014_C,total RNA,Homo sapiens
GSE43974,GSM1075648,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_54,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329014_D,total RNA,Homo sapiens
GSE43974,GSM1075649,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_46,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329014_E,total RNA,Homo sapiens
GSE43974,GSM1075650,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_87,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329014_G,total RNA,Homo sapiens
GSE43974,GSM1075651,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_88,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329014_H,total RNA,Homo sapiens
GSE43974,GSM1075652,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_88,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329014_I,total RNA,Homo sapiens
GSE43974,GSM1075653,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_87,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329014_J,total RNA,Homo sapiens
GSE43974,GSM1075654,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_42,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329014_K,total RNA,Homo sapiens
GSE43974,GSM1075655,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_89,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329014_L,total RNA,Homo sapiens
GSE43974,GSM1075656,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_33,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_A,total RNA,Homo sapiens
GSE43974,GSM1075657,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_89,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_B,total RNA,Homo sapiens
GSE43974,GSM1075658,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_55,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329015_C,total RNA,Homo sapiens
GSE43974,GSM1075659,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_90,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_D,total RNA,Homo sapiens
GSE43974,GSM1075660,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_88,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_E,total RNA,Homo sapiens
GSE43974,GSM1075661,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_31,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_F,total RNA,Homo sapiens
GSE43974,GSM1075662,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_56,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329015_G,total RNA,Homo sapiens
GSE43974,GSM1075663,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_91,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329015_H,total RNA,Homo sapiens
GSE43974,GSM1075664,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_43,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_I,total RNA,Homo sapiens
GSE43974,GSM1075665,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_89,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_J,total RNA,Homo sapiens
GSE43974,GSM1075666,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_92,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329015_K,total RNA,Homo sapiens
GSE43974,GSM1075667,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_32,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329019_A,total RNA,Homo sapiens
GSE43974,GSM1075668,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_93,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329019_C,total RNA,Homo sapiens
GSE43974,GSM1075669,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_57,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329019_D,total RNA,Homo sapiens
GSE43974,GSM1075670,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_90,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329019_E,total RNA,Homo sapiens
GSE43974,GSM1075671,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_44,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329019_F,total RNA,Homo sapiens
GSE43974,GSM1075672,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_33,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329019_H,total RNA,Homo sapiens
GSE43974,GSM1075673,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_91,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1",,,,5937329019_I,total RNA,Homo sapiens
GSE43974,GSM1075674,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_34,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329019_J,total RNA,Homo sapiens
GSE43974,GSM1075675,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_90,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329019_K,total RNA,Homo sapiens
GSE43974,GSM1075676,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_92,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329019_L,total RNA,Homo sapiens
GSE43974,GSM1075677,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_94,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329024_A,total RNA,Homo sapiens
GSE43974,GSM1075678,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_91,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329024_B,total RNA,Homo sapiens
GSE43974,GSM1075679,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_93,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329024_C,total RNA,Homo sapiens
GSE43974,GSM1075680,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_94,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329024_D,total RNA,Homo sapiens
GSE43974,GSM1075681,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_95,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329024_E,total RNA,Homo sapiens
GSE43974,GSM1075682,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_45,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329024_F,total RNA,Homo sapiens
GSE43974,GSM1075683,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_46,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329024_G,total RNA,Homo sapiens
GSE43974,GSM1075684,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_47,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329024_J,total RNA,Homo sapiens
GSE43974,GSM1075685,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_58,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329024_K,total RNA,Homo sapiens
GSE43974,GSM1075686,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_59,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329024_L,total RNA,Homo sapiens
GSE43974,GSM1075687,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_48,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 0;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329025_A,total RNA,Homo sapiens
GSE43974,GSM1075688,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_96,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329025_C,total RNA,Homo sapiens
GSE43974,GSM1075689,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_47,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329025_E,total RNA,Homo sapiens
GSE43974,GSM1075690,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_35,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329025_F,total RNA,Homo sapiens
GSE43974,GSM1075691,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_95,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329025_G,total RNA,Homo sapiens
GSE43974,GSM1075692,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_92,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329025_H,total RNA,Homo sapiens
GSE43974,GSM1075693,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_93,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329025_I,total RNA,Homo sapiens
GSE43974,GSM1075694,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_94,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329025_J,total RNA,Homo sapiens
GSE43974,GSM1075695,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_36,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329025_K,total RNA,Homo sapiens
GSE43974,GSM1075696,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_60,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329025_L,total RNA,Homo sapiens
GSE43974,GSM1075697,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_95,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_A,total RNA,Homo sapiens
GSE43974,GSM1075698,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_97,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_B,total RNA,Homo sapiens
GSE43974,GSM1075699,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_96,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_C,total RNA,Homo sapiens
GSE43974,GSM1075700,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_61,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_D,total RNA,Homo sapiens
GSE43974,GSM1075701,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_98,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329028_E,total RNA,Homo sapiens
GSE43974,GSM1075702,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_48,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_G,total RNA,Homo sapiens
GSE43974,GSM1075703,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_62,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_H,total RNA,Homo sapiens
GSE43974,GSM1075704,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_99,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_I,total RNA,Homo sapiens
GSE43974,GSM1075705,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_100,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329028_J,total RNA,Homo sapiens
GSE43974,GSM1075706,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_101,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329028_K,total RNA,Homo sapiens
GSE43974,GSM1075707,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_96,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329028_L,total RNA,Homo sapiens
GSE43974,GSM1075708,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_97,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329029_A,total RNA,Homo sapiens
GSE43974,GSM1075709,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_49,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329029_B,total RNA,Homo sapiens
GSE43974,GSM1075710,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_98,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329029_C,total RNA,Homo sapiens
GSE43974,GSM1075711,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_102,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329029_D,total RNA,Homo sapiens
GSE43974,GSM1075712,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_49,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329029_F,total RNA,Homo sapiens
GSE43974,GSM1075713,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_103,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329029_G,total RNA,Homo sapiens
GSE43974,GSM1075714,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_104,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329029_H,total RNA,Homo sapiens
GSE43974,GSM1075715,GPL10558,47323,NR,STA,NR,1h,1,1,,,,,,,Kidney_donor_Living_T3_34,Kidney_donor_Living_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	living paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329029_I,total RNA,Homo sapiens
GSE43974,GSM1075716,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_99,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329029_J,total RNA,Homo sapiens
GSE43974,GSM1075717,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_DCD_T3_63,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329029_K,total RNA,Homo sapiens
GSE43974,GSM1075718,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_DCD_T3_64,Kidney_donor_DCD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329029_L,total RNA,Homo sapiens
GSE43974,GSM1075719,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_100,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329030_A,total RNA,Homo sapiens
GSE43974,GSM1075720,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_105,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329030_B,total RNA,Homo sapiens
GSE43974,GSM1075721,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T1_50,Kidney_donor_DCD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329030_C,total RNA,Homo sapiens
GSE43974,GSM1075722,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_101,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329030_D,total RNA,Homo sapiens
GSE43974,GSM1075723,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_106,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329030_F,total RNA,Homo sapiens
GSE43974,GSM1075724,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_107,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329030_G,total RNA,Homo sapiens
GSE43974,GSM1075725,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_108,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 1",,,,5937329030_H,total RNA,Homo sapiens
GSE43974,GSM1075726,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_97,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased left and right biopsies same donor (0=left, 1=right): 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329030_I,total RNA,Homo sapiens
GSE43974,GSM1075727,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_98,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329030_J,total RNA,Homo sapiens
GSE43974,GSM1075728,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_99,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329030_K,total RNA,Homo sapiens
GSE43974,GSM1075729,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_109,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329030_L,total RNA,Homo sapiens
GSE43974,GSM1075730,GPL10558,47323,Control,Normal,Control,0,1,1,,,,,,,Kidney_donor_Living_T1_37,Kidney_donor_Living_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 0;	timepoint biopsy: 1;	living paired biopsies: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329033_A,total RNA,Homo sapiens
GSE43974,GSM1075731,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_102,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329033_B,total RNA,Homo sapiens
GSE43974,GSM1075732,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_50,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329033_C,total RNA,Homo sapiens
GSE43974,GSM1075733,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_100,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1;	delayed graft function (0=no, 1=yes): 0",,,,5937329033_D,total RNA,Homo sapiens
GSE43974,GSM1075734,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T2_110,Kidney_donor_BD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 2;	deceased paired biopsies: 2;	delayed graft function (0=no, 1=yes): 0",,,,5937329033_E,total RNA,Homo sapiens
GSE43974,GSM1075735,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_51,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329033_F,total RNA,Homo sapiens
GSE43974,GSM1075736,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_BD_T1_101,Kidney_donor_BD_T1,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 1;	deceased donors, only left kidney included in the analysis: 1",,,,5937329033_G,total RNA,Homo sapiens
GSE43974,GSM1075737,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_52,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329033_H,total RNA,Homo sapiens
GSE43974,GSM1075738,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_103,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329033_I,total RNA,Homo sapiens
GSE43974,GSM1075739,GPL10558,47323,,DGF,DGF,1h,0,1,,,,,,,Kidney_donor_BD_T3_104,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 1",,,,5937329033_J,total RNA,Homo sapiens
GSE43974,GSM1075740,GPL10558,47323,Control,Normal,Control,0,0,1,,,,,,,Kidney_donor_DCD_T2_53,Kidney_donor_DCD_T2,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 2;	timepoint biopsy: 2;	deceased unpaired biopsies: 1;	delayed graft function (0=no, 1=yes): 1",,,,5937329033_K,total RNA,Homo sapiens
GSE43974,GSM1075741,GPL10558,47323,NR,STA,NR,1h,0,1,,,,,,,Kidney_donor_BD_T3_105,Kidney_donor_BD_T3,"tissue: kidney biopsy;	donor type (0=living, 1=bd, 2=nhb): 1;	timepoint biopsy: 3;	deceased paired biopsies: 3;	delayed graft function (0=no, 1=yes): 0",,,,5937329033_L,total RNA,Homo sapiens
GSE44131,GSM1079417,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_5V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079418,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_38Vex,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079419,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_43V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079420,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_90V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079421,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_96V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079422,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_97V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079423,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_132V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079424,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_133V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079425,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_165V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079426,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_165Vex,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079427,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_246V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079428,GPL6244,29096,NR,STA,Normal,,,1,,,,,,,G1_248V0,Normal transplant kidney biopsies,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079429,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_1V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079430,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_2V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079431,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_3V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079432,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_8V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079433,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_10V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079434,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_11V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079435,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_15V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079436,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_53V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079437,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_89V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079438,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_103V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079439,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_104V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079440,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_115V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079441,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_116V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079442,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_156V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079443,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_206V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079444,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_208V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079445,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,G2_249V0,Non-specific IFTA,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079446,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_13V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079447,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_16V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079448,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_27V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079449,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_52V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079450,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_135V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079451,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_169V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079452,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_244V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079453,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G3_251V0,TGP DSA-/C4d- (g+ptc > 1),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079454,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_101V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079455,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_143V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079456,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_149Vex,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079457,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_153V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079458,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_154V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079459,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_178V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079460,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_181V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079461,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_231V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079462,GPL6244,29096,CR,CAN+TGP,TGP,,,1,,,,,,,G4_238V0,TGP DSA+/C4d-,tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079463,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_33V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079464,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_39V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079465,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_118Vex,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079466,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_120V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079467,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_140V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079468,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_142V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079469,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_151V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079470,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_176V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079471,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_179V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079472,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_192V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE44131,GSM1079473,GPL6244,29096,CR,CAN+TGP,CAMR/TGP,,,1,,,,,,,G5_204V0,CAMR/TGP (C4d+/DSA+),tissue: renal biopsy,"One biopsy core was collected into a vial containing 1ml of RNALater__ (Ambion, Catalog Number AM7023), stored at -20_C for 24 hours, and then transferred to -70_C until RNA isolation. Renal tissue content in all cores was verified using a dissecting microscope and any non-renal tissue was removed. Total RNA was isolated using the QIAGEN Rneasy Mini Kit (Catalog Number 74104, Qiagen, USA) and was quantified using the NanoDrop 2000 (Thermo Scientific, Wilmington, Delaware). To further assess RNA quality, samples were assessed by the Agilent 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA,) and samples with an RNA Integrity Number score cut off >7 were deemed suitable for Gene Chip Microarray Hybridization. The complete protocol for converting total RNA into biotin-labeled RNA by Affymetrix Human Gene 1.0 ST Array hybridization containing 28,869 gene probe sets can be found in the manufacturer__s protocol for the Ambion Whole Transcript Expression Kit (Catalog Number 4425209, Ambion, Austin, TX) and Affymetix Gene chip Whole Transcript Terminal Labeling Kit (Catalog Number 900671, Affymetrix, Santa Clara, CA).",,,,total RNA,Homo sapiens
GSE47183_A,GSM1146201,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Glom-DN1",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146202,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Glom-DN10",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146203,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Glom-DN2",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146204,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Glom-DN5",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146205,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Glom-DN8",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146206,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Glom-DN914",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146207,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Glom-DN932",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146208,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Glom-MCD1",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146209,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Glom-MCD2",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146210,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Glom-MCD3",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146211,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Glom-MCD5",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146212,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Glom-TMD",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the glomeruli of human Thin Membrane Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146213,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Glom-TMD1",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the glomeruli of human Thin Membrane Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146214,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Glom-TMD5",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the glomeruli of human Thin Membrane Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146215,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H1-Glom-TN2",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146216,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H1-Glom-TN4",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146217,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H1-Glom-TN996",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146218,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H1-Glom-TN997",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146219,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H2-Glom-TN2",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146220,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H2-Glom-TN4",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146221,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H2-Glom-TN996",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146222,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H2-Glom-TN997",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146223,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Glom-MCD10",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146224,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Glom-MCD12",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146225,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Glom-MCD6",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146226,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Glom-MCD7",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146227,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Glom-MCD9",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146228,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Glom-MCD919",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146229,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Glom-TN2",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146230,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Glom-TN4",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146231,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Glom-TN995",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146232,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Glom-TN996",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146233,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Glom-TN997",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146234,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Glom-TN997_1",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146235,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS428",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146236,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS433",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146237,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS441",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146238,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS443",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146239,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS446",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146240,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS449",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146241,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS457",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146242,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS458",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146243,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS459",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146244,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS915",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146245,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS917",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146246,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS918",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146247,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Glom-FSGS927",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146248,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN403",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146249,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN415",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146250,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN416",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146251,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN417",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146252,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN421",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146253,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN422",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146254,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN424",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146255,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN425",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146256,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN431",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146257,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN432",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146258,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN434",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146259,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN435",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146260,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN436",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146261,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN437",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146262,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN439",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146263,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN452",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146264,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN453",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146265,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN455",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146266,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN456",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146267,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN460",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_A,GSM1146268,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Glom-MGN461",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146269,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Glom-DN901",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146270,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Glom-DN910",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146271,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Glom-DN914",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146272,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Glom-DN916",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146273,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Glom-DN932",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146274,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Glom-DN941",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146275,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Glom-DN947",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Glomeruli from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the glomeruli of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146276,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and Minimal Change Disease, H7-Glom-FSGS&MCD905",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis and Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146277,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and Minimal Change Disease, H7-Glom-FSGS&MCD922",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis and Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146278,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and Minimal Change Disease, H7-Glom-FSGS&MCD923",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis and Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146279,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and Minimal Change Disease, H7-Glom-FSGS&MCD931",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis and Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146280,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and Minimal Change Disease, H7-Glom-FSGS&MCD940",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis and Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146281,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and Minimal Change Disease, H7-Glom-FSGS&MCD944",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis and Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146282,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS912",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146283,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS915",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146284,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS917",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146285,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS918",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146286,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS920",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146287,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS927",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146288,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS933",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146289,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS970",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146290,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS971",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146291,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Glom-FSGS972",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Glomeruli from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the glomeruli of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146292,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Glom-MCD903",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146293,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Glom-MCD919",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146294,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Glom-MCD921",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146295,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Glom-MCD945",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146296,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Glom-MCD973",Kidney Biopsy from Human Minimal Change Disease,"tissue: Glomeruli from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the glomeruli of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146297,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN902",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146298,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN904",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146299,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN906",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146300,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN907",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146301,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN908",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146302,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN909",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146303,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN911",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146304,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN913",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146305,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN924",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146306,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN925",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146307,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN926",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146308,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN928",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146309,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN929",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146310,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN930",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146311,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN934",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146312,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN935",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146313,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN936",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146314,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN937",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146315,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN938",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146316,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN939",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146317,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN942",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146318,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN943",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146319,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Glom-RPGN946",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Glomeruli from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the glomeruli of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146320,GPL11670,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H7-Glom-TN995",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146321,GPL11670,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H7-Glom-TN996",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47183_B,GSM1146322,GPL11670,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H7-Glom-TN997",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Glomeruli from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the glomeruli of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146323,GPL14663,12020,,Normal,Cadaveric Donor,,1,0,,,,,,,"Cadaveric Donor, H1-Tub-CD1",Kidney Biopsy from Human Cadaveric Donor,tissue: Tubulointerstitium from kidney biopsy,None,,,Gene Expression data from the tubulointerstitial compartment of human Cadaveric Donor kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146324,GPL14663,12020,,Normal,Cadaveric Donor,,1,0,,,,,,,"Cadaveric Donor, H1-Tub-CD2",Kidney Biopsy from Human Cadaveric Donor,tissue: Tubulointerstitium from kidney biopsy,None,,,Gene Expression data from the tubulointerstitial compartment of human Cadaveric Donor kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146325,GPL14663,12020,,Normal,Cadaveric Donor,,1,0,,,,,,,"Cadaveric Donor, H1-Tub-CD3",Kidney Biopsy from Human Cadaveric Donor,tissue: Tubulointerstitium from kidney biopsy,None,,,Gene Expression data from the tubulointerstitial compartment of human Cadaveric Donor kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146326,GPL14663,12020,,Normal,Cadaveric Donor,,1,0,,,,,,,"Cadaveric Donor, H1-Tub-CD4",Kidney Biopsy from Human Cadaveric Donor,tissue: Tubulointerstitium from kidney biopsy,None,,,Gene Expression data from the tubulointerstitial compartment of human Cadaveric Donor kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146327,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN1",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146328,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN10",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146329,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN11",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146330,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN1108",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146331,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN2",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146332,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN3",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146333,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN5",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146334,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN6",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146335,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN7",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146336,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN8",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146337,GPL14663,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H1-Tub-DN9",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146338,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Tub-MCD1",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146339,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Tub-MCD2",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146340,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Tub-MCD3",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146341,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H1-Tub-MCD4",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146342,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Tub-TMD1",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Thin Membrane Disease  kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146343,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Tub-TMD2",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Thin Membrane Disease  kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146344,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Tub-TMD3",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Thin Membrane Disease  kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146345,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Tub-TMD4",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Thin Membrane Disease  kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146346,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Tub-TMD5",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Thin Membrane Disease  kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146347,GPL14663,12020,,noIMD,Thin Membrane Disease,,1,0,,,,,,,"Thin Membrane Disease, H1-Tub-TMD6",Kidney Biopsy from Human Thin Membrane Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Thin Membrane Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Thin Membrane Disease  kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146348,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Tub-MCD11",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146349,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Tub-MCD6",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146350,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Tub-MCD7",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146351,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Tub-MCD8",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146352,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H3-Tub-MCD9",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146353,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Tub-TN1185",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the tubulointerstitial compartment of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146354,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Tub-TN1186",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the tubulointerstitial compartment of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146355,GPL14663,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H3-Tub-TN2",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the tubulointerstitial compartment of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146356,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS320",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146357,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS326",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146358,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS327",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146359,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS328",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146360,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS332",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146361,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS339",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146362,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS341",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146363,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS344",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146364,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS345",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146365,GPL14663,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H5-Tub-FSGS347",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146366,GPL14663,12020,,noIMD,Hypertensive nephropathy,,1,0,,,,,,,"Hypertensive nephropathy, H5-Tub-HT11",Kidney Biopsy from Human Hypertensive nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Hypertensive nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146367,GPL14663,12020,,IMD,IgA Nephropathy,,1,0,,,,,,,"IgA Nephropathy, H5-Tub-IgA27",Kidney Biopsy from Human IgA Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: IgA Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146368,GPL14663,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H5-Tub-MCD8",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146369,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN303",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146370,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN315",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146371,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN316",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146372,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN317",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146373,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN321",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146374,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN322",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146375,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN324",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146376,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN325",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146377,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN330",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146378,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN331",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146379,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN333",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146380,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN334",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146381,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN335",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146382,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN337",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146383,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN351",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146384,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN354",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146385,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN355",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_A,GSM1146386,GPL14663,12020,,IMD,Membranous Glomerulonephritis,,1,0,,,,,,,"Membranous Glomerulonephritis, H5-Tub-MGN356",Kidney Biopsy from Human Membranous Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Membranous Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146387,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Tub-DN1101",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146388,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Tub-DN1108",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146389,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Tub-DN1110",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146390,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Tub-DN1114",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146391,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Tub-DN1132",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146392,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Tub-DN1133",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146393,GPL11670,12020,,noIMD,Diabetic Nephropathy,,1,0,,,,,,,"Diabetic Nephropathy, H7-Tub-DN1139",Kidney Biopsy from Human Diabetic Nephropathy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Diabetic Nephropathy",None,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146394,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and__Minimal Change Disease, H7-Tub-FSGS&MCD1104",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and__Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146395,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and__Minimal Change Disease, H7-Tub-FSGS&MCD1117",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and__Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146396,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and__Minimal Change Disease, H7-Tub-FSGS&MCD1124",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and__Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146397,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis and__Minimal Change Disease, H7-Tub-FSGS&MCD1136",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis and__Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis and__Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146398,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Tub-FSGS1115",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146399,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Tub-FSGS1125",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146400,GPL11670,12020,,noIMD,Focal and Segmental Glomerulosclerosis,,1,0,,,,,,,"Focal and Segmental Glomerulosclerosis, H7-Tub-FSGS1162",Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Focal and Segmental Glomerulosclerosis",None,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146401,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Tub-MCD1111",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146402,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Tub-MCD1112",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146403,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Tub-MCD1116",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146404,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Tub-MCD1137",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146405,GPL11670,12020,,noIMD,Minimal Change Disease,,1,0,,,,,,,"Minimal Change Disease, H7-Tub-MCD1163",Kidney Biopsy from Human Minimal Change Disease,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Minimal Change Disease",None,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146406,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1102",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146407,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1103",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146408,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1106",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146409,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1107",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146410,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1109",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146411,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1113",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146412,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1118",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146413,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1119",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146414,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1120",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146415,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1121",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146416,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1122",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146417,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1123",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146418,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1126",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146419,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1127",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146420,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1128",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146421,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1129",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146422,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1130",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146423,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1131",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146424,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1134",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146425,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1135",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146426,GPL11670,12020,,IMD,Rapidly Progressive Glomerulonephritis,,1,0,,,,,,,"Rapidly Progressive Glomerulonephritis, H7-Tub-RPGN1138",Kidney Biopsy from Human Rapidly Progressive Glomerulonephritis,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Rapidly Progressive Glomerulonephritis",None,,,Gene Expression data from the tubulointerstitial compartment of human Rapidly Progressive Glomerulonephritis kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146427,GPL11670,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H7-Tub-TN1185",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the tubulointerstitial compartment of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146428,GPL11670,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H7-Tub-TN1186",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the tubulointerstitial compartment of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE47184_B,GSM1146429,GPL11670,12020,,,Tumor Nephrectomy,,1,0,,,,,,,"Tumor Nephrectomy, H7-Tub-TN1187",Kidney Biopsy from Human Tumor Nephrectomy,"tissue: Tubulointerstitium from kidney biopsy;	disease status: Tumor Nephrectomy",None,,,Gene Expression data from the tubulointerstitial compartment of human Tumor Nephrectomy kidney,total RNA,Homo sapiens
GSE48581,GSM1181496,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT1,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181497,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT2,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181498,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT3,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181499,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT4,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181500,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT5,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181501,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT6,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181502,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT7,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181503,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT8,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181504,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT9,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181505,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT10,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181506,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT11,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181507,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT12,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181508,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT13,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181509,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT14,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181510,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT15,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181511,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT16,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181512,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT17,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181513,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT18,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181514,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT19,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181515,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,INT20,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): mixed","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181516,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT21,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181517,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT22,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181518,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT23,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181519,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT24,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181520,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT25,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181521,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT26,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181522,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT27,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181523,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT28,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181524,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT29,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181525,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT30,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181526,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT31,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181527,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,INT32,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): mixed","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181528,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT33,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181529,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT34,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181530,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT35,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181531,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT36,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181532,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT37,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181533,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT38,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181534,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT39,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181535,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,INT40,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): mixed","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181536,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT41,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181537,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT42,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181538,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT43,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181539,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT44,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181540,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT45,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181541,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT46,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181542,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT47,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181543,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT48,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181544,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT49,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181545,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT50,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181546,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT51,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181547,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT52,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181548,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT53,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181549,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT54,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181550,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT55,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181551,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT56,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181552,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT57,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181553,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT58,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181554,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT59,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181555,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT60,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181556,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT61,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181557,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT62,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181558,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT63,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181559,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT64,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181560,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT65,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181561,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT66,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181562,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT67,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181563,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT68,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181564,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT69,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181565,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT70,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181566,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT71,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181567,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT72,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181568,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT73,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181569,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT74,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181570,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT75,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181571,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT76,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181572,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT77,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181573,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT78,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181574,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT79,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181575,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT80,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181576,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT81,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181577,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT82,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181578,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT83,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181580,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT84,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181582,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT85,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181584,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT86,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181586,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT87,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181588,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT88,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181590,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT89,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181591,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT90,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181592,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT91,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181593,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT92,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181594,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT93,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181595,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT94,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181596,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT95,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181597,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT96,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181598,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT97,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181599,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT98,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181600,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT99,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181601,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT100,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181602,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT101,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181603,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT102,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181604,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT103,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181605,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT104,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181606,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT105,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181607,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT106,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181608,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT107,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181609,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT108,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181610,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT109,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181611,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT110,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181612,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT111,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181613,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT112,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181614,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT113,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181615,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT114,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181616,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT115,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181617,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT116,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181618,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT117,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181619,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,INT118,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): mixed","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181620,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT119,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181621,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT120,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181622,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT121,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181623,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT122,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181624,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT123,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181625,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT124,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181626,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT125,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181627,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT126,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181628,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT127,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181629,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT128,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181630,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,INT129,Nephrectomy,"tissue: nephrectomy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): nephrectomy","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181631,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,INT130,Nephrectomy,"tissue: nephrectomy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): nephrectomy","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181632,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT131,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181633,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT132,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181634,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT133,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181635,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT134,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181636,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT135,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181637,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT136,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181638,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT137,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181639,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT138,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181640,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT139,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181641,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT140,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181643,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT141,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181644,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,INT142,Nephrectomy,"tissue: nephrectomy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): nephrectomy","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181645,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT143,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181648,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT144,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181651,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT145,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181653,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT146,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181654,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT147,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181656,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT148,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181658,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT149,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181660,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT150,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181661,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT151,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181662,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT152,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181663,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT153,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181664,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT154,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181665,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT155,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181666,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT156,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181667,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT157,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181668,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,INT158,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): mixed","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181669,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT159,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181670,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT160,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181671,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT161,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181672,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT162,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181673,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT163,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181674,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT164,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181675,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT165,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181676,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT166,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181677,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT167,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181678,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT168,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181679,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT169,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181680,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT170,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181681,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT171,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181682,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT172,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181683,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT173,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181684,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT174,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181685,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT175,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181686,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT176,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181687,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT177,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181688,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT178,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181689,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT179,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181690,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT180,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181691,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT181,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181692,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT182,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181693,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT183,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181694,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT184,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181695,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT185,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181696,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT186,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181697,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT187,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181698,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT188,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181699,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT189,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181700,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT190,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181701,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT191,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181702,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT192,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181703,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT193,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181704,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT194,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181705,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT195,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181706,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT196,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181707,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT197,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181708,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT198,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181709,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT199,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181710,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT200,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181711,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT201,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181712,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT202,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181713,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,INT203,Nephrectomy,"tissue: nephrectomy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): nephrectomy","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181714,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT204,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181715,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT205,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181716,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT206,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181717,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT207,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181718,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT208,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181719,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT209,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181720,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT210,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181721,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT211,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181722,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT212,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181723,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT213,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181724,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT214,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181725,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT215,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181726,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT216,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181727,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT217,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181728,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT218,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181729,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,INT219,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181730,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT220,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181731,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT221,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181732,GPL570,54675,NR,STA,NR,,,1,,,,,,,INT222,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181733,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,INT223,renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181734,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT224",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181735,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT225",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181736,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT226",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181737,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT227",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181738,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT228",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181739,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT229",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181740,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT230",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181741,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT231",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181742,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT232",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181743,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT233",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181744,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT234",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181745,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT235",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181746,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT236",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181747,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT237",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181748,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT238",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181749,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT239",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181750,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT240",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181751,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT241",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181752,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT242",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181753,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT243",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181754,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT244",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181755,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT245",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181756,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT246",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181757,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT247",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181758,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT248",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181759,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT249",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181760,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomies (U of A)_INT250,Nephrectomy,"tissue: nephrectomy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): nephrectomy","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181761,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT251",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181762,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT252",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181763,GPL570,54675,AR,Mixed,mixed,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT253",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): mixed","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181764,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT254",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181765,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT255",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181766,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT256",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181767,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT257",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181768,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT258",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181769,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT259",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181770,GPL570,54675,Control,Normal,Nephrectomy,,,1,,,,,,,Nephrectomies (U of A)_INT260,Nephrectomy,"tissue: nephrectomy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): nephrectomy","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181771,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT261",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181772,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT262",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181773,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT263",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181774,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT264",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181775,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT265",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181776,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT266",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181777,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT267",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181778,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT268",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181779,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT269",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181780,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT270",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181781,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT271",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181782,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT272",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181783,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT273",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181784,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT274",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181785,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT275",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181786,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT276",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181787,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT277",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181788,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT278",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181789,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT279",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181790,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT280",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181791,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT281",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181792,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT282",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181793,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT283",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181794,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT284",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181795,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT285",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181796,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT286",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181797,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT287",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181798,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT288",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181799,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT289",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181800,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT290",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181801,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT291",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181802,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT292",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181803,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT293",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181804,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT294",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181805,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT295",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181806,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT296",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181807,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT297",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181808,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT298",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181809,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT299",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181810,GPL570,54675,AR,ABMR,ABMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT300",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): ABMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181811,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT301",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181812,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT302",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181813,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT303",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181814,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT304",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181815,GPL570,54675,NR,STA,NR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT305",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): non-rejecting","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE48581,GSM1181816,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,"renal allograft biopsy,  (U of A/Chicago)_INT306",renal allograft biopsy,"tissue: renal allograft biopsy;	diagnosis (tcmr, abmr, mixed, non-rejecting, nephrectomy): TCMR","All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.;	The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.",,,,total RNA,Homo sapiens
GSE50058,GSM1213295,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT342 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213302,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT655 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213304,GPL570,54675,Normal,Normal,STA,,,1,,,,,,,KT239 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213309,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT591 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213311,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT1016 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213315,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1090 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213316,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1092 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213318,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT610 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213319,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT618 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213320,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT669 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213321,GPL570,54675,Normal,Normal,STA,,,1,,,,,,,KT925 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213323,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT827 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213324,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT962 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213325,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1063 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213327,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1089 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213329,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT698 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213332,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1003 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213333,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1099 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213334,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1141 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213335,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT689 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213336,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT965 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213337,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT713 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213338,GPL570,54675,Normal,Normal,STA,,,1,,,,,,,KT769 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213340,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT554 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213341,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT682 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213342,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT948 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213343,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT592 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213344,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT688 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213345,GPL570,54675,AR,AR+CAN,STA,,,1,,,,,,,KT696 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213346,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT758 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213347,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT1012 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213348,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT1029 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213349,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT1030 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213350,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT728 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213351,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT773 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213352,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT809 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213353,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT529 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213354,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT552 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213355,GPL570,54675,AR,AR,STA,,,1,,,,,,,KT619 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213356,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT628 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213357,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT659 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213358,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT867 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213359,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT871 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213360,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT917 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213361,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT966 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213362,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT1009 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213363,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT954 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213370,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT566 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213379,GPL570,54675,AR,AR,STA,,,1,,,,,,,KT657 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213380,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT710 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213381,GPL570,54675,AR,Mixed,AR,,,1,,,,,,,KT885 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213383,GPL570,54675,AR,AR,AR,,,1,,,,,,,KT1202 - STA,renal allograft biopsy_stable patient - NOT TRUE??,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213385,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,,KT1114 - AR,renal allograft biopsy_patient with acute rejection,"patient group: patient with acute rejection (AR);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213386,GPL570,54675,AR,AR,AR,,,1,,,,,,,KT1218 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50058,GSM1213388,GPL570,54675,STA,STA,STA,,,1,,,,,,,KT630 - STA,renal allograft biopsy_stable patient,"patient group: stable patient (STA);	tissue: renal allograft biopsy",,,,,total RNA,Homo sapiens
GSE50084,GSM1213867,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_1,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213868,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_2,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213869,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_3,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213870,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_4,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213871,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_5,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213872,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_6,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213873,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_7,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213874,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_8,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213875,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_9,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213876,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_10,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213877,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_11,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213878,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_12,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213879,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_13,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213880,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_14,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213881,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_15,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213882,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_16,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213883,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_17,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213884,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_18,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213885,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_19,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213886,GPL6244,29096,NR,STA,no DSA,,,1,,,,,,,Biopsy_No_DSA_20,"No DSA, PRA 0% and normal Biopsy/Mild IF/TA",tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213887,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_1,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213888,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_2,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213889,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_3,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213890,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_4,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213891,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_5,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213892,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_6,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213893,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_7,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213894,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_8,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213895,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_9,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213896,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_10,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213897,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_11,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213898,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_12,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213899,GPL6244,29096,CR,CAN,IFTA,,,1,,,,,,,Biopsy_DSA_normal_13,DSA+ and normal biopsy/mild IF/TA,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213900,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_1,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213901,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_2,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213902,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_3,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213903,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_4,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213904,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_5,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213905,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_6,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213906,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_7,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213907,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_8,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213908,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_9,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213909,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_10,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213910,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_11,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213911,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_12,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213912,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_13,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213913,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_14,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213914,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_15,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213915,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_16,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213916,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_17,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213917,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_18,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213918,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_19,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213919,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_20,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213920,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_21,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213921,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_22,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213922,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_23,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213923,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_24,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213924,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_25,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213925,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_26,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213926,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_27,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE50084,GSM1213927,GPL6244,29096,R,ABMR,DSA+/AMR+,,,1,,,,,,,Biopsy_DSA_rejection_28,DSA+ and acute or chronic rejection,tissue: biopsy,"Biopsies were examined by light microscopy using hematoxylin and eosin, periodic acid-Schiff, trichrome and C4d immunoperoxidase stains and scored using the Banff criteria. Immunoperoxidase staining for C4d was performed on paraffin embedded sections using a polyclonal rabbit anti-human antibody (Cell Marque) at a dilution of 1:100 with the Dako Envision system. Positive peritubular capillary C4d staining was scored minimal (c4d1), focal (c4d2) or diffuse (c4d3) when there was uniform finely granular decoration involving more than 1-10%, 11-50% and greater than 50% for minimal, focal and diffuse respectively. Anti-HLA antibodies were studied by Luminex HLA Single Antigen Bead assays (LABScreen, One Lambda Inc., Canoga Park, CA) that utilize a panel of color-coded beads coated with purified single HLA antigens. The beads include HLA A, B, Cw, DR, and DQ antigens. The antibody specificity and strength were analyzed with HLA Fusion software V2.0 (One Lambda Inc.).__The cutoff value for a positive DSA was a mean fluorescence intensity (MFI)  ___1000.",,,Gene expression data from DSA biopsy sample,total RNA,Homo sapiens
GSE52694,GSM1274225,GPL10558,23719,NR,STA,STA,2m,,1,,,,,,,sample collected from patient 1A ___2 months after transplantation,stable renal graft function____2 months,"patient id: 1A;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_1A,total RNA,Homo sapiens
GSE52694,GSM1274226,GPL10558,23719,NR,STA,STA,2m,,1,,,,,,,sample collected from patient 2A ___2 months after transplantation,stable renal graft function____2 months,"patient id: 2A;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_2A,total RNA,Homo sapiens
GSE52694,GSM1274227,GPL10558,23719,NR,STA,STA,2m,,1,,,,,,,sample collected from patient 3A ___2 months after transplantation,stable renal graft function____2 months,"patient id: 3A;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_3A,total RNA,Homo sapiens
GSE52694,GSM1274228,GPL10558,23719,NR,STA,STA,2m,,1,,,,,,,sample collected from patient 4A ___2 months after transplantation,stable renal graft function____2 months,"patient id: 4A;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_4A,total RNA,Homo sapiens
GSE52694,GSM1274229,GPL10558,23719,NR,STA,STA,2m,,1,,,,,,,sample collected from patient 5A ___2 months after transplantation,stable renal graft function____2 months,"patient id: 5A;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_5A,total RNA,Homo sapiens
GSE52694,GSM1274230,GPL10558,23719,NR,STA,STA,2m,,1,,,,,,,sample collected from patient 6A ___2 months after transplantation,stable renal graft function____2 months,"patient id: 6A;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_6A,total RNA,Homo sapiens
GSE52694,GSM1274231,GPL10558,23719,,DGF,dysfunction,2m,,1,,,,,,,sample collected from patient 1B ___2 months after transplantation,deteriorated renal graft function____2 months,"patient id: 1B;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_1B,total RNA,Homo sapiens
GSE52694,GSM1274232,GPL10558,23719,,DGF,dysfunction,2m,,1,,,,,,,sample collected from patient 2B ___2 months after transplantation,deteriorated renal graft function____2 months,"patient id: 2B;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_2B,total RNA,Homo sapiens
GSE52694,GSM1274233,GPL10558,23719,,DGF,dysfunction,2m,,1,,,,,,,sample collected from patient 3B ___2 months after transplantation,deteriorated renal graft function____2 months,"patient id: 3B;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_3B,total RNA,Homo sapiens
GSE52694,GSM1274234,GPL10558,23719,,DGF,dysfunction,2m,,1,,,,,,,sample collected from patient 4B ___2 months after transplantation,deteriorated renal graft function____2 months,"patient id: 4B;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_4B,total RNA,Homo sapiens
GSE52694,GSM1274235,GPL10558,23719,,DGF,dysfunction,2m,,1,,,,,,,sample collected from patient 5B ___2 months after transplantation,deteriorated renal graft function____2 months,"patient id: 5B;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_5B,total RNA,Homo sapiens
GSE52694,GSM1274236,GPL10558,23719,,DGF,dysfunction,2m,,1,,,,,,,sample collected from patient 6B ___2 months after transplantation,deteriorated renal graft function____2 months,"patient id: 6B;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_6B,total RNA,Homo sapiens
GSE52694,GSM1274237,GPL10558,23719,,DGF,dysfunction,2m,,1,,,,,,,sample collected from patient 7B ___2 months after transplantation,deteriorated renal graft function____2 months,"patient id: 7B;	time after transplantation: ___2 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_7B,total RNA,Homo sapiens
GSE52694,GSM1274238,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 1C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 1C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_1C,total RNA,Homo sapiens
GSE52694,GSM1274239,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 2C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 2C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_2C,total RNA,Homo sapiens
GSE52694,GSM1274240,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 3C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 3C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_3C,total RNA,Homo sapiens
GSE52694,GSM1274241,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 4C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 4C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_4C,total RNA,Homo sapiens
GSE52694,GSM1274242,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 5C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 5C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_5C,total RNA,Homo sapiens
GSE52694,GSM1274243,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 6C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 6C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_6C,total RNA,Homo sapiens
GSE52694,GSM1274244,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 7C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 7C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_7C,total RNA,Homo sapiens
GSE52694,GSM1274245,GPL10558,23719,NR,STA,STA,3m,,1,,,,,,,sample collected from patient 8C at 3 months after transplantation,stable renal graft function_3 months,"patient id: 8C;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: no;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_8C,total RNA,Homo sapiens
GSE52694,GSM1274246,GPL10558,23719,,DGF,dysfunction,3m,,1,,,,,,,sample collected from patient 1D at 3 months after transplantation,deteriorated renal graft function_3 months,"patient id: 1D;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_1D,total RNA,Homo sapiens
GSE52694,GSM1274247,GPL10558,23719,,DGF,dysfunction,3m,,1,,,,,,,sample collected from patient 2D at 3 months after transplantation,deteriorated renal graft function_3 months,"patient id: 2D;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_2D,total RNA,Homo sapiens
GSE52694,GSM1274248,GPL10558,23719,,DGF,dysfunction,3m,,1,,,,,,,sample collected from patient 3D at 3 months after transplantation,deteriorated renal graft function_3 months,"patient id: 3D;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_3D,total RNA,Homo sapiens
GSE52694,GSM1274249,GPL10558,23719,,DGF,dysfunction,3m,,1,,,,,,,sample collected from patient 4D at 3 months after transplantation,deteriorated renal graft function_3 months,"patient id: 4D;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_4D,total RNA,Homo sapiens
GSE52694,GSM1274250,GPL10558,23719,,DGF,dysfunction,3m,,1,,,,,,,sample collected from patient 5D at 3 months after transplantation,deteriorated renal graft function_3 months,"patient id: 5D;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_5D,total RNA,Homo sapiens
GSE52694,GSM1274251,GPL10558,23719,,DGF,dysfunction,3m,,1,,,,,,,sample collected from patient 6D at 3 months after transplantation,deteriorated renal graft function_3 months,"patient id: 6D;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_6D,total RNA,Homo sapiens
GSE52694,GSM1274252,GPL10558,23719,,DGF,dysfunction,3m,,1,,,,,,,sample collected from patient 7D at 3 months after transplantation,deteriorated renal graft function_3 months,"patient id: 7D;	time after transplantation: 3 months;	deterioration of graft function within 2 years after transplantation: yes;	sample type: renal graft biopsy",Comparison of patients with stable and deteriorated renal graft function (defined as as the increase in serum creatinine level of more than 25% of its value at 3 months) during 2 years afte transplantation by analyzing RNA profiles at the time of   border line changes diagnosis  in early (___2 months) or protocolar (3 months) renal graft  biopsies.,,,BORDERLINE_PRAGUE_7D,total RNA,Homo sapiens
GSE53605,GSM1296666,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 1K-1KCAN,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296667,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 2K-2KCAN,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296668,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 9KCAN,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296669,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 107-K,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296670,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 108-K,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296671,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 111-K,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296672,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 134-K,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296673,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 136-K,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296674,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 117KCAN,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296675,GPL571,22277,CR,CAN,IFTA,,,1,,,,,,,IF/TA 175KCAN,Kidney biopsies from transplant recipients with histological diagnosis of IF/TA,"tissue: kidney biopsy;	histological diagnosis: IF/TA",,,,,total RNA,Homo sapiens
GSE53605,GSM1296676,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 28K3,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296677,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 4K18,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296678,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 17K20,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296679,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 59K9,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296680,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 94-K,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296681,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 113K_1mo,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296682,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 162K18,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296683,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 164K69,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296684,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR 179K6,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296685,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR BxBC 1K_4mo,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296686,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR BxBC 2K_40mo,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296687,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR BxBC 30K_22mo,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296688,GPL571,22277,AR,Mixed,ACR,,,1,,,,,,,ACR BxBC 31K_77mo,Kidney biopsies from transplant recipients with histological diagnosis of Acute Rejection (AR or ACR),"tissue: kidney biopsy;	histological diagnosis: Acute Rejection (AR or ACR)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296689,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 40K9mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296690,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 45K6,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296691,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 30K9mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296692,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 6-55-K,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296693,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 17K3,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296694,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 62K6mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296695,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 87K6,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296696,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 97K1mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296697,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 98K1mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296698,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 106K_1mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296699,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT 110K_1mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296700,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT BxBC 9K_81mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296701,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT BxBC 11K_32mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296702,GPL571,22277,,CAN,CNIT,,,1,,,,,,,CNIT BxBC 16K_3mo,Kidney biopsies from transplant recipients with histological diagnosis of calcineurin inhibitor toxicity (CNIT),"tissue: kidney biopsy;	histological diagnosis: calcineurin inhibitor toxicity (CNIT)",,,,,total RNA,Homo sapiens
GSE53605,GSM1296703,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal 109K12,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296704,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal 93K12,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296705,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal 27K9mo,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296706,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal 31K9mo,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296707,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal 37K9mo,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296708,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal 145K9,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296709,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal 146K9,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296710,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_21,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296711,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_42,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296712,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_45,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296713,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_48,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296714,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_51,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296715,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_75,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296716,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_76,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296717,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_91,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296718,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_93,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296719,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_106,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53605,GSM1296720,GPL571,22277,NR,STA,Normal,,,1,,,,,,,Normal NW_115,Normal allografts,"tissue: kidney biopsy;	histological diagnosis: Normal allografts",,,,,total RNA,Homo sapiens
GSE53769,GSM1300286,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1039, biopsy pair 1039-28, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300287,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1047, biopsy pair 1047-02, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300288,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1073, biopsy pair 1073-07, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300289,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1084, biopsy pair 1084-09, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300290,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1133, biopsy pair 1133-27, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300291,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1134, biopsy pair 1134-24, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300292,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1135, biopsy pair 1135-25, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300293,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1140, biopsy pair 1140-30, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300294,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1141, biopsy pair 1141-29, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300295,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1156, biopsy pair 1156-35, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300296,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1159, biopsy pair 1159-32, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300297,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1160, biopsy pair 1160-33, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300298,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1161, biopsy pair 1161-34, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300299,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1162, biopsy pair 1162-39, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300300,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1163, biopsy pair 1163-38, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300301,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1171, biopsy pair 1171-41, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300302,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1172, biopsy pair 1172-42, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300303,GPL16686,53617,Control,Normal,Control,0,,1,,,,,,,"zero-hour biopsy 1174, biopsy pair 1174-43, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: zero-hour biopsy",,,,Gene expression data from zero-hour biopsy,total RNA,Homo sapiens
GSE53769,GSM1300304,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 24, biopsy pair 1134-24, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300305,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 25, biopsy pair 1135-25, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE53769,GSM1300306,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 27, biopsy pair 1133-27, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300307,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 28, biopsy pair 1039-28, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE53769,GSM1300308,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 29, biopsy pair 1141-29, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE53769,GSM1300309,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 02, biopsy pair 1047-02, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE53769,GSM1300310,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 30, biopsy pair 1140-30, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300311,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 32, biopsy pair 1159-32, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300312,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 33, biopsy pair 1160-33, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300313,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 34, biopsy pair 1161-34, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300314,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 35, biopsy pair 1156-35, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300315,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 38, biopsy pair 1163-38, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300316,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 39, biopsy pair 1162-39, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE53769,GSM1300317,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 41, biopsy pair 1171-41, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300318,GPL16686,53617,NR,STA,Normal,,,1,,,,,,,"post-Tx biopsy 42, biopsy pair 1172-42, PBx group (control)",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, protocol biopsy (PBx) without pathology",,,,"Gene expression data from post-TX biopsy, protocol biopsy (PBx) without pathology",total RNA,Homo sapiens
GSE53769,GSM1300319,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 43, biopsy pair 1174-43, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE53769,GSM1300320,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 07, biopsy pair 1073-07, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE53769,GSM1300321,GPL16686,53617,NR,DGF,ATN,,,1,,,,,,,"post-Tx biopsy 09, biopsy pair 1084-09, AKI group",kidney allograft biopsy,"tissue: kidney;	biopsy type: post-TX biopsy, acute tubular necrosis (ATN)",,,,"Gene expression data from post-TX biopsy, acute tubular necrosis (ATN)",total RNA,Homo sapiens
GSE54888,GSM1326154,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-11,preimplantation kidney biopsy,"donor: 11;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 11,total RNA,Homo sapiens
GSE54888,GSM1326155,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-14,preimplantation kidney biopsy,"donor: 14;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 14,total RNA,Homo sapiens
GSE54888,GSM1326156,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-2,preimplantation kidney biopsy,"donor: 2;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 2,total RNA,Homo sapiens
GSE54888,GSM1326157,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-7,preimplantation kidney biopsy,"donor: 7;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 7,total RNA,Homo sapiens
GSE54888,GSM1326158,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-12,preimplantation kidney biopsy,"donor: 12;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 12,total RNA,Homo sapiens
GSE54888,GSM1326159,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-132,preimplantation kidney biopsy,"donor: 132;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 132,total RNA,Homo sapiens
GSE54888,GSM1326160,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-136,preimplantation kidney biopsy,"donor: 136;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 136,total RNA,Homo sapiens
GSE54888,GSM1326161,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-13,preimplantation kidney biopsy,"donor: 13;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 13,total RNA,Homo sapiens
GSE54888,GSM1326162,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-16,preimplantation kidney biopsy,"donor: 16;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 16,total RNA,Homo sapiens
GSE54888,GSM1326163,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-170,preimplantation kidney biopsy,"donor: 170;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 170,total RNA,Homo sapiens
GSE54888,GSM1326164,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-175,preimplantation kidney biopsy,"donor: 175;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 175,total RNA,Homo sapiens
GSE54888,GSM1326165,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-177,preimplantation kidney biopsy,"donor: 177;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 177,total RNA,Homo sapiens
GSE54888,GSM1326166,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-21,preimplantation kidney biopsy,"donor: 21;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 21,total RNA,Homo sapiens
GSE54888,GSM1326167,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-245,preimplantation kidney biopsy,"donor: 245;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 245,total RNA,Homo sapiens
GSE54888,GSM1326168,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-269,preimplantation kidney biopsy,"donor: 269;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 269,total RNA,Homo sapiens
GSE54888,GSM1326169,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-26,preimplantation kidney biopsy,"donor: 26;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 26,total RNA,Homo sapiens
GSE54888,GSM1326170,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-272,preimplantation kidney biopsy,"donor: 272;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 272,total RNA,Homo sapiens
GSE54888,GSM1326171,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-295,preimplantation kidney biopsy,"donor: 295;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 295,total RNA,Homo sapiens
GSE54888,GSM1326172,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-299,preimplantation kidney biopsy,"donor: 299;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 299,total RNA,Homo sapiens
GSE54888,GSM1326173,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-300,preimplantation kidney biopsy,"donor: 300;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 300,total RNA,Homo sapiens
GSE54888,GSM1326174,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-317,preimplantation kidney biopsy,"donor: 317;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 317,total RNA,Homo sapiens
GSE54888,GSM1326175,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-319,preimplantation kidney biopsy,"donor: 319;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: --",,,,preimplantation kidney biopsy from deceased donor 319,total RNA,Homo sapiens
GSE54888,GSM1326176,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-320,preimplantation kidney biopsy,"donor: 320;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 320,total RNA,Homo sapiens
GSE54888,GSM1326177,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-322,preimplantation kidney biopsy,"donor: 322;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 322,total RNA,Homo sapiens
GSE54888,GSM1326178,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-323,preimplantation kidney biopsy,"donor: 323;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 323,total RNA,Homo sapiens
GSE54888,GSM1326179,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-32,preimplantation kidney biopsy,"donor: 32;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 32,total RNA,Homo sapiens
GSE54888,GSM1326180,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-339,preimplantation kidney biopsy,"donor: 339;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 339,total RNA,Homo sapiens
GSE54888,GSM1326181,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-72,preimplantation kidney biopsy,"donor: 72;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 72,total RNA,Homo sapiens
GSE54888,GSM1326182,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-8,preimplantation kidney biopsy,"donor: 8;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 8,total RNA,Homo sapiens
GSE54888,GSM1326183,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-15,preimplantation kidney biopsy,"donor: 15;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 15,total RNA,Homo sapiens
GSE54888,GSM1326184,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-174,preimplantation kidney biopsy,"donor: 174;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 174,total RNA,Homo sapiens
GSE54888,GSM1326185,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-17,preimplantation kidney biopsy,"donor: 17;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 17,total RNA,Homo sapiens
GSE54888,GSM1326186,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-184,preimplantation kidney biopsy,"donor: 184;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 184,total RNA,Homo sapiens
GSE54888,GSM1326187,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-22,preimplantation kidney biopsy,"donor: 22;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 22,total RNA,Homo sapiens
GSE54888,GSM1326188,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-270,preimplantation kidney biopsy,"donor: 270;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 270,total RNA,Homo sapiens
GSE54888,GSM1326189,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-271,preimplantation kidney biopsy,"donor: 271;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 271,total RNA,Homo sapiens
GSE54888,GSM1326190,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-275,preimplantation kidney biopsy,"donor: 275;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 275,total RNA,Homo sapiens
GSE54888,GSM1326191,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-276,preimplantation kidney biopsy,"donor: 276;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 276,total RNA,Homo sapiens
GSE54888,GSM1326192,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-277,preimplantation kidney biopsy,"donor: 277;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 277,total RNA,Homo sapiens
GSE54888,GSM1326193,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-28,preimplantation kidney biopsy,"donor: 28;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 28,total RNA,Homo sapiens
GSE54888,GSM1326194,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-309,preimplantation kidney biopsy,"donor: 309;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 309,total RNA,Homo sapiens
GSE54888,GSM1326195,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-318,preimplantation kidney biopsy,"donor: 318;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 318,total RNA,Homo sapiens
GSE54888,GSM1326196,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-335,preimplantation kidney biopsy,"donor: 335;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 335,total RNA,Homo sapiens
GSE54888,GSM1326197,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-338,preimplantation kidney biopsy,"donor: 338;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 338,total RNA,Homo sapiens
GSE54888,GSM1326198,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-36,preimplantation kidney biopsy,"donor: 36;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 36,total RNA,Homo sapiens
GSE54888,GSM1326199,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-37,preimplantation kidney biopsy,"donor: 37;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: --",,,,preimplantation kidney biopsy from deceased donor 37,total RNA,Homo sapiens
GSE54888,GSM1326200,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-56,preimplantation kidney biopsy,"donor: 56;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 56,total RNA,Homo sapiens
GSE54888,GSM1326201,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-6,preimplantation kidney biopsy,"donor: 6;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: --",,,,preimplantation kidney biopsy from deceased donor 6,total RNA,Homo sapiens
GSE54888,GSM1326202,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-172,preimplantation kidney biopsy,"donor: 172;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 172,total RNA,Homo sapiens
GSE54888,GSM1326203,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-173,preimplantation kidney biopsy,"donor: 173;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 173,total RNA,Homo sapiens
GSE54888,GSM1326204,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-19,preimplantation kidney biopsy,"donor: 19;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: yes;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 19,total RNA,Homo sapiens
GSE54888,GSM1326205,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-293,preimplantation kidney biopsy,"donor: 293;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: Low",,,,preimplantation kidney biopsy from deceased donor 293,total RNA,Homo sapiens
GSE54888,GSM1326206,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-294,preimplantation kidney biopsy,"donor: 294;	tissue type: preimplantation kidney biopsy;	dgf occurrence: without DGF;	dgf lasting more than 14 days: --;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 294,total RNA,Homo sapiens
GSE54888,GSM1326207,GPL6244,33252,Control,Normal,Control,0,0,1,,,,,,,TRIB-76,preimplantation kidney biopsy,"donor: 76;	tissue type: preimplantation kidney biopsy;	dgf occurrence: DGF;	dgf lasting more than 14 days: no;	estimated creatinine clearance: High",,,,preimplantation kidney biopsy from deceased donor 76,total RNA,Homo sapiens
GSE57387,GSM1381712,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P3600,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381713,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P3957,3 month kidney biopsy post transplant,"m12 cadi: 8;	tissue type: percutaneous allograft biopsy;	m12 cadi: 7",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381714,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P4291,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 8;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381715,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P5647,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 7;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381716,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P5947,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381717,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P6219,3 month kidney biopsy post transplant,"m3 cadi: 5;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381718,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6526,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381719,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6604,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381720,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6606,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381721,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P6609,3 month kidney biopsy post transplant,"m3 cadi: 7;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381722,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6633,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381723,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P6634,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381724,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6637,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381725,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6642,3 month kidney biopsy post transplant,"m12 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: 0",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381726,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6643,3 month kidney biopsy post transplant,"m12 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: 0",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381727,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6644,3 month kidney biopsy post transplant,"m12 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: 2",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381728,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6646,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381729,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P6647,3 month kidney biopsy post transplant,"m3 cadi: 6;	m12 cadi: 5;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381730,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P6648,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381731,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6649,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381732,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6650,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381733,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P7148,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381734,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P7160,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 8;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381735,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P7165,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 5;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381736,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P7449,3 month kidney biopsy post transplant,"m12 cadi: 5;	tissue type: percutaneous allograft biopsy;	m12 cadi: 5",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381737,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P7709,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381738,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P7714,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381739,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P7720,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381740,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P7764,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 5;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381741,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P7879,3 month kidney biopsy post transplant,"m12 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: 0",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381742,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P9246,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381743,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P12351,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381744,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P12598,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381745,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P12666,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381746,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P12758,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381747,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P12773,3 month kidney biopsy post transplant,"m12 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: 3",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381748,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P12886,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381749,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P14029,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381750,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P14190,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381751,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P14212,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381752,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P14221,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381753,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P14307,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381754,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P14912,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381755,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P15063,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381756,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P15197,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381757,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P15531,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381758,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P15761,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381759,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P16220,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381760,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P16573,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381761,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P16756,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381762,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P16865,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381763,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P17767,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381764,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P18399,3 month kidney biopsy post transplant,"m12 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: 0",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381765,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P18463,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381766,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P18673,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381767,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P19210,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381768,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P19338,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381769,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P19769,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 6;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381770,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P20066,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 7;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381771,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P20212,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381772,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P20325,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381773,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P21037,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381774,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P21359,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381775,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P21504,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381776,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P22255,3 month kidney biopsy post transplant,"m12 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: 0",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381777,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P24369,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381778,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P24467,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381779,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P24557,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381780,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P25395,3 month kidney biopsy post transplant,"m12 cadi: 4;	tissue type: percutaneous allograft biopsy;	m12 cadi: 4",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381781,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P26166,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381782,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P26608,3 month kidney biopsy post transplant,"m12 cadi: 4;	tissue type: percutaneous allograft biopsy;	m12 cadi: 4",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381783,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P26747,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381784,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P27222,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 3;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381785,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P27306,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381786,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28104,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381787,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28131,3 month kidney biopsy post transplant,"m12 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: 1",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381788,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28211,3 month kidney biopsy post transplant,"m12 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: 0",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381789,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28214,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381790,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28317,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 7;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381791,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P28655,3 month kidney biopsy post transplant,"m3 cadi: 4;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381792,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P28899,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 11;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381793,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P28900,3 month kidney biopsy post transplant,"m12 cadi: 6;	tissue type: percutaneous allograft biopsy;	m12 cadi: 7",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381794,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28942,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381795,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28992,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381796,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P29077,3 month kidney biopsy post transplant,"m3 cadi: 7;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381797,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P29221,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 4;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381798,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P29757,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381799,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P29987,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381800,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P30009,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381801,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P30106,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381802,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P30609,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381803,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P30765,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 6;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381804,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P32851,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 0;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381805,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P32937,3 month kidney biopsy post transplant,"m3 cadi: 0;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381806,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P34886,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381807,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P34943,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381808,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P35131,3 month kidney biopsy post transplant,"m3 cadi: 1;	m12 cadi: 2;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381809,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P35132,3 month kidney biopsy post transplant,"m3 cadi: 3;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381810,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P35536,3 month kidney biopsy post transplant,"m12 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: 1",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381811,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P36312,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381812,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P36313,3 month kidney biopsy post transplant,"m3 cadi: 2;	m12 cadi: 1;	tissue type: percutaneous allograft biopsy",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381813,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P5889,3 month kidney biopsy post transplant,"m3 cadi: 7;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381814,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6485,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381815,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6491,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381816,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6607,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381817,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P6610,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381818,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P7145,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381819,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P8403,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381820,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P8751,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381821,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P12616,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381822,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P12673,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381823,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P12683,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381824,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P12839,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381825,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P14608,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381826,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P14690,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381827,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P14768,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381828,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P15313,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381829,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P15762,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381830,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P16637,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381831,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P17063,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381832,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P17064,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381833,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P17145,3 month kidney biopsy post transplant,"m3 cadi: 5;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381834,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P18496,3 month kidney biopsy post transplant,"m3 cadi: 7;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381835,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P18557,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381836,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P18805,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381837,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P19792,3 month kidney biopsy post transplant,"m3 cadi: 4;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381838,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P19884,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381839,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P19996,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381840,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P20741,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381841,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P20787,3 month kidney biopsy post transplant,"m3 cadi: 4;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381842,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P20891,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381843,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P21008,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381844,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P21093,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381845,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P21279,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381846,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P22526,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381847,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P22830,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381848,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P22987,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381849,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P24797,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381850,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P26670,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381851,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P27071,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381852,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P28901,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381853,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P29561,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381854,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P29719,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381855,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P29934,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381856,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P30944,3 month kidney biopsy post transplant,"m3 cadi: 4;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381857,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P33263,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381858,GPL5175,17881,NR,CAN,CAN,3m,,1,,,,,,,BX_M3_P34400,3 month kidney biopsy post transplant,"m3 cadi: 3;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381859,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P35241,3 month kidney biopsy post transplant,"m3 cadi: 1;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381860,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P35866,3 month kidney biopsy post transplant,"m3 cadi: 0;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381861,GPL5175,17881,NR,STA,STA,3m,,1,,,,,,,BX_M3_P36682,3 month kidney biopsy post transplant,"m3 cadi: 2;	tissue type: percutaneous allograft biopsy;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381862,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P13799,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381863,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P14027,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381864,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P15517,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381865,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P15811,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381866,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P27107,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381867,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P35925,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381868,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P6641,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381869,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P36051,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE57387,GSM1381870,GPL5175,17881,NR,,,3m,,1,,,,,,,BX_M3_P36244,3 month kidney biopsy post transplant,"tissue type: percutaneous allograft biopsy;	m3 cadi: --;	m12 cadi: --",not applicable,,,3month kidney biopsy post transplant,total RNA,Homo sapiens
GSE58601,GSM1414836,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_1,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414837,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_2,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414838,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_3,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414839,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_4,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414840,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_5,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414841,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_6,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414842,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_7,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414843,GPL6244,29096,CR,CAN+TGP,TGP. Graft loss,,,1,,,,,,,Biopsy_Graft_Loss_8,Biopsy from graft loss patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft loss biopsy,total RNA,Homo sapiens
GSE58601,GSM1414844,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_1,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414845,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_2,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414846,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_3,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414847,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_4,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414848,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_5,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414849,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_6,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414850,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_7,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414851,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_8,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414852,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_9,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414853,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_10,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414854,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_11,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414855,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_12,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414856,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_13,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414857,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_14,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414858,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_15,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414859,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_16,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414860,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_17,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414861,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_18,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414862,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_19,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE58601,GSM1414863,GPL6244,29096,NR,CAN+TGP,TGP. No graft loss,,,1,,,,,,,Biopsy_No_Graft_Loss_20,Biopsy from graft functioning patient,"tissue: kidney;	tissue source: biopsy",,,,Gene expression data from graft functioning biopsy,total RNA,Homo sapiens
GSE60807,GSM1489141,GPL6480,41093,Control,Normal,Control,,0,1,1,43,,,,,I23,Kidney Biopsy,"gender: male;	age: 43;	donor death: Trauma;	last donor creatinine: 0.95;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489142,GPL6480,41093,Control,Normal,Control,,0,1,1,63,,,,,I58,Kidney Biopsy,"gender: male;	age: 63;	donor death: Cerebrovascular;	last donor creatinine: 0.73;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489143,GPL6480,41093,Control,Normal,Control,,0,1,0,52,,,,,I49,Kidney Biopsy,"gender: female;	age: 52;	donor death: Trauma;	last donor creatinine: 0.6;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489144,GPL6480,41093,Control,Normal,Control,,0,1,1,67,,,,,I06,Kidney Biopsy,"gender: male;	age: 67;	donor death: Cerebrovascular;	last donor creatinine: 0.95;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489145,GPL6480,41093,Control,Normal,Control,,0,1,1,22,,,,,T05,Kidney Biopsy,"gender: male;	age: 22;	donor death: Trauma;	last donor creatinine: 0.98;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489146,GPL6480,41093,Control,Normal,Control,,0,1,0,47,,,,,I46,Kidney Biopsy,"gender: female;	age: 47;	donor death: Trauma;	last donor creatinine: 0.57;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489147,GPL6480,41093,Control,Normal,Control,,0,1,1,57,,,,,I31,Kidney Biopsy,"gender: male;	age: 57;	donor death: Cerebrovascular;	last donor creatinine: 0.93;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489148,GPL6480,41093,Control,Normal,Control,,0,1,1,57,,,,,I07,Kidney Biopsy,"gender: male;	age: 67;	donor death: Cerebrovascular;	last donor creatinine: 0.95;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489149,GPL6480,41093,Control,Normal,Control,,0,1,0,18,,,,,I18,Kidney Biopsy,"gender: female;	age: 18;	donor death: Other;	last donor creatinine: 0.51;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489150,GPL6480,41093,Control,Normal,Control,,0,1,1,52,,,,,I27,Kidney Biopsy,"gender: male;	age: 52;	donor death: Trauma;	last donor creatinine: 0.82;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489151,GPL6480,41093,Control,Normal,Control,,0,1,0,64,,,,,T12,Kidney Biopsy,"gender: female;	age: 64;	donor death: Cerebrovascular;	last donor creatinine: 0.60;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489152,GPL6480,41093,Control,Normal,Control,,0,1,0,44,,,,,I13,Kidney Biopsy,"gender: female;	age: 44;	donor death: Cerebrovascular;	last donor creatinine: 0.84;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489153,GPL6480,41093,Control,Normal,Control,,0,1,1,51,,,,,T13,Kidney Biopsy,"gender: male;	age: 51;	donor death: Cerebrovascular;	last donor creatinine: 1.00;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489154,GPL6480,41093,Control,Normal,Control,,0,1,1,69,,,,,I32,Kidney Biopsy,"gender: male;	age: 69;	donor death: Cerebrovascular;	last donor creatinine: 0.9;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489155,GPL6480,41093,Control,Normal,Control,,0,1,1,33,,,,,I17,Kidney Biopsy,"gender: male;	age: 33;	donor death: Cerebrovascular;	last donor creatinine: 0.82;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489156,GPL6480,41093,Control,Normal,Control,,0,1,1,48,,,,,I29,Kidney Biopsy,"gender: male;	age: 48;	donor death: Cerebrovascular;	last donor creatinine: 0.77;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489157,GPL6480,41093,Control,Normal,Control,,0,1,0,41,,,,,I30,Kidney Biopsy,"gender: female;	age: 41;	donor death: Cerebrovascular;	last donor creatinine: 0.59;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489158,GPL6480,41093,Control,Normal,Control,,0,1,1,59,,,,,I47,Kidney Biopsy,"gender: male;	age: 59;	donor death: Trauma;	last donor creatinine: 0.83;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489159,GPL6480,41093,Control,Normal,Control,,0,1,0,77,,,,,I34,Kidney Biopsy,"gender: female;	age: 77;	donor death: Cerebrovascular;	last donor creatinine: 0.7;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489160,GPL6480,41093,Control,Normal,Control,,0,1,1,21,,,,,I52,Kidney Biopsy,"gender: male;	age: 21;	donor death: Trauma;	last donor creatinine: 0.56;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489161,GPL6480,41093,Control,Normal,Control,,0,1,1,48,,,,,I25,Kidney Biopsy,"gender: male;	age: 48;	donor death: Cerebrovascular;	last donor creatinine: 0.8;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489162,GPL6480,41093,Control,Normal,Control,,0,1,1,41,,,,,I26,Kidney Biopsy,"gender: male;	age: 41;	donor death: Trauma;	last donor creatinine: 0.92;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489163,GPL6480,41093,Control,Normal,Control,,0,1,0,40,,,,,I15,Kidney Biopsy,"gender: female;	age: 40;	donor death: Cerebrovascular;	last donor creatinine: 0.8;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489164,GPL6480,41093,Control,Normal,Control,,0,1,0,49,,,,,I24,Kidney Biopsy,"gender: female;	age: 49;	donor death: Cerebrovascular;	last donor creatinine: 0.68;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489165,GPL6480,41093,Control,Normal,Control,,0,1,1,58,,,,,I01,Kidney Biopsy,"gender: male;	age: 58;	donor death: Cerebrovascular;	last donor creatinine: 0.8;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489166,GPL6480,41093,Control,Normal,Control,,0,1,1,73,,,,,I54,Kidney Biopsy,"gender: male;	age: 73;	donor death: Cerebrovascular;	last donor creatinine: 1.13;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489167,GPL6480,41093,Control,Normal,Control,,0,1,1,60,,,,,T09,Kidney Biopsy,"gender: male;	age: 60;	donor death: Cerebrovascular;	last donor creatinine: 1.00;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489168,GPL6480,41093,Control,Normal,Control,,0,1,0,39,,,,,I41,Kidney Biopsy,"gender: female;	age: 39;	donor death: Cerebrovascular;	last donor creatinine: 0.88;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489169,GPL6480,41093,Control,Normal,Control,,0,1,1,62,,,,,I21,Kidney Biopsy,"gender: male;	age: 62;	donor death: Trauma;	last donor creatinine: 0.99;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489170,GPL6480,41093,Control,Normal,Control,,0,1,0,59,,,,,I36,Kidney Biopsy,"gender: female;	age: 59;	donor death: Cerebrovascular;	last donor creatinine: 0.46;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489171,GPL6480,41093,Control,Normal,Control,,0,1,1,67,,,,,I04,Kidney Biopsy,"gender: male;	age: 67;	donor death: Trauma;	last donor creatinine: 0.9;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489172,GPL6480,41093,Control,Normal,Control,,0,1,1,56,,,,,T15,Kidney Biopsy,"gender: male;	age: 56;	donor death: Cerebrovascular;	last donor creatinine: 0.70;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489173,GPL6480,41093,Control,Normal,Control,,0,1,0,68,,,,,V11,Kidney Biopsy,"gender: female;	age: 68;	donor death: Cerebrovascular;	last donor creatinine: 0.7;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489174,GPL6480,41093,Control,Normal,Control,,0,1,0,82,,,,,T23,Kidney Biopsy,"gender: female;	age: 82;	donor death: Cerebrovascular;	last donor creatinine: 0.5;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489175,GPL6480,41093,Control,Normal,Control,,0,1,1,21,,,,,V01,Kidney Biopsy,"gender: male;	age: 21;	donor death: Trauma;	last donor creatinine: 0.6;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489176,GPL6480,41093,Control,Normal,Control,,0,1,1,68,,,,,T21,Kidney Biopsy,"gender: male;	age: 68;	donor death: Cerebrovascular;	last donor creatinine: 1.00;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE60807,GSM1489177,GPL6480,41093,Control,Normal,Control,,0,1,0,27,,,,,T20,Kidney Biopsy,"gender: female;	age: 27;	donor death: Cerebrovascular;	last donor creatinine: 0.60;	tissue: kidney",,,,"Renal Gene Expression;	Total RNA incl. miRNA",total RNA,Homo sapiens
GSE66494,GSM1623299,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_01,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #01;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#01; Renal biopsy specimens #01 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623300,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_02,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #02;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#02; Renal biopsy specimens #02 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623301,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_03,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #03;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#03; Renal biopsy specimens #03 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623302,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_04,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #04;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#04; Renal biopsy specimens #04 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623303,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_05,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #05;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#05; Renal biopsy specimens #05 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623304,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_06,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #06;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#06; Renal biopsy specimens #06 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623305,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_07,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #07;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#07; Renal biopsy specimens #07 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623306,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_08,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #08;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#08; Renal biopsy specimens #08 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623307,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_09,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #09;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#09; Renal biopsy specimens #09 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623308,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_10,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #10;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#10; Renal biopsy specimens #10 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623309,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_11,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #11;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#11; Renal biopsy specimens #11 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623310,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_12,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #12;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#12; Renal biopsy specimens #12 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623311,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_13,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #13;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#13; Renal biopsy specimens #13 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623312,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_14,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #14;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#14; Renal biopsy specimens #14 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623313,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_15,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #15;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#15; Renal biopsy specimens #15 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623314,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_16,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #16;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#16; Renal biopsy specimens #16 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623315,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_17,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #17;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#17; Renal biopsy specimens #17 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623316,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_18,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #18;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#18; Renal biopsy specimens #18 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623317,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_19,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #19;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#19; Renal biopsy specimens #19 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623318,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_20,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #20;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#20; Renal biopsy specimens #20 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623319,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_21,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #21;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#21; Renal biopsy specimens #21 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623320,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_22,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #22;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#22; Renal biopsy specimens #22 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623321,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_23,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #23;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#23; Renal biopsy specimens #23 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623322,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_24,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #24;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#24; Renal biopsy specimens #24 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623323,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_26,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #26;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#26; Renal biopsy specimens #26 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623324,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_27,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #27;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#27; Renal biopsy specimens #27 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623325,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_28,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #28;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#28; Renal biopsy specimens #28 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623326,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_29,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #29;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#29; Renal biopsy specimens #29 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623327,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_30,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #30;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#30; Renal biopsy specimens #30 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623328,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_31,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #31;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#31; Renal biopsy specimens #31 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623329,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_32,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #32;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#32; Renal biopsy specimens #32 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623330,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_33,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #33;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#33; Renal biopsy specimens #33 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623331,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_34,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #34;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#34; Renal biopsy specimens #34 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623332,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_35,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #35;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#35; Renal biopsy specimens #35 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623333,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_36,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #36;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#36; Renal biopsy specimens #36 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623334,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_37,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #37;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#37; Renal biopsy specimens #37 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623335,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_38,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #38;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#38; Renal biopsy specimens #38 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623336,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_39,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #39;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#39; Renal biopsy specimens #39 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623337,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_40,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #40;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#40; Renal biopsy specimens #40 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623338,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_41,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #41;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#41; Renal biopsy specimens #41 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623339,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_42,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #42;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#42; Renal biopsy specimens #42 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623340,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_43,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #43;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#43; Renal biopsy specimens #43 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623341,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_44,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #44;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#44; Renal biopsy specimens #44 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623342,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_45,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #45;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#45; Renal biopsy specimens #45 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623343,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_46,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #46;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#46; Renal biopsy specimens #46 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623344,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_47,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #47;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#47; Renal biopsy specimens #47 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623345,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_48,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #48;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#48; Renal biopsy specimens #48 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623346,GPL6480,41000,,CKD,CKD,,,0,,,,,,,Discovery_CKD_49,discovery set_renal biopsy specimen,"study set: discovery set;	sample type: Renal biopsy specimens;	specimen id: #49;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#49; Renal biopsy specimens #49 in discovery set,total RNA,Homo sapiens
GSE66494,GSM1623347,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Discovery_Control_01,discovery set_normal kidney,"study set: discovery set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control1; Normal kidney total RNA in discovery set, replicate1",total RNA,Homo sapiens
GSE66494,GSM1623348,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Discovery_Control_02,discovery set_normal kidney,"study set: discovery set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control2; Normal kidney total RNA in discovery set, replicate2",total RNA,Homo sapiens
GSE66494,GSM1623349,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Discovery_Control_03,discovery set_normal kidney,"study set: discovery set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control3; Normal kidney total RNA in discovery set, replicate3",total RNA,Homo sapiens
GSE66494,GSM1623350,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Discovery_Control_04,discovery set_normal kidney,"study set: discovery set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control4; Normal kidney total RNA in discovery set, replicate4",total RNA,Homo sapiens
GSE66494,GSM1623351,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Discovery_Control_05,discovery set_normal kidney,"study set: discovery set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control5; Normal kidney total RNA in discovery set, replicate5",total RNA,Homo sapiens
GSE66494,GSM1623352,GPL6480,41000,CR,IMD,RPGN,,,0,,,1,70,,,Validation_CKD_01,validation set_renal biopsy specimen,"study set: validation set;	sample type: Renal biopsy specimens;	specimen id: #101;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#101; Renal biopsy specimens #101 in validation set,total RNA,Homo sapiens
GSE66494,GSM1623353,GPL6480,41000,,IMD,Membranous Glomerulonephritis ,,,0,,,1,64,,,Validation_CKD_02,validation set_renal biopsy specimen,"study set: validation set;	sample type: Renal biopsy specimens;	specimen id: #102;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#102; Renal biopsy specimens #102 in validation set,total RNA,Homo sapiens
GSE66494,GSM1623354,GPL6480,41000,CR,IMD,IgAN,,,0,,,1,70,,,Validation_CKD_03,validation set_renal biopsy specimen,"study set: validation set;	sample type: Renal biopsy specimens;	specimen id: #103;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#103; Renal biopsy specimens #103 in validation set,total RNA,Homo sapiens
GSE66494,GSM1623355,GPL6480,41000,CR,noIMD,Diabetic Nephropathy ,,,0,,,0,26,,,Validation_CKD_04,validation set_renal biopsy specimen,"study set: validation set;	sample type: Renal biopsy specimens;	specimen id: #104;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#104; Renal biopsy specimens #104 in validation set,total RNA,Homo sapiens
GSE66494,GSM1623356,GPL6480,41000,CR,noIMD,Chronic Tubulointerstitial nephritis,,,0,,,1,27,,,Validation_CKD_05,validation set_renal biopsy specimen,"study set: validation set;	sample type: Renal biopsy specimens;	specimen id: #105;	tissue: kidney;	disease status: chronic kidney disease (CKD)",,,,#105; Renal biopsy specimens #105 in validation set,total RNA,Homo sapiens
GSE66494,GSM1623357,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Validation_Control_01,validation set_normal kidney,"study set: validation set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control101; Normal kidney total RNA in validation set, replicate1",total RNA,Homo sapiens
GSE66494,GSM1623358,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Validation_Control_02,validation set_normal kidney,"study set: validation set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control102; Normal kidney total RNA in validation set, replicate2",total RNA,Homo sapiens
GSE66494,GSM1623359,GPL6480,41000,Control,Normal,Normal,,,0,,,,,,,Validation_Control_03,validation set_normal kidney,"study set: validation set;	sample type: Normal kidney total RNA;	tissue: kidney;	disease status: normal kidney",,,,"Control103; Normal kidney total RNA in validation set, replicate3",total RNA,Homo sapiens
GSE69438,GSM1701203,GPL11670,17586,,noIMD,Diabetic Nephropathy ,,,0,,,,,,,Diabetic Nephropathy Cprobe_17,Kidney Biopsy from Human Diabetic Nephropathy,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Diabetic Nephropathy kidney,total RNA,Homo sapiens
GSE69438,GSM1701204,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_31,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701205,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_40,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701206,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_13,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701207,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_30,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701208,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_36,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701209,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_1,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701210,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_28,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701211,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_23,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701212,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_38,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701213,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_33,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701214,GPL11670,17586,,noIMD,Focal and Segmental Glomerulosclerosis ,,,0,,,,,,,Focal and Segmental Glomerulosclerosis Cprobe_25,Kidney Biopsy from Human Focal and Segmental Glomerulosclerosis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Focal and Segmental Glomerulosclerosis kidney,total RNA,Homo sapiens
GSE69438,GSM1701215,GPL11670,17586,,noIMD,Hypertensive nephropathy ,,,0,,,,,,,Hypertensive nephropathy Cprobe_42,Kidney Biopsy from Human Hypertensive nephropathy,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Hypertensive nephropathy kidney,total RNA,Homo sapiens
GSE69438,GSM1701216,GPL11670,17586,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy Cprobe_7,Kidney Biopsy from Human IgA Nephropathy,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE69438,GSM1701217,GPL11670,17586,,IMD,IgAN,,,0,,,,,,,IgA Nephropathy Cprobe_8,Kidney Biopsy from Human IgA Nephropathy,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human IgA Nephropathy kidney,total RNA,Homo sapiens
GSE69438,GSM1701218,GPL11670,17586,,noIMD,Minimal Change Disease ,,,0,,,,,,,Minimal Change Disease Cprobe_39,Kidney Biopsy from Human Minimal Change Disease,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Minimal Change Disease kidney,total RNA,Homo sapiens
GSE69438,GSM1701219,GPL11670,17586,,IMD,Membranous Glomerulonephritis ,,,0,,,,,,,Membranous Glomerulonephritis Cprobe_35,Kidney Biopsy from Human Membranous Glomerulonephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701220,GPL11670,17586,,IMD,Membranous Glomerulonephritis ,,,0,,,,,,,Membranous Glomerulonephritis Cprobe_12,Kidney Biopsy from Human Membranous Glomerulonephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701221,GPL11670,17586,,IMD,Membranous Glomerulonephritis ,,,0,,,,,,,Membranous Glomerulonephritis Cprobe_14,Kidney Biopsy from Human Membranous Glomerulonephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701222,GPL11670,17586,,IMD,Membranous Glomerulonephritis ,,,0,,,,,,,Membranous Glomerulonephritis Cprobe_6,Kidney Biopsy from Human Membranous Glomerulonephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Membranous Glomerulonephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701223,GPL11670,17586,,CKD,CKD ,,,0,,,,,,,CKD Cprobe_10,Kidney Biopsy from Human CKD,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human CKD,total RNA,Homo sapiens
GSE69438,GSM1701224,GPL11670,17586,,CKD,CKD ,,,0,,,,,,,CKD Cprobe_11,Kidney Biopsy from Human CKD,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human CKD,total RNA,Homo sapiens
GSE69438,GSM1701225,GPL11670,17586,,CKD,CKD ,,,0,,,,,,,CKD Cprobe_3,Kidney Biopsy from Human CKD,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human CKD,total RNA,Homo sapiens
GSE69438,GSM1701226,GPL11670,17586,,CKD,CKD ,,,0,,,,,,,CKD Cprobe_44,Kidney Biopsy from Human CKD,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human CKD,total RNA,Homo sapiens
GSE69438,GSM1701227,GPL11670,17586,,CKD,CKD ,,,0,,,,,,,CKD Cprobe_24,Kidney Biopsy from Human CKD,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human CKD,total RNA,Homo sapiens
GSE69438,GSM1701228,GPL11670,17586,,CKD,CKD ,,,0,,,,,,,CKD Cprobe_32,Kidney Biopsy from Human CKD,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human CKD,total RNA,Homo sapiens
GSE69438,GSM1701229,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_15,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701230,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_4,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701231,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_41,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701232,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_2,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701233,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_29,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701234,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_43,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701235,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_26,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701236,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_19,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701237,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_21,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701238,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_27,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701239,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_22,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701240,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_16,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701241,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_9,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701242,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_5,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701243,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_18,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69438,GSM1701244,GPL11670,17586,,IMD,LN,,,0,,,,,,,Lupus Nephritis Cprobe_20,Kidney Biopsy from Human Lupus Nephritis,tissue: Tubulointerstitium from kidney biopsy,none,,,Gene Expression data from the tubulointerstitial compartment of human Lupus Nephritis kidney,total RNA,Homo sapiens
GSE69677,GSM1706532,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937345100_A","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937345100_A,total RNA,Homo sapiens
GSE69677,GSM1706533,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937345100_B","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937345100_B,total RNA,Homo sapiens
GSE69677,GSM1706534,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937345100_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937345100_C,total RNA,Homo sapiens
GSE69677,GSM1706535,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937345100_D","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937345100_D,total RNA,Homo sapiens
GSE69677,GSM1706537,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937345100_F","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937345100_F,total RNA,Homo sapiens
GSE69677,GSM1706538,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937345100_G","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937345100_G,total RNA,Homo sapiens
GSE69677,GSM1706540,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937345100_I","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937345100_I,total RNA,Homo sapiens
GSE69677,GSM1706541,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937345100_J","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937345100_J,total RNA,Homo sapiens
GSE69677,GSM1706542,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_A","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_A,total RNA,Homo sapiens
GSE69677,GSM1706543,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_B","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_B,total RNA,Homo sapiens
GSE69677,GSM1706544,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_C,total RNA,Homo sapiens
GSE69677,GSM1706545,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_D","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_D,total RNA,Homo sapiens
GSE69677,GSM1706546,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_E","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_E,total RNA,Homo sapiens
GSE69677,GSM1706547,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_F","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_F,total RNA,Homo sapiens
GSE69677,GSM1706548,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_G","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_G,total RNA,Homo sapiens
GSE69677,GSM1706549,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_I","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_I,total RNA,Homo sapiens
GSE69677,GSM1706551,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419039_K","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419039_K,total RNA,Homo sapiens
GSE69677,GSM1706552,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419042_A","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419042_A,total RNA,Homo sapiens
GSE69677,GSM1706553,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5993419042_B","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5993419042_B,total RNA,Homo sapiens
GSE69677,GSM1706554,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419042_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419042_C,total RNA,Homo sapiens
GSE69677,GSM1706555,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5993419042_D","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5993419042_D,total RNA,Homo sapiens
GSE69677,GSM1706556,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419042_E","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419042_E,total RNA,Homo sapiens
GSE69677,GSM1706557,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5993419042_F","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5993419042_F,total RNA,Homo sapiens
GSE69677,GSM1706558,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419042_G","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419042_G,total RNA,Homo sapiens
GSE69677,GSM1706560,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419042_I","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419042_I,total RNA,Homo sapiens
GSE69677,GSM1706561,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5993419042_J","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5993419042_J,total RNA,Homo sapiens
GSE69677,GSM1706562,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419042_K","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419042_K,total RNA,Homo sapiens
GSE69677,GSM1706563,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5993419042_L","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5993419042_L,total RNA,Homo sapiens
GSE69677,GSM1706564,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329057_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329057_C,total RNA,Homo sapiens
GSE69677,GSM1706565,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329057_E","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329057_E,total RNA,Homo sapiens
GSE69677,GSM1706566,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329057_G","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329057_G,total RNA,Homo sapiens
GSE69677,GSM1706567,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329057_I","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329057_I,total RNA,Homo sapiens
GSE69677,GSM1706568,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329057_K","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329057_K,total RNA,Homo sapiens
GSE69677,GSM1706569,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329079_A","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329079_A,total RNA,Homo sapiens
GSE69677,GSM1706571,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329079_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329079_C,total RNA,Homo sapiens
GSE69677,GSM1706572,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937329079_D","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937329079_D,total RNA,Homo sapiens
GSE69677,GSM1706573,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329079_E","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329079_E,total RNA,Homo sapiens
GSE69677,GSM1706574,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937329079_F","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937329079_F,total RNA,Homo sapiens
GSE69677,GSM1706575,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329079_G","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329079_G,total RNA,Homo sapiens
GSE69677,GSM1706576,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937329079_H","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937329079_H,total RNA,Homo sapiens
GSE69677,GSM1706577,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329079_I","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329079_I,total RNA,Homo sapiens
GSE69677,GSM1706579,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329079_K","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329079_K,total RNA,Homo sapiens
GSE69677,GSM1706580,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5937329079_L","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5937329079_L,total RNA,Homo sapiens
GSE69677,GSM1706581,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_B","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_B,total RNA,Homo sapiens
GSE69677,GSM1706582,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_C,total RNA,Homo sapiens
GSE69677,GSM1706583,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_E","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_E,total RNA,Homo sapiens
GSE69677,GSM1706584,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_F","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_F,total RNA,Homo sapiens
GSE69677,GSM1706585,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_G","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_G,total RNA,Homo sapiens
GSE69677,GSM1706586,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_H","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_H,total RNA,Homo sapiens
GSE69677,GSM1706587,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_I","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_I,total RNA,Homo sapiens
GSE69677,GSM1706589,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419100_K","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419100_K,total RNA,Homo sapiens
GSE69677,GSM1706590,GPL14951,29360,CR,Mixed,Chronic TCMR,,,1,,,,,,,"Chronic TCMR, 5993419100_L","FFPE renal biopsy, chronic TCMR","patient type: chronic T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,5993419100_L,total RNA,Homo sapiens
GSE69677,GSM1706591,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419094_A","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419094_A,total RNA,Homo sapiens
GSE69677,GSM1706592,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419094_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419094_C,total RNA,Homo sapiens
GSE69677,GSM1706593,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419094_E","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419094_E,total RNA,Homo sapiens
GSE69677,GSM1706594,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419094_G","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419094_G,total RNA,Homo sapiens
GSE69677,GSM1706595,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5993419094_I","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5993419094_I,total RNA,Homo sapiens
GSE69677,GSM1706596,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_A","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_A,total RNA,Homo sapiens
GSE69677,GSM1706597,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_B","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_B,total RNA,Homo sapiens
GSE69677,GSM1706598,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_C","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_C,total RNA,Homo sapiens
GSE69677,GSM1706599,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_D","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_D,total RNA,Homo sapiens
GSE69677,GSM1706600,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_E","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_E,total RNA,Homo sapiens
GSE69677,GSM1706601,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_F","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_F,total RNA,Homo sapiens
GSE69677,GSM1706602,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_G","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_G,total RNA,Homo sapiens
GSE69677,GSM1706603,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_I","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_I,total RNA,Homo sapiens
GSE69677,GSM1706604,GPL14951,29360,Control,Normal,Control,,0,1,,,,,,,"Cadaveric Donor, 5937329086_K","FFPE renal biopsy, cadaveric donor","patient type: cadaveric donor;	tissue: renal biopsy",,,,5937329086_K,total RNA,Homo sapiens
GSE69677,GSM1706605,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175132_A","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175132_A,total RNA,Homo sapiens
GSE69677,GSM1706606,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175132_B","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175132_B,total RNA,Homo sapiens
GSE69677,GSM1706607,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175132_C","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175132_C,total RNA,Homo sapiens
GSE69677,GSM1706608,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175132_E","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175132_E,total RNA,Homo sapiens
GSE69677,GSM1706609,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175132_G","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175132_G,total RNA,Homo sapiens
GSE69677,GSM1706610,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175132_I","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175132_I,total RNA,Homo sapiens
GSE69677,GSM1706611,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175132_K","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175132_K,total RNA,Homo sapiens
GSE69677,GSM1706612,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175099_A","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175099_A,total RNA,Homo sapiens
GSE69677,GSM1706613,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175099_C","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175099_C,total RNA,Homo sapiens
GSE69677,GSM1706614,GPL14951,29360,AR,TCMR,Acute TCMR,,,1,,,,,,,"Acute TCMR, 6334175099_E","FFPE renal biopsy, acute TCMR","patient type: acute T-cell mediated rejection (TCMR);	tissue: renal biopsy",,,,6334175099_E,total RNA,Homo sapiens
GSE72925,GSM1874736,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,immunosuppresion,KT1265_2_18_09,kidney biopsy at time of transplantation,"diagnosis: TCMR;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874738,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,immunosuppresion,KT1329_1_26_11,kidney biopsy at time of transplantation,"diagnosis: TCMR;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874740,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,immunosuppresion,KT1508_1_26_11,kidney biopsy at time of transplantation,"diagnosis: TCMR;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874745,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,immunosuppresion,KT595_02-14-07,kidney biopsy after transplantation,"diagnosis: TCMR;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874749,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,immunosuppresion,KT761_02-01-07,kidney biopsy after transplantation,"diagnosis: TCMR;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874751,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,immunosuppresion,KT768-1_1_27_11,kidney biopsy after transplantation,"diagnosis: TCMR;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874752,GPL570,54675,AR,TCMR,TCMR,,,1,,,,,,immunosuppresion,KT869_03-21-07,kidney biopsy after transplantation,"diagnosis: TCMR;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874761,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT1087_2_18_09,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874765,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT1261_2_18_09,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874772,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT1342_2_6_09,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874779,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT335_02-12-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874780,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT337_02-01-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874781,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT350_02-07-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874784,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT409_01-31-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874788,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT466_02-01-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874794,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT539_01-25-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874813,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT952_02-08-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874814,GPL570,54675,CAN,CAN,IFTA,,,1,,,,,,immunosuppresion,KT996_02-08-07,kidney biopsy after transplantation,"diagnosis: IFTA;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874815,GPL570,54675,AR,AR,AR,,,1,,,,,,immunosuppresion,KT1230_1_26_11,kidney biopsy after transplantation,"diagnosis: Normal/BKVB;	tissue: kidney --- NOT TRUE??",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874816,GPL570,54675,STA,STA,Normal/BKVB,,,1,,,,,,immunosuppresion,KT1354_1_26_11_2,kidney biopsy after transplantation,"diagnosis: Normal/BKVB;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874817,GPL570,54675,STA,AR+CAN,Normal/BKVB,,,1,,,,,,immunosuppresion,KT1537_1_26_11,kidney biopsy after transplantation,"diagnosis: Normal/BKVB;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874818,GPL570,54675,STA,STA,Normal/BKVB,,,1,,,,,,immunosuppresion,KT1558_1_26_11,kidney biopsy after transplantation,"diagnosis: Normal/BKVB;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874819,GPL570,54675,STA,STA,Normal/BKVB,,,1,,,,,,immunosuppresion,KT1637_1_27_11,kidney biopsy at time of transplantation,"diagnosis: Normal/BKVB;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874820,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT1006_1_26_11,kidney biopsy at time of transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874833,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT1340_2_6_09,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874838,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT1493_1_26_11,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874839,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT333_01-24-07,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874843,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT392_01-31-07,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874844,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT400_01-25-07,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874846,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT418_02-07-07,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874849,GPL570,54675,CAN,CAN,Normal,,,1,,,,,,immunosuppresion,KT504_01-26-07,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874852,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT542_02-08-07,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874863,GPL570,54675,STA,STA,Normal,,,1,,,,,,immunosuppresion,KT632-1_1_27_11,kidney biopsy at time of transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874867,GPL570,54675,CAN,CAN,Normal,,,1,,,,,,immunosuppresion,KT701_01-25-07,kidney biopsy after transplantation,"diagnosis: Normal;	tissue: kidney",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE72925,GSM1874888,GPL570,54675,CAN,CAN,CAN,,,1,,,,,,immunosuppresion,KT1216_2_24_09,kidney biopsy after transplantation,"diagnosis: PVAN;	tissue: kidney ---- BK nephropathy, Scar, glomerular thrombosis",,,,"Cross-sectional;	kidney tissue",total RNA,Homo sapiens
GSE7392,GSM178455,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#1 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178456,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#1 T=12m),Human kidney bx,12month protocol bx (post-renal transplantation),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178457,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Normal (Norm#1 T=0),Human kidney bx,Time zero bx - Normal pathology,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178458,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,Normal (Norm#1 T=12m),Human kidney bx,T=12m bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178459,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#2 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178460,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#2 T=12m),Human kidney bx,T=12m bx - Fibrotic path (GIF/TA),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178461,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Normal (Norm#2 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178463,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,Normal (Norm#2 T=12m),Human kidney bx,T=12m bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178464,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#3 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178465,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#3 T=12m),Human kidney bx,T=12m bx - Fibrotic path (GIF/TA),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178466,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#4 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178467,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#4 T=12m),Human kidney bx,T=12m bx - Fibrotic path (GIF/TA),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178468,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Normal (Norm#4 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178469,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,Normal (Norm#4 T=12m),Human kidney bx,T=12m bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178470,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#6 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178471,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#6 T=12m),Human kidney bx,T=12m bx - Fibrotic path (GIF/TA),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178472,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Normal (Norm#6 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178473,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,Normal (Norm#6 T=12m),Human kidney bx,T=12m bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178498,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#7 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178500,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#7 T=12m),Human kidney bx,T=12m bx - Fibrotic path (GIF/TA),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178501,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Normal (Norm#8 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178502,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,Normal (Norm#8 T=12m),Human kidney bx,T=12m bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178503,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#9 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178504,GPL570,54675,CR,CAN,IFTA,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#9 T=12m),Human kidney bx,T=12m bx - Fibrotic path (GIF/TA),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178506,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Normal (Norm#10 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178507,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,Normal (Norm#10 T=12m),Human kidney bx,T=12m bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178508,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Normal (Norm#5 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178509,GPL570,54675,NR,STA,Normal,1y,,1,,,,,,,Normal (Norm#5 T=12m),Human kidney bx,T=12m bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178510,GPL570,54675,Control,Normal,Control,0,,1,,,,,,,Subclinical interstitial fibrosis (GIF#8 T=0),Human kidney bx,Time zero bx - Normal path,,,,Standard Affymetrix,total RNA,Homo sapiens
GSE7392,GSM178511,GPL570,54675,CR,CAN,Fibrosis,1y,,1,,,,,,,Subclinical interstitial fibrosis (GIF#8 T=12m),Human kidney bx,T=12m bx - Fibrotic path (GIF/TA),,,,Standard Affymetrix,total RNA,Homo sapiens
GSE76882,GSM2039481,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10140,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039482,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10165,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039483,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10205,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039484,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10206,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039485,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10208,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039486,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 10210,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039487,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10211,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039488,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10218,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039489,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10219,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039490,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10221,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039491,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10222,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039492,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10224,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039493,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10242,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039494,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10266,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039495,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10272,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039496,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10274,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039497,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10275,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039498,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10304,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039499,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10305,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039500,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10306,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039501,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10308,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039502,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10309,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039503,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10312,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039504,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10313,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039505,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10357,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039506,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10403,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039507,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10404,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039508,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10406,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039509,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10407,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039510,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10408,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039511,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10411,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039512,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10413,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039513,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10414,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039514,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10416,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039515,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10417,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039516,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10418,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039517,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10419,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039518,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10420,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039519,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10423,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039520,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10426,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039521,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10427,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039522,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10428,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039523,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10430,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039524,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10431,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039525,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10432,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039526,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10433,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039527,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10434,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039528,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10436,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039529,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10437,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039530,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10438,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039531,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10440,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039532,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10441,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039533,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10445,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039534,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10482,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039535,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10484,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039536,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10485,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039537,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10486,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039538,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10492,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039539,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10495,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039540,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10499,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039541,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10502,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039542,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10503,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039543,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10504,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039544,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10507,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039545,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10508,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039546,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10516,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039547,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10517,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039548,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10518,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039549,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10530,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039550,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10531,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039551,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10532,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039552,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10534,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039553,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10535,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039554,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10536,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039555,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10553,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039556,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10555,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039557,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10556,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039558,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10557,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039559,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10636,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039560,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10637,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039561,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10638,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039562,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10639,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039563,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10640,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039564,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10641,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039565,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10643,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039566,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10645,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039567,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10695,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039568,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10698,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039569,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10702,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039570,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10703,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039571,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10705,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039572,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10730,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039573,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 10731,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039574,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10732,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039575,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 10733,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039576,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10737,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039577,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10774,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039578,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10777,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039579,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10821,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039580,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10843,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039581,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10845,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039582,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10849,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039583,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10850,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039584,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10868,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039585,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10869,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039586,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10870,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039587,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10871,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039588,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10879,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039589,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10880,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039590,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10882,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039591,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10883,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039592,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10884,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039593,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10885,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039594,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10886,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039595,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 10888,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039596,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10898,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039597,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10899,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039598,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10905,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039599,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 10906,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039600,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10911,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039601,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10950,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039602,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10953,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039603,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 10982,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039604,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10988,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039605,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10990,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039606,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10992,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039607,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 10993,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039608,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 10995,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039609,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11008,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039610,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11009,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039611,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11010,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039612,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 11012,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039613,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11013,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039614,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11014,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039615,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11016,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039616,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11017,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039617,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11018,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039618,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11019,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039619,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11020,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039620,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 11024,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039621,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11025,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039622,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11026,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039623,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11027,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039624,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11158,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039625,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11160,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039626,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11162,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039627,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 11266,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039628,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11267,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039629,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11279,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039630,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11282,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039631,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11283,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039632,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11327,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039633,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11331,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039634,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 11332,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039635,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11338,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039636,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11346,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039637,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11349,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039638,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11380,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039639,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11381,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039640,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11382,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039641,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11383,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039642,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11384,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039643,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11416,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039644,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11421,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039645,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11440,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039646,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11443,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039647,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11444,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039648,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 11446,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039649,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11447,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039650,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11448,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039651,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11449,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039652,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11450,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039653,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11497,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039654,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11521,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039655,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11522,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039656,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11570,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039657,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11571,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039658,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 11584,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039659,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11593,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039660,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11597,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039661,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11599,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039662,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 11601,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039663,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 11690,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039664,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11691,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039665,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11692,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039666,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11872,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039667,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 11946,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039668,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11948,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039669,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11949,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039670,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11950,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039671,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 11951,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039672,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11952,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039673,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 11953,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039674,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12011,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039675,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12012,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039676,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12064,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039677,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12067,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039678,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 12071,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039679,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 12072,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039680,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 12144,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039681,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 12145,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039682,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 12146,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039683,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 12147,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039684,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 12148,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039685,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12149,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039686,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12251,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039687,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12252,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039688,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12253,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039689,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12254,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039690,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12256,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039691,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12263,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039692,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12311,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039693,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 12313,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039694,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12314,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039695,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 12317,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039696,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 12318,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039697,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12432,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039698,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 12434,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039699,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12686,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039700,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 12692,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039701,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12694,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039702,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12700,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039703,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12704,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039704,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12706,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039705,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12717,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039706,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12720,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039707,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12725,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039708,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12726,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039709,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12727,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039710,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12728,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039711,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12729,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039712,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12730,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039713,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12731,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039714,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12732,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039715,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12733,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039716,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12734,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039717,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12750,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039718,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12751,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039719,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,IFTA_AR 12752,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation with acute rejection IFTA_AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039720,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12753,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039721,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12754,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039722,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12755,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039723,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12756,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039724,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12757,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039725,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12759,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039726,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12760,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039727,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12761,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039728,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12867,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039729,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12868,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039730,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12869,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039731,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12870,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039732,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12871,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039733,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12872,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039734,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12875,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039735,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12880,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039736,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12891,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039737,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12893,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039738,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12894,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039739,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12935,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039740,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12936,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039741,GPL13158,17564,NR,DGF,ADNR,,,1,,,,,,,ADNR 12943,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: acute dysfunction but no rejection ADNR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039742,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12944,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039743,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12946,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039744,GPL13158,17564,CR,CAN,IFTA_i,,,1,,,,,,,IFTA_i 12947,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with inflammation IFTA_i",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039745,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12948,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039746,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12949,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039747,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 12960,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039748,GPL13158,17564,CR,CAN,IFTA,,,1,,,,,,,IFTA 12961,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy IFTA",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039749,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 20020,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039750,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 20024,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039751,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 20046,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039752,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 20053,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039753,GPL13158,17564,AR,AR+CAN,IFTA_AR,,,1,,,,,,,AR 20061,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: Interstitial fibrosis and tubular atrophy with acute rejection AR",N/A,,,,total RNA,Homo sapiens
GSE76882,GSM2039754,GPL13158,17564,NR,STA,Normal,,,1,,,,,,,TX 20068,Kidney Biopsy Tissue,"tissue: Kidney Biopsy Tissue;	disease state: normal functioning transplants TX",N/A,,,,total RNA,Homo sapiens
GSE82337,GSM2190622,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx1,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190623,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx2,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190624,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx3,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190625,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx4,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190626,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx5,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190627,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx6,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190628,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx7,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190629,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx8,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190630,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx9,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190631,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx10,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190632,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx11,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190633,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx12,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190634,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx13,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190635,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx14,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190637,GPL10558,47323,,,XM+,10d,1,1,,,,,,none,10d_XM+_NoC5_Bx15,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190638,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx1,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190639,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx2,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190640,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx3,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190641,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx4,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190642,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx5,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190644,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx6,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190646,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx7,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190647,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx8,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190649,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx9,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190650,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx10,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190651,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx11,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190652,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx12,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190654,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx13,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190655,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx14,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190656,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx15,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190658,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx16,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190659,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx17,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190660,GPL10558,47323,,,XM+,10d,1,1,,,,,,Eculizumab,10d_XM+_C5+_On_Bx18,Kidney_10d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 10d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190662,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx1,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190663,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx2,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190664,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx3,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190665,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx4,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190667,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx5,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190668,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx6,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190669,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx7,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190670,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx8,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190672,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx9,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190673,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx10,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190674,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx11,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190676,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx12,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190677,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx13,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190678,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_NoC5_Bx14,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_NoC5;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190680,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx1,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190681,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx2,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190682,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx3,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190683,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx4,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190685,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx5,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190686,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx6,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190687,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx7,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190689,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx8,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190690,GPL10558,47323,,,XM+,90d,1,1,,,,,,Eculizumab,90d_XM+_C5+_On_Bx9,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_On;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190691,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx10,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190693,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx11,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190694,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx12,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190696,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx13,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190697,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx14,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190698,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx15,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190700,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx16,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190701,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx17,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190702,GPL10558,47323,,,XM+,90d,1,1,,,,,,none,90d_XM+_C5+_Off_Bx18,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM+_C5+_Off;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190704,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx1,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190705,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx2,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190706,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx3,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190707,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx4,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190708,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx5,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190709,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx6,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190710,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx7,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190711,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx8,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190712,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx9,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190713,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx10,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190714,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx11,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190715,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx12,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE82337,GSM2190716,GPL10558,47323,,,XM-,90d,1,1,,,,,,,90d_XM-_Bx13,Kidney_90d_protocol,"tissue: kidney;	crossmatch type (positive =xm+, negative =xm-): XM-;	protocol duration: 90d",Specimens are frozen in RNALater and stored at -80 oC until use.,,,18-gauge kidney allograft biopsy,total RNA,Homo sapiens
GSE9493,GSM240785,GPL570,54675,AR,TCMR,AR IA,,1,1,,,1,52,,,"Patient TX40, renal graft bx 1.48, diagnosis AR IA",Acute rejection biopsy type IA from human kidney allograft,"Patient identifier: TX40, Sex: male, Age of patient: 52, Renal graft bx: 1.48, Banff'97: AR IA,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IA.,total RNA,Homo sapiens
GSE9493,GSM240786,GPL570,54675,AR,TCMR,AR IA,,0,1,,,1,41,,,"Patient TX22, renal graft bx 1.27, diagnosis AR IA",Acute rejection biopsy type IA from human kidney allograft,"Patient identifier: TX22, Sex: male, Age of patient: 41, Type of donor: deceased, Serum creatinine: 187 microMol/L/L, Renal graft bx: 1.27, Banff'97: AR IA,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IA.,total RNA,Homo sapiens
GSE9493,GSM240787,GPL570,54675,AR,TCMR,AR IA,,0,1,,,1,47,,,"Patient TX01, renal graft bx 1.15, diagnosis AR IA",Acute rejection biopsy type IA from human kidney allograft,"Patient identifier: TX01, Sex: male, Age of patient: 47, Type of donor: deceased, Serum creatinine: 230 microMol/L/L, Renal graft bx: 1.15, Banff'97: AR IA,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IA.,total RNA,Homo sapiens
GSE9493,GSM240788,GPL570,54675,AR,TCMR,AR IB,,0,1,,,0,54,,,"Patient TX25, renal graft bx 1.31, diagnosis AR IB",Acute rejection biopsy type IB from human kidney allograft,"Patient identifier: TX25, Sex: female, Age of patient: 54, Type of donor: deceased, Serum creatinine: 466 microMol/L/L, Renal graft bx: 1.31, Banff'97: AR IB,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IB.,total RNA,Homo sapiens
GSE9493,GSM240789,GPL570,54675,AR,TCMR,AR IB,,0,1,,,1,22,,,"Patient TX03, renal graft bx 1.03, diagnosis AR IB",Acute rejection biopsy type IB from human kidney allograft,"Patient identifier: TX03, Sex: male, Age of patient: 22, Type of donor: deceased, Serum creatinine: 161 microMol/L/L, Renal graft bx: 1.03, Banff'97: AR IB,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IB.,total RNA,Homo sapiens
GSE9493,GSM240790,GPL570,54675,AR,TCMR,AR IB,,0,1,,,1,35,,,"Patient TX20, renal graft bx 1.25, diagnosis AR IB",Acute rejection biopsy type IB from human kidney allograft,"Patient identifier: TX25, Sex: male, Age of patient: 35, Type of donor: deceased, Serum creatinine: 171 microMol/L/L, Renal graft bx: 1.25, Banff'97: AR IB,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IB.,total RNA,Homo sapiens
GSE9493,GSM240791,GPL570,54675,AR,TCMR,AR IIA,,0,1,,,1,53,,,"Patient TX11, renal graft bx 1.12, diagnosis AR IIA",Acute rejection biopsy type IIA from human kidney allograft,"Patient identifier: TX11, Sex: male, Age of patient: 53, Type of donor: deceased, Serum creatinine: 228 microMol/L/L, Renal graft bx: 1.12, Banff'97: AR IIA,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IIA.,total RNA,Homo sapiens
GSE9493,GSM240792,GPL570,54675,AR,TCMR,AR IIB,,0,1,,,0,48,,,"Patient TX50, renal graft bx 1.58, diagnosis AR IIB",Acute rejection biopsy type IIB from human kidney allograft,"Patient identifier: TX50, Sex: female, Age of patient: 48, Type of donor: deceased, Serum creatinine: 328 microMol/L/L, Renal graft bx: 1.58, Banff'97: AR IIB,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IIB.,total RNA,Homo sapiens
GSE9493,GSM240793,GPL570,54675,AR,AR+CAN,AR+CAN,,0,1,,,0,45,,,"Patient TX53, renal graft bx 1.62, diagnosis AR+CAN",Biopsy with acute rejection and chronic allograft nephropathy from human transplanted kidney,"Patient identifier: TX53, Sex: female, Age of patient: 45, Type of donor: deceased, Serum creatinine: 122 microMol/L, Renal graft bx: 1.62, Banff'97: AR+CAN,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection plus chronic allograft nephropathy.,total RNA,Homo sapiens
GSE9493,GSM240794,GPL570,54675,AR,AR+CAN,AR+CAN,,0,1,,,0,35,,,"Patient TX58, renal graft bx 1.67, diagnosis AR+CAN",Biopsy with acute rejection and chronic allograft nephropathy from human transplanted kidney,"Patient identifier: TX58, Sex: female, Age of patient: 35, Type of donor: deceased, Serum creatinine: 200 microMol/L, Renal graft bx: 1.67, Banff'97: AR+CAN,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection plus chronic allograft nephropathy.,total RNA,Homo sapiens
GSE9493,GSM240795,GPL570,54675,AR,AR+CAN,AR+CAN,,0,1,,,1,53,,,"Patient TX11, renal graft bx 1.61, diagnosis AR+CAN",Biopsy with acute rejection and chronic allograft nephropathy from human transplanted kidney,"Patient identifier: TX11, Sex: male, Age of patient: 53, Type of donor: deceased, Serum creatinine: 204 microMol/L, Renal graft bx: 1.61, Banff'97: AR+CAN,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection plus chronic allograft nephropathy.,total RNA,Homo sapiens
GSE9493,GSM240796,GPL570,54675,AR,AR+CAN,AR+CAN,,0,1,,,0,34,,,"Patient TX10, renal graft bx 1.11, diagnosis AR+CAN",Biopsy with acute rejection and chronic allograft nephropathy from human transplanted kidney,"Patient identifier: TX10, Sex: female, Age of patient: 34, Type of donor: deceased, Serum creatinine: 356 microMol/L, Renal graft bx: 1.11, Banff'97: AR+CAN,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection plus chronic allograft nephropathy.,total RNA,Homo sapiens
GSE9493,GSM240797,GPL570,54675,AR,AR+CAN,AR+CAN,,0,1,,,0,34,,,"Patient TX10, renal graft bx 1.17, diagnosis AR+CAN",Biopsy with acute rejection and chronic allograft nephropathy from human transplanted kidney,"Patient identifier: TX10, Sex: female, Age of patient: 34, Type of donor: deceased, Serum creatinine: 640 microMol/L, Renal graft bx: 1.17, Banff'97: AR+CAN,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection plus chronic allograft nephropathy.,total RNA,Homo sapiens
GSE9493,GSM240798,GPL570,54675,AR,AR+CAN,AR+CAN,,0,1,,,0,44,,,"Patient TX56, renal graft bx 1.65, diagnosis AR+CAN",Biopsy with acute rejection and chronic allograft nephropathy from human transplanted kidney,"Patient identifier: TX56, Sex: female, Age of patient: 44, Type of donor: deceased, Serum creatinine: 806 microMol/L, Renal graft bx: 1.65, Banff'97: AR+CAN,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection plus chronic allograft nephropathy.,total RNA,Homo sapiens
GSE9493,GSM240799,GPL570,54675,AR,AR+CAN,AR+CAN,,,1,,,1,38,,,"Patient TX54, renal graft bx 1.63, diagnosis AR+CAN",Biopsy with acute rejection and chronic allograft nephropathy from human transplanted kidney,"Patient identifier: TX54, Sex: male, Age of patient: 38, Serum creatinine: 900 microMol/L, Renal graft bx: 1.65, Banff'97: AR+CAN,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection plus chronic allograft nephropathy.,total RNA,Homo sapiens
GSE9493,GSM240800,GPL570,54675,AR,Mixed,BL,,0,1,,,0,29,,,"Patient TX06, renal graft bx 1.07, diagnosis borderline changes",Biopsy with borderline rejection / suspicious changes from human kidney allograft,"Patient identifier: TX06, Sex: female, Age of patient: 29, Type of donor: deceased, Serum creatinine: 199 microMol/L, Renal graft bx: 1.07, Banff'97: borderline changes,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of borderline changes.,total RNA,Homo sapiens
GSE9493,GSM240801,GPL570,54675,AR,Mixed,BL,,0,1,,,0,29,,,"Patient TX06, renal graft bx 1.06, diagnosis borderline changes",Biopsy with borderline rejection / suspicious changes from human kidney allograft,"Patient identifier: TX06, Sex: female, Age of patient: 29, Type of donor: deceased, Serum creatinine: 200 microMol/L, Renal graft bx: 1.06, Banff'97: borderline changes,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of borderline changes.,total RNA,Homo sapiens
GSE9493,GSM240802,GPL570,54675,AR,Mixed,BL,,0,1,,,1,46,,,"Patient TX01, renal graft bx 1.01, diagnosis borderline changes",Biopsy with borderline rejection / suspicious changes from human kidney allograft,"Patient identifier: TX01, Sex: male, Age of patient: 46, Type of donor: deceased, Serum creatinine: 270 microMol/L, Renal graft bx: 1.01, Banff'97: borderline changes,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of borderline changes.,total RNA,Homo sapiens
GSE9493,GSM240803,GPL570,54675,CR,CAN,CAN I,,0,1,,,1,67,,,"Patient TX42, renal graft bx 1.50, diagnosis CAN I",Chronic allograft nephropathy biopsy grade I from human transplanted kidney,"Patient identifier: TX42, Sex: male, Age of patient: 67, Type of donor: deceased, Serum creatinine: 110 microMol/L, Renal graft bx: 1.50, Banff'97: CAN I,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade I.,total RNA,Homo sapiens
GSE9493,GSM240804,GPL570,54675,CR,CAN,CAN I,,,1,,,1, ,,,"Patient TX02, renal graft bx 1.02, diagnosis CAN I",Chronic allograft nephropathy biopsy grade I from human transplanted kidney,"Patient identifier: TX02, Sex: male, Serum creatinine: 120 microMol/L, Renal graft bx: 1.02, Banff'97: CAN I,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade I.,total RNA,Homo sapiens
GSE9493,GSM240805,GPL570,54675,CR,CAN,CAN I,,,1,,,0,27,,,"Patient TX52, renal graft bx 1.60, diagnosis CAN I",Chronic allograft nephropathy biopsy grade I from human transplanted kidney,"Patient identifier: TX52, Sex: female, Age of patient: 27, Serum creatinine: 121 microMol/L, Renal graft bx: 1.60, Banff'97: CAN I,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade I.,total RNA,Homo sapiens
GSE9493,GSM240806,GPL570,54675,CR,CAN,CAN I,,,1,,,1,55,,,"Patient TX51, renal graft bx 1.59, diagnosis CAN I",Chronic allograft nephropathy biopsy grade I from human transplanted kidney,"Patient identifier: TX51, Sex: male, Age of patient: 55, Serum creatinine: 267 microMol/L, Renal graft bx: 1.59, Banff'97: CAN I,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade I.,total RNA,Homo sapiens
GSE9493,GSM240807,GPL570,54675,CR,CAN,CAN II,,0,1,,,0,46,,,"Patient TX23, renal graft bx 1.29, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX23, Sex: female, Age of patient: 46, Type of donor: deceased, Serum creatinine: 161 microMol/L, Renal graft bx: 1.29, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240808,GPL570,54675,CR,CAN,CAN II,,0,1,,,0,47,,,"Patient TX31, renal graft bx 1.38, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX31, Sex: female, Age of patient: 47, Type of donor: deceased, Serum creatinine: 167 microMol/L, Renal graft bx: 1.38, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240809,GPL570,54675,CR,CAN,CAN II,,1,1,,,0,24,,,"Patient TX33, renal graft bx 1.40, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX33, Sex: female, Age of patient: 24, Type of donor: living, Serum creatinine: 175 microMol/L, Renal graft bx: 1.40, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240810,GPL570,54675,CR,CAN,CAN II,,0,1,,,1,59,,,"Patient TX46, renal graft bx 1.54, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX46, Sex: male, Age of patient: 59, Type of donor: deceased, Serum creatinine: 200 microMol/L, Renal graft bx: 1.54, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240811,GPL570,54675,CR,CAN,CAN II,,0,1,,,1,49,,,"Patient TX44, renal graft bx 1.52, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX44, Sex: male, Age of patient: 49, Type of donor: deceased, Serum creatinine: 182 microMol/L, Renal graft bx: 1.52, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240812,GPL570,54675,CR,CAN,CAN II,,0,1,,,1,60,,,"Patient TX48, renal graft bx 1.56, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX48, Sex: male, Age of patient: 60, Type of donor: deceased, Serum creatinine: 186 microMol/L, Renal graft bx: 1.56, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240813,GPL570,54675,CR,CAN,CAN II,,0,1,,,0,60,,,"Patient TX13, renal graft bx 1.16, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX13, Sex: female, Age of patient: 60, Type of donor: deceased, Serum creatinine: 332 microMol/L, Renal graft bx: 1.16, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240814,GPL570,54675,CR,CAN,CAN II,,0,1,,,1,43,,,"Patient TX45, renal graft bx 1.53, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX45, Sex: male, Age of patient: 43, Type of donor: deceased, Serum creatinine: 200 microMol/L, Renal graft bx: 1.53, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240815,GPL570,54675,CR,CAN,CAN II,,,1,,,0,43,,,"Patient TX55, renal graft bx 1.64, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX55, Sex: female, Age of patient: 43, Serum creatinine: 240 microMol/L, Renal graft bx: 1.64, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240816,GPL570,54675,CR,CAN,CAN II,,0,1,,,0,45,,,"Patient TX49, renal graft bx 1.57, diagnosis CAN II",Chronic allograft nephropathy biopsy grade II from human transplanted kidney,"Patient identifier: TX49, Sex: female, Age of patient: 45, Type of donor: deceased, Serum creatinine: 298 microMol/L, Renal graft bx: 1.57, Banff'97: CAN II,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade II.,total RNA,Homo sapiens
GSE9493,GSM240817,GPL570,54675,CR,CAN,CAN III,,0,1,,,1,55,,,"Patient TX38, renal graft bx 1.46, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX38, Sex: male, Age of patient: 55, Type of donor: deceased, Serum creatinine: 201 microMol/L, Renal graft bx: 1.46, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240818,GPL570,54675,CR,CAN,CAN III,,0,1,,,1,45,,,"Patient TX24, renal graft bx 1.30, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX24, Sex: male, Age of patient: 45, Type of donor: deceased, Serum creatinine: 210 microMol/L, Renal graft bx: 1.30, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240819,GPL570,54675,CR,CAN,CAN III,,0,1,,,1,61,,,"Patient TX34, renal graft bx 1.42, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX34, Sex: male, Age of patient: 61, Type of donor: deceased, Serum creatinine: 250 microMol/L, Renal graft bx: 1.42, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240820,GPL570,54675,CR,CAN,CAN III,,1,1,,,1,40,,,"Patient TX29, renal graft bx 1.36, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX29, Sex: male, Age of patient: 40, Type of donor: living, Serum creatinine: 427 microMol/L, Renal graft bx: 1.36, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240821,GPL570,54675,CR,CAN,CAN III,,0,1,,,1,39,,,"Patient TX07, renal graft bx 1.08, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX07, Sex: male, Age of patient: 39, Type of donor: deceased, Serum creatinine: 495 microMol/L, Renal graft bx: 1.08, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240822,GPL570,54675,CR,CAN,CAN III,,,1,,,1,33,,,"Patient TX26, renal graft bx 1.32, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX26, Sex: male, Age of patient: 33, Serum creatinine: 572 microMol/L, Renal graft bx: 1.32, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240823,GPL570,54675,CR,CAN,CAN III,,0,1,,,1,39,,,"Patient TX04, renal graft bx 1.04, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX04, Sex: male, Age of patient: 39, Type of donor: deceased, Renal graft bx: 1.04, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240824,GPL570,54675,CR,CAN,CAN III,,,1,,,1,58,,,"Patient TX32, renal graft bx 1.39, diagnosis CAN III",Chronic allograft nephropathy biopsy grade III from human transplanted kidney,"Patient identifier: TX32, Sex: male, Age of patient: 58, Serum creatinine: 1000 microMol/L, Renal graft bx: 1.39, Banff'97: CAN III,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade III.,total RNA,Homo sapiens
GSE9493,GSM240825,GPL570,54675,NR,STA,NR,,0,1,,,1, ,,,"Patient TX41, renal graft bx 1.49, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: TX49, Sex: male, Type of donor: deceased, Serum creatinine: 104 microMol/L, Renal graft bx: 1.49, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240826,GPL570,54675,NR,STA,NR,,0,1,,,1,42,,,"Patient TX21, renal graft bx 1.26, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: TX21, Sex: male, Age of patient: 42, Type of donor: deceased, Serum creatinine: 118 microMol/L, Renal graft bx: 1.26, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240827,GPL570,54675,NR,STA,NR,,,1,,,1,33,,,"Patient TX12, renal graft bx 1.13, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: TX12, Sex: male, Age of patient: 33, Serum creatinine: 130 microMol/L, Renal graft bx: 1.13, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240828,GPL570,54675,NR,STA,NR,,0,1,,,1,33,,,"Patient TX08, renal graft bx 1.09, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: TX08, Sex: male, Age of patient: 33, Type of donor: deceased, Serum creatinine: 158 microMol/L, Renal graft bx: 1.09, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240829,GPL570,54675,NR,STA,NR,,0,1,,,0,54,,,"Patient TX25, renal graft bx 1.33, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: TX25, Sex: female, Age of patient: 54, Type of donor: deceased, Serum creatinine: 192 microMol/L, Renal graft bx: 1.33, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240830,GPL570,54675,NR,STA,NR,,1,1,,,1,43,,,"Patient TX37, renal graft bx 1.45, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: TX37, Sex: male, Age of patient: 43, Type of donor: living, Serum creatinine: 199 microMol/L, Renal graft bx: 1.45, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240831,GPL570,54675,NR,STA,NR,,1,1,,,1,54,,,"Patient TX27, renal graft bx 1.34, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: TX27, Sex: male, Age of patient: 54, Type of donor: living, Serum creatinine: 219 microMol/L, Renal graft bx: 1.34, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240832,GPL570,54675,Control,Normal,Control,,,1,,,0,61,,,"Patient C01, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C01, Sex: female, Age of patient: 61, Serum creatinine: 65 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240833,GPL570,54675,Control,Normal,Control,,,1,,,1,71,,,"Patient C03, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C03, Sex: male, Age of patient: 71, Serum creatinine: 61 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240834,GPL570,54675,Control,Normal,Control,,,1,,,1,28,,,"Patient C04, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C04, Sex: male, Age of patient: 28, Serum creatinine: 75 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240835,GPL570,54675,Control,Normal,Control,,,1,,,0,37,,,"Patient C05, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C05, Sex: female, Age of patient: 37, Serum creatinine: 36 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240836,GPL570,54675,Control,Normal,Control,,,1,,,1,44,,,"Patient C06, control kidney from nephrectomy, with clamping",Human control kidney from nephrectomy,"Patient identifier: C06, Sex: male, Age of patient: 44, Serum creatinine: 88 microMol/L, Control kidney from nephrectomy sample with clamping",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240837,GPL570,54675,Control,Normal,Control,,,1,,,1,44,,,"Patient C06, control kidney from nephrectomy, without clamping",Human control kidney from nephrectomy,"Patient identifier: C06, Sex: male, Age of patient: 44, Serum creatinine: 88 microMol/L, Control kidney from nephrectomy sample without clamping",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240838,GPL570,54675,Control,Normal,Control,,,1,,,1,64,,,"Patient C10, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C10, Sex: male, Age of patient: 64, Serum creatinine: 91 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240839,GPL570,54675,Control,Normal,Control,,,1,,,1,82,,,"Patient C11, control kidney from nephrectomy, cortex",Human control kidney from nephrectomy,"Patient identifier: C11, Sex: male, Age of patient: 82, Serum creatinine: 113 microMol/L, Control kidney sample (cortex)  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240840,GPL570,54675,Control,Normal,Control,,,1,,,1,82,,,"Patient C11, control kidney from nephrectomy, cortex + medulla",Human control kidney from nephrectomy,"Patient identifier: C11, Sex: male, Age of patient: 82, Serum creatinine: 113 microMol/L, Control kidney sample (cortex+medulla)  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240841,GPL570,54675,Control,Normal,Control,,,1,,,1,76,,,"Patient C13, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C13, Sex: male, Age of patient: 76, Serum creatinine: 88 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240842,GPL570,54675,Control,Normal,Control,,,1,,,1,74,,,"Patient C14, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C14, Sex: male, Age of patient: 74, Serum creatinine: 107 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240843,GPL570,54675,Control,Normal,Control,,,1,,,1,60,,,"Patient C15, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C15, Sex: male, Age of patient: 60, Serum creatinine: 93 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240844,GPL570,54675,Control,Normal,Control,,,1,,,1,71,,,"Patient C16, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: C16, Sex: male, Age of patient: 71, Serum creatinine: 114 microMol/L, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240943,GPL570,54613,CR,CAN,CAN I,,0,1,,,1,42,,,"Patient 1-ME, renal graft bx, diagnosis CAN I",Chronic allograft nephropathy biopsy grade I from human transplanted kidney,"Patient identifier: 1-ME, Sex: male, Age of patient: 42, Type of donor: deceased, Serum creatinine: 177 microMol/L, Renal graft bx: 1-ME, Banff'97: CAN I,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade I.,total RNA,Homo sapiens
GSE9493,GSM240944,GPL570,54613,CR,CAN,CAN I,,0,1,,,1,57,,,"Patient 3-AO, renal graft bx, diagnosis CAN I",Chronic allograft nephropathy biopsy grade I from human transplanted kidney,"Patient identifier: 3-AO, Sex: male, Age of patient: 57, Type of donor: deceased, Serum creatinine: 131 microMol/L, Renal graft bx: 3-AO, Banff'97: CAN I,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade I.,total RNA,Homo sapiens
GSE9493,GSM240945,GPL570,54613,CR,CAN,CAN I,,,1,,,1,35,,,"Patient 4-MS, renal graft bx, diagnosis CAN I",Chronic allograft nephropathy biopsy grade I from human transplanted kidney,"Patient identifier: 4-MS, Sex: male, Age of patient: 35, Serum creatinine: 231 microMol/L, Renal graft bx: 4-MS, Banff'97: CAN I,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of chronic allograft nephropathy grade I.,total RNA,Homo sapiens
GSE9493,GSM240946,GPL570,54613,NR,STA,NR,,0,1,,,1, ,,,"Patient 70-PJ, renal graft bx, diagnosis non-rejecting",Biopsy from non-rejecting human kidney allograft,"Patient identifier: 70-PJ, Sex: male, Type of donor: deceased, Serum creatinine: 128 microMol/L, Renal graft bx: 70-PJ, Banff'97: non-rejecting,",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection.,total RNA,Homo sapiens
GSE9493,GSM240947,GPL570,54613,Control,Normal,Control,,,1,,,, ,,,"Patient 281004-L7, control kidney from nephrectomy",Human control kidney from nephrectomy,"Patient identifier: 281004-L7, Control kidney sample  from nephrectomy",,,,Gene expression data from human normal adult kidney (from nephrectomy).,total RNA,Homo sapiens
GSE9493,GSM240948,GPL570,54613,Control,Normal,Healthy,,,0,,,1,24-26-46-49-62,,,"Human adult normal kidney control, pool of 5 samples",Human control kidney (pool of 5 adult healthy samples),"Pool of 5 normal adult kidney samples, Sex: male, Age: 24-26-46-49-62, Lot#A507273",,,,Gene expression data from human normal adult kidney (commercial pool),total RNA,Homo sapiens
GSE9493,GSM442670,GPL570,54675,NR,STA,NR,,,1,,,0,53,,,"Patient 4285557, renal graft bx Z01, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 4285557;	sex: female;	age of patient: 53;	serum creatinine: 107 microMol/L;	renal graft bx: Z01;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442671,GPL570,54675,NR,STA,NR,,,1,,,0,52,,,"Patient 7409460, renal graft bx Z02, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 7409460;	sex: female;	age of patient: 52;	serum creatinine: n.d. Renal graft bx: Z02;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442672,GPL570,54675,AR,Mixed,BL,,,1,,,1,47,,,"Patient 7668988, renal graft bx Z05, diagnosis borderline changes",Biopsy with borderline rejection / suspicious changes from human kidney allograft,"patient identifier: 652033;	sex: male;	age of patient: 47;	serum creatinine: 94 microMol/L;	renal graft bx: Z05;	banff'97: borderline changes",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of borderline changes,total RNA,Homo sapiens
GSE9493,GSM442673,GPL570,54675,NR,STA,NR,,,1,,,1,53,,,"Patient 525928, renal graft bx Z06, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 525928;	sex: male;	age of patient: 53;	serum creatinine: 167 microMol/L;	renal graft bx: Z06;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442674,GPL570,54675,AR,TCMR,"AR IB, IIA",,,1,,,1,53,,,"Patient 525928, renal graft bx Z07, diagnosis AR IB, IIA","Acute rejection biopsy grade Ib, IIA from human transplanted kidney","patient identifier: 525928;	sex: male;	age of patient: 53;	serum creatinine: 163 microMol/L;	renal graft bx: Z07;	banff'97: AR IB, IIA",,,,"Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IB, IIA",total RNA,Homo sapiens
GSE9493,GSM442675,GPL570,54675,NR,STA,NR,,,1,,,1,45,,,"Patient 718181, renal graft bx Z10, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 718181;	sex: male;	age of patient: 45;	serum creatinine: 95 microMol/L;	renal graft bx: Z10;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442676,GPL570,54675,NR,STA,NR,,,1,,,1,45,,,"Patient 718181, renal graft bx Z11, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 718181;	sex: male;	age of patient: 45;	serum creatinine: 106 microMol/L;	renal graft bx: Z11;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442677,GPL570,54675,NR,STA,NR,,,1,,,1,30,,,"Patient 7358285, renal graft bx Z13, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 7358285;	sex: male;	age of patient: 30;	serum creatinine: 159 microMol/L;	renal graft bx: Z13;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442678,GPL570,54675,NR,STA,NR,,,1,,,0,64,,,"Patient 7974116, renal graft bx Z14, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 7974116;	sex: female;	age of patient: 64;	serum creatinine: 115 microMol/L;	renal graft bx: Z14;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442679,GPL570,54675,NR,STA,NR,,,1,,,0,64,,,"Patient 7974116, renal graft bx Z15, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 7974116;	sex: female;	age of patient: 64;	serum creatinine: 114 microMol/L;	renal graft bx: Z15;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442680,GPL570,54675,NR,STA,NR,,,1,,,1,53,,,"Patient 2727137, renal graft bx Z16, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 2727137;	sex: male;	age of patient: 53;	serum creatinine: 117 microMol/L;	renal graft bx: Z16;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442681,GPL570,54675,NR,STA,NR,,,1,,,1,29,,,"Patient 4260341, renal graft bx Z17, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 4260341;	sex: male;	age of patient: 29;	serum creatinine: 152 microMol/L;	renal graft bx: Z17;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442682,GPL570,54675,NR,STA,NR,,,1,,,1,29,,,"Patient 4260341, renal graft bx Z18, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 4260341;	sex: male;	age of patient: 29;	serum creatinine: 108 microMol/L;	renal graft bx: Z18;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442683,GPL570,54675,AR,TCMR,AR IIA,,,1,,,1,59,,,"Patient 4138406, renal graft bx Z19, diagnosis AR IIA",Acute rejection biopsy grade IIB from human transplanted kidney,"patient identifier: 4138406;	sex: male;	age of patient: 59;	serum creatinine: 144 microMol/L;	renal graft bx: Z19;	banff'97: AR IIA",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of acute rejection IIA,total RNA,Homo sapiens
GSE9493,GSM442684,GPL570,54675,NR,STA,NR,,,1,,,0,52,,,"Patient 7409460, renal graft bx Z20, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 7409460;	sex: female;	age of patient: 52;	serum creatinine: n.d. microMol/L;	renal graft bx: Z20;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE9493,GSM442685,GPL570,54675,NR,STA,NR,,,1,,,0,30,,,"Patient 6836879, renal graft bx Z21, diagnosis non-rejecting",Biopsy from non-rejecting human transplanted kidney,"patient identifier: 6836879;	sex: female;	age of patient: 30;	serum creatinine: 94 microMol/L;	renal graft bx: Z21;	banff'97: non-rejecting",,,,Gene expression data from core human renal allograft biopsy (16 gauge) with histological diagnosis of no rejection,total RNA,Homo sapiens
GSE47097,GSM1144714,GPL6883,24526,AR,Mixed,AR,,0,1,0,62,1,54,,,4669609027_A,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1552;	recipient age: 54;	recipient gender: male;	donor age: 62;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: matched;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 20;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 15","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 1,total RNA,Homo sapiens
GSE47097,GSM1144715,GPL6883,24526,AR,Mixed,AR,,0,1,1,32,1,44,,,4669609027_B,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1597;	recipient age: 44;	recipient gender: male;	donor age: 32;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 30;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 8","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 2,total RNA,Homo sapiens
GSE47097,GSM1144716,GPL6883,24526,AR,Mixed,AR,,0,1,1,18,1,67,,,4669609027_C,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1529;	recipient age: 67;	recipient gender: male;	donor age: 18;	donor gender: male;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 34;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 13","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 3,total RNA,Homo sapiens
GSE47097,GSM1144717,GPL6883,24526,AR,Mixed,AR,,1,1,0,48,0,43,,,4669609027_D,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR2268;	recipient age: 43;	recipient gender: female;	donor age: 48;	donor gender: female;	donor type: Living;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 47.11;	delayed graft function: no dialysis postTx;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 12","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 4,total RNA,Homo sapiens
GSE47097,GSM1144718,GPL6883,24526,AR,Mixed,AR,,0,1,1,37,1,42,,,4669609027_E,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1477;	recipient age: 42;	recipient gender: male;	donor age: 37;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 10;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 8","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 5,total RNA,Homo sapiens
GSE47097,GSM1144719,GPL6883,24526,NR,STA,NR,,0,1,0,45,1,40,,,4669609027_F,Control,"sample id no.: CTRL1752;	recipient age: 40;	recipient gender: male;	donor age: 45;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 19;	induction therapy: ATG;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 18","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 6,total RNA,Homo sapiens
GSE47097,GSM1144720,GPL6883,24526,AR,Mixed,AR,,0,1,0,51,1,67,,,4669609027_G,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1603;	recipient age: 67;	recipient gender: male;	donor age: 51;	donor gender: female;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 23;	delayed graft function: dialysis postTx=DGF;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 13","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 7,total RNA,Homo sapiens
GSE47097,GSM1144721,GPL6883,24526,AR,Mixed,AR,,1,1,0,63,1,64,,,4669609027_H,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1685;	recipient age: 64;	recipient gender: male;	donor age: 63;	donor gender: female;	donor type: Living;	hla-a matching: matched;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 3;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 8","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 8,total RNA,Homo sapiens
GSE47097,GSM1144722,GPL6883,24526,AR,Mixed,AR,,0,1,1,57,0,71,,,4669609044_A,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1611;	recipient age: 71;	recipient gender: female;	donor age: 57;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 27;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 15","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 9,total RNA,Homo sapiens
GSE47097,GSM1144723,GPL6883,24526,AR,Mixed,AR,,0,1,1,26,1,43,,,4669609044_B,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1787;	recipient age: 43;	recipient gender: male;	donor age: 26;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 37;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 12","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 10,total RNA,Homo sapiens
GSE47097,GSM1144724,GPL6883,24526,AR,Mixed,AR,,0,1,0,34,1,50,,,4669609044_C,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1467;	recipient age: 50;	recipient gender: male;	donor age: 34;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 28;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 9","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 11,total RNA,Homo sapiens
GSE47097,GSM1144725,GPL6883,24526,AR,Mixed,AR,,0,1,0,35,0,43,,,4669609044_D,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1499;	recipient age: 43;	recipient gender: female;	donor age: 35;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 16;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 39","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 12,total RNA,Homo sapiens
GSE47097,GSM1144726,GPL6883,24526,NR,STA,NR,,0,1,1,51,1,53,,,4669609044_E,Control,"sample id no.: CTRL1660;	recipient age: 53;	recipient gender: male;	donor age: 51;	donor gender: male;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 21;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 12","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 13,total RNA,Homo sapiens
GSE47097,GSM1144727,GPL6883,24526,AR,Mixed,AR,,0,1,0,61,1,59,,,4669609044_F,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1488;	recipient age: 59;	recipient gender: male;	donor age: 61;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 30;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 18","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 14,total RNA,Homo sapiens
GSE47097,GSM1144728,GPL6883,24526,AR,Mixed,AR,,0,1,0,32,1,52,,,4669609044_G,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1843;	recipient age: 52;	recipient gender: male;	donor age: 32;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	cold ischemia time (hours): 23;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 13","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 15,total RNA,Homo sapiens
GSE47097,GSM1144729,GPL6883,24526,AR,Mixed,AR,,0,1,1,54,1,64,,,4669609044_H,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1639;	recipient age: 64;	recipient gender: male;	donor age: 54;	donor gender: male;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 35;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 73","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 16,total RNA,Homo sapiens
GSE47097,GSM1144730,GPL6883,24526,AR,Mixed,AR,,0,1,0,56,1,58,,,4801420004_A,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR2049;	recipient age: 58;	recipient gender: male;	donor age: 56;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 20;	delayed graft function: no dialysis postTx;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 69","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 17,total RNA,Homo sapiens
GSE47097,GSM1144731,GPL6883,24526,AR,Mixed,AR,,1,1,0,47,1,47,,,4801420004_B,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1695;	recipient age: 47;	recipient gender: male;	donor age: 47;	donor gender: female;	donor type: Living;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 25.05;	cold ischemia time (hours): 1;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 13","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 18,total RNA,Homo sapiens
GSE47097,GSM1144732,GPL6883,24526,NR,STA,NR,,0,1,1,37,1,49,,,4801420004_C,Control,"sample id no.: CTRL1648;	recipient age: 49;	recipient gender: male;	donor age: 37;	donor gender: male;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 25;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 39","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 19,total RNA,Homo sapiens
GSE47097,GSM1144733,GPL6883,24526,AR,Mixed,AR,,1,1,0,49,1,30,,,4801420004_D,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR2090;	recipient age: 30;	recipient gender: male;	donor age: 49;	donor gender: female;	donor type: Living;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	delayed graft function: no dialysis postTx;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 61","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 20,total RNA,Homo sapiens
GSE47097,GSM1144734,GPL6883,24526,AR,Mixed,AR,,1,1,1,65,1,33,,,4801420004_E,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1561;	recipient age: 33;	recipient gender: male;	donor age: 65;	donor gender: male;	donor type: Living;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 91.22;	cold ischemia time (hours): 2;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 7","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 21,total RNA,Homo sapiens
GSE47097,GSM1144735,GPL6883,24526,AR,Mixed,AR,,1,1,0,37,1,41,,,4801420004_F,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1874;	recipient age: 41;	recipient gender: male;	donor age: 37;	donor gender: female;	donor type: Living;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	delayed graft function: no dialysis postTx;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 35","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 22,total RNA,Homo sapiens
GSE47097,GSM1144736,GPL6883,24526,AR,Mixed,AR,,0,1,0,52,1,52,,,4801420004_G,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR2006;	recipient age: 52;	recipient gender: male;	donor age: 52;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 79.56;	cold ischemia time (hours): 24;	delayed graft function: no dialysis postTx;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 99","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 23,total RNA,Homo sapiens
GSE47097,GSM1144737,GPL6883,24526,AR,Mixed,AR,,0,1,1,58,0,31,,,4801420004_H,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR2236;	recipient age: 31;	recipient gender: female;	donor age: 58;	donor gender: male;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: >=1 mismatch;	hla-dr matching: matched;	virtual pra: 85.15;	cold ischemia time (hours): 16;	delayed graft function: no dialysis postTx;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 7","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 24,total RNA,Homo sapiens
GSE47097,GSM1144738,GPL6883,24526,AR,Mixed,AR,,0,1,0,43,1,68,,,4801489019_A,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1558;	recipient age: 68;	recipient gender: male;	donor age: 43;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 16;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 13","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 25,total RNA,Homo sapiens
GSE47097,GSM1144739,GPL6883,24526,AR,Mixed,AR,,0,1,0,15,0,25,,,4801489019_B,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1742;	recipient age: 25;	recipient gender: female;	donor age: 15;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 17;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 16","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 26,total RNA,Homo sapiens
GSE47097,GSM1144740,GPL6883,24526,AR,Mixed,AR,,0,1,0,17,1,47,,,4801489019_C,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1579;	recipient age: 47;	recipient gender: male;	donor age: 17;	donor gender: female;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 32.6;	cold ischemia time (hours): 19;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 9","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 27,total RNA,Homo sapiens
GSE47097,GSM1144741,GPL6883,24526,AR,Mixed,AR,,0,1,1,32,0,46,,,4801489019_D,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1444;	recipient age: 46;	recipient gender: female;	donor age: 32;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 36;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 28","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 28,total RNA,Homo sapiens
GSE47097,GSM1144742,GPL6883,24526,AR,Mixed,AR,,1,1,0,61,1,37,,,4801489019_E,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR2174;	recipient age: 37;	recipient gender: male;	donor age: 61;	donor gender: female;	donor type: Living;	hla-a matching: matched;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	delayed graft function: no dialysis postTx;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 22","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 29,total RNA,Homo sapiens
GSE47097,GSM1144743,GPL6883,24526,AR,Mixed,AR,,0,1,0,31,1,50,,,4801489019_F,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1507;	recipient age: 50;	recipient gender: male;	donor age: 31;	donor gender: female;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 24;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 9","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 30,total RNA,Homo sapiens
GSE47097,GSM1144744,GPL6883,24526,AR,Mixed,AR,,0,1,0,32,0,49,,,4801489019_G,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1971;	recipient age: 49;	recipient gender: female;	donor age: 32;	donor gender: female;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: >=1 mismatch;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 15;	delayed graft function: dialysis postTx=DGF;	induction therapy: IL2 receptor MoAb;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 10","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 31,total RNA,Homo sapiens
GSE47097,GSM1144745,GPL6883,24526,AR,Mixed,AR,,1,1,0,22,0,33,,,4801489019_H,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1471;	recipient age: 33;	recipient gender: female;	donor age: 22;	donor gender: female;	donor type: Living;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 18.92;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 3","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 32,total RNA,Homo sapiens
GSE47097,GSM1144746,GPL6883,24526,AR,Mixed,AR,,0,1,1,32,1,55,,,4801489021_A,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1550;	recipient age: 55;	recipient gender: male;	donor age: 32;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 19;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 8","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 33,total RNA,Homo sapiens
GSE47097,GSM1144747,GPL6883,24526,AR,Mixed,AR,,0,1,0,17,0,58,,,4801489021_B,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1578;	recipient age: 58;	recipient gender: female;	donor age: 17;	donor gender: female;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 56.22;	cold ischemia time (hours): 15;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 10","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 34,total RNA,Homo sapiens
GSE47097,GSM1144748,GPL6883,24526,AR,Mixed,AR,,1,1,1,28,1,53,,,4801489021_C,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1705;	recipient age: 53;	recipient gender: male;	donor age: 28;	donor gender: male;	donor type: Living;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 2;	delayed graft function: no dialysis postTx;	maintenance therapy: double therapy;	rejection time (days after transplantation): 9","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 35,total RNA,Homo sapiens
GSE47097,GSM1144749,GPL6883,24526,AR,Mixed,AR,,0,1,1,33,0,25,,,4801489021_D,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1664;	recipient age: 25;	recipient gender: female;	donor age: 33;	donor gender: male;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 19;	delayed graft function: no dialysis postTx;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 53","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 36,total RNA,Homo sapiens
GSE47097,GSM1144750,GPL6883,24526,AR,Mixed,AR,,0,1,1,30,1,24,,,4801489021_E,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1450;	recipient age: 24;	recipient gender: male;	donor age: 30;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: >=1 mismatch;	virtual pra: 0;	cold ischemia time (hours): 26;	delayed graft function: dialysis postTx=DGF;	maintenance therapy: double therapy;	rejection time (days after transplantation): 15","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 37,total RNA,Homo sapiens
GSE47097,GSM1144751,GPL6883,24526,AR,Mixed,AR,,0,1,1,22,1,49,,,4801489021_F,Acute renal allograft rejection - Steroid resistant,"sample id no.: AR1510;	recipient age: 49;	recipient gender: male;	donor age: 22;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 0;	cold ischemia time (hours): 36;	delayed graft function: dialysis postTx=DGF;	maintenance therapy: double therapy;	rejection time (days after transplantation): 12","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 38,total RNA,Homo sapiens
GSE47097,GSM1144752,GPL6883,24526,AR,Mixed,AR,,0,1,0,48,1,40,,,4801489021_G,Acute renal allograft rejection - Steroid responsive,"sample id no.: AR1462;	recipient age: 40;	recipient gender: male;	donor age: 48;	donor gender: female;	donor type: Post mortal;	hla-a matching: matched;	hla-b matching: matched;	hla-dr matching: matched;	virtual pra: 28.9;	cold ischemia time (hours): 26;	delayed graft function: dialysis postTx=DGF;	maintenance therapy: double therapy;	rejection time (days after transplantation): 22","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 39,total RNA,Homo sapiens
GSE47097,GSM1144753,GPL6883,24526,NR,STA,NR,,0,1,1,38,1,28,,,4801489021_H,Control,"sample id no.: CTRL1780;	recipient age: 28;	recipient gender: male;	donor age: 38;	donor gender: male;	donor type: Post mortal;	hla-a matching: >=1 mismatch;	hla-b matching: >=1 mismatch;	hla-dr matching: matched;	virtual pra: 28.02;	cold ischemia time (hours): 14;	maintenance therapy: triple therapy;	rejection time (days after transplantation): 10","All patients who received a renal allograft in our center between 1995 and 2005, and suffered from a histologically proven, first rejection episode, from whom a renal biopsy had been taken prior to the start of anti-rejection treatment, were selected. Only patients receiving pulse therapy with methylprednisolone (3 days with 1 g bolus) as anti-rejection treatment were included. The primary clinical endpoint was response to anti-rejection treatment with methylprednisolone, as described previously (Rekers et al. Transplantation 2012; 94: 596-602). Steroid resistant acute rejection was defined as lack of clinical response to methylprednisolone, and a requirement for anti-thymocyte globulin treatment within 14 days after the start of the steroid therapy. The response to steroid therapy was monitored by creatinine concentration measurements. Maintenance immunosuppression consisted of prednisone and a calcineurin inhibitor (Cyclosporine A or Tacrolimus), with or without Mycophenolate Mofetil.",,,SAMPLE 40,total RNA,Homo sapiens
GSE65326,GSM1592523,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753669160_A,12 month kidney biopsy post transplant,"ifta: 2;	cd68_hpf: 12.82",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592524,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753669160_B,12 month kidney biopsy post transplant,"ifta: 2;	cd68_hpf: 5.66",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592525,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753669160_D,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 15.86",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592526,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753669160_E,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 8.71",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592527,GPL10558,47323,NR,STA,NR,12m,,1,,,,,,,5753669160_F,12 month kidney biopsy post transplant,"ifta: 0;	cd68_hpf: 3.84",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592528,GPL10558,47323,NR,STA,NR,12m,,1,,,,,,,5753669160_G,12 month kidney biopsy post transplant,"ifta: 0;	cd68_hpf: 1.78",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592529,GPL10558,47323,NR,STA,NR,12m,,1,,,,,,,5727946049_E,12 month kidney biopsy post transplant,"ifta: 0;	cd68_hpf: 3.63",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592530,GPL10558,47323,NR,STA,NR,12m,,1,,,,,,,5727946049_F,12 month kidney biopsy post transplant,"ifta: 0;	cd68_hpf: 3.06",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592531,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946049_G,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 7.06",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592532,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946049_H,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 2.42",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592533,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946049_I,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 2.92",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592534,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946049_J,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 1",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592535,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946049_K,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 11.6",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592536,GPL10558,47323,NR,STA,NR,12m,,1,,,,,,,5727946075_F,12 month kidney biopsy post transplant,"ifta: 0;	cd68_hpf: 5",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592537,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946075_I,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 6.41",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592538,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946075_J,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 18.64",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592539,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5727946075_K,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 8.72",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592540,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753677001_B,12 month kidney biopsy post transplant,"ifta: 2;	cd68_hpf: 14.11",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592541,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753677001_C,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 9.78",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592542,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753677001_D,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 5.44",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592543,GPL10558,47323,CR,CAN,IFTA,12m,,1,,,,,,,5753677001_F,12 month kidney biopsy post transplant,"ifta: 1;	cd68_hpf: 23.8",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592544,GPL10558,47323,NR,STA,NR,12m,,1,,,,,,,5753677001_G,12 month kidney biopsy post transplant,"ifta: 0;	cd68_hpf: 1.48",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens
GSE65326,GSM1592545,GPL10558,47323,,,,12m,,1,,,,,,,5753677001_I,12 month kidney biopsy post transplant,"ifta: -;	cd68_hpf: 2.88",,,,12 month kidney biopsy post transplant,total RNA,Homo sapiens